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Abstract of the thesis 
The main purpose of this thesis was to investigate fundamental mechanisms of 
ulcer formation by measurement of plantar pressures in diabetic neuropathic patients, 
who develop plantar ulcers, compared to diabetic patients with ischaemia as well as 
neuropathy, who in sharp contrast, do not normally develop plantar ulcers. 
A methodology has been developed for accurate and reproducible measurement 
of in-shoe foot pressures using F-Scan technology. Cyclic and sustained loading using 
an Instron machine were applied in laboratory conditions to investigate time-dependent 
behaviour of F-Scan insole and procedures for optimal calibration and use were 
suggested. Clinical validation of the methodology was performed using reliability, 
variability and reproducibility tests and from these, specific recommendations were 
derived for the use of F-Scan technique in the clinic. 
This technique showed that in-shoe plantar pressures were considerably elevated 
in neuro-ischaemic feet to an even greater extent than in purely neuropathic feet. 
However the pattern of pressure loading in neuro-ischaemic feet was no different from 
controls, whereas those with pure neuropathy had a variable pressure loading during 
walking. 
Factors which affect foot pressures and methods of reducing them were also 
studied. The reduction in pressure following callus removal was measured, followed by 
an assessment of pressure rise, as callus reforms. A new type of individually moulded 
(ethyl-vinyl-acetate) insert was shown to reduce pressures substantially, especially 
when it has bedded-in. Trainers also had an important, although lesser effect, sometimes 
sufficient for routine use and still preferable to unfitted High Street shoes, with 
considerable saving in cost. 
Another factor in the evolution of foot ulcer might be abnormal microvascular 
responses. Vasodilatation was induced by iontophoresis of acetylcholine (endothelium- 
dependent vasodilator) and sodium nitroprusside (SNP - direct smooth muscle relaxant). 
Responses to acetylcholine were impaired in all diabetic patients, whereas responses to 
SNP were specifically reduced in presence of neuropathy. This new finding could be 
important in pathogenesis of foot abnormalities in diabetes. 
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Chapter 1. DIABETIC FOOT COMPLICATIONS 
1.1 Introduction 
The diabetic foot is one of the most significant complication of diabetes mellitus 
(Frykberg, 1991). Foot problems have a high incidence in patients with diabetes: 60 
000 major lower extremity amputations are performed annually on diabetic patients in 
the USA only, of which 84% are a result of foot ulcers (Levin et al. 1993). 
In the UK more hospital beds are occupied by patients with diabetes who have foot 
problems than all other complications of diabetes combined (Maims, 1968). Diabetic 
foot ulcers are estimated to occur in 15% of all diabetic patients (110 million in the 
world) during their lifetime (Reiber 1996). In Britain the prevalence of foot ulceration 
has been estimated between 5.3% to 7.4% (Veves et al 1992). The associated annual cost 
to the National Health Service for the diabetic foot inpatient care has been conservatively 
estimated to be £223.4 million (Laing et al, 1991). Treatments that reduce hospital stays 
by managing these lesions on an out-patient basis or prevent them occurring would be 
preferred. Recently the St. Vincent Declaration, which has been made in conjunction 
with WHO, aims to reduce the amputation rate by 50%. 
Definition 
The diabetic foot can be defined in two categories: 
1. the purely neuropathic foot, characterised by the presence of neuropathy, but without 
ischaemia. 
2. the neuro-ischaemic foot, characterised by both diabetic neuropathy and peripheral 
vascular disease. 
The correct diagnosis of each type is important, as each has characteristic 
complications, such as different types of ulcer, requiring specific treatment. 
Assessing the vascular status in addition to the neurological status would help in 
diagnosing the type of diabetic foot. Thus the neuropathic foot is diagnosed when 
neuropathy is present but foot pulses are palpable and the ankle-brachial pressure index 
is > 1, whereas the neuro-ischaemic foot is diagnosed when neuropathy is present but 
foot pulses are impalpable and/or Doppler index is < 0.8. 
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Figure 1.1 The diabetic neuropathic foot is warm, dry and usually painless, with 
palpable pulses and abundant callus formation. Its most important and frequent 
complication is the neLironathic ulcer commonly Occurring, on the plantar surface. 
Fig 1.2 The diabetic neuro-ischaemic foot is characterised by neuro-ischaemic 
ulceration on the margins of the foot, and by rest pain and gangrene in the presence of 
peripheral neuropathy. 
There has been little research into causes of neuro-ischaemic ulceration, 
although considerable attention has been paid to the neuropathic ulcer. This introduction 
will review the literature on risk factors associated with ulcer formation in diabetes, 
focusing on the two types of diabetic foot: 
- the diabetic neuropathic foot 
- the diabetic neuro-ischaemic foot. 
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1.2 The diabetic neuropathic foot 
The earliest description of a diabetic neuropathic plantar ulcer was made by Mott 
in 1818 (cited in Croft et al., 1982). These ulcers were recognised as a complication of 
diabetes before 1870 (Faris, 1991), but it was not until the end of the 19th Century that 
hypotheses concerning their aetiology were published. Treves (1884) believed diminished 
"nutrition' of certain parts" of the foot; "dulled" sensation of the sole; and the effects of 
"pressure upon the skin" were "the chief factors in the production of perforating ulcers". 
He thought "disturbance of nutrition" was the most important aetiological factor after 
observing plantar ulcers in patients without "perverted sensation in the limb" and "nothing 
peculiar in the pressure to which the part" was subjected. Pryce (1887) believed 
"locomotor ataxy" (motor neuropathy) and "peripheral neuritis" (sensory neuropathy) to be 
causative factors in ulceration; and noted that the previously ulcerated feet of patients with 
diabetes sometimes showed a "glossy skin" -a suggestion of autonomic neuropathy. 
Therefore a variety of factors were thought to play a role in the aetiology of foot 
ulceration. 
Risk factors for foot ulceration in diabetes mellitus 
1.2.1 Diabetic peripheral neuropathy 
Ulcers on the plantar surface of the foot are typically found in diabetic patients 
with peripheral neuropathy. Sensory loss plays a vital role in predisposing to the 
development of these lesions (Masson et al., 1989). Peripheral neuropathy is a 
complication of long-term diabetes mellitus that is apparently related to the glycaemic 
control and duration of the disease (Pirart, 1977). A strong correlation with age and a 
predominance among male patients has also been found (Greene et al., 1990). 
Somatic sensorimotor neuropathy is the most common and recognisable type of nerve 
disorder in patients with diabetic foot (Frykberg, 1991). Sensory involvement begins 
distally in the toes and progresses proximally (Dyck, 1987) leading to loss of pain and 
thermal sensation, impaired or absent ankle reflexes and reduced vibration perception and 
light touch sensation. The inability to, perceive pain predisposes the foot to injury from 
1 
"nutrition" in this context most likely refers to a reduced blood supply, with a subsequently 
reduced supply of oxygen and nutrients, such as glucose, to the tissues. 
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burns, and mechanical injury e. g. from treading on sharp objects or the repeated forces of 
gait. Denervation of the motor fibres to the extensor digitorum brevis, lumbrical and 
interosseous muscles can cause the metatarsophalangeal joints to become hyperextended 
and the interphalangeal joints flexed. Subsequent claw-toe deformities lead to anterior 
displacement of the sub-metatarsal fat cushions and prominent metatarsal heads (Bojsen- 
Moller, 1979). Atrophy of plantar adipose tissue of the heel and the sub-metatarsal fat 
cushions may also lead to bony prominence (Gooding et al., 1986, Jahss et al., 1992). 
However pure sensorimotor neuropathy is unusual (LeQuesne et al., 1991): a close 
association with autonomic neuropathy exists (Edmonds, 1987). 
Autonomic neuropathy in the foot is characterised by impaired sweating resulting 
sometimes in dry, cracked skin which acts as a portal of entry for sepsis, and vasomotor 
denervation (Archer et al., 1984; Corbin et al., 1987; Irwin et al., 1988). The latter 
causes a huge increase in peripheral blood flow, opening of arteriovenous shunts, and 
can lead to arterial medial wall degeneration with calcification (Watkins, 1990). A 
warm foot associated with a high blood flow which may be more than five times normal 
are characteristic features of the neuropathic foot. These major haemodynamic changes 
are at least in part responsible for oedema in the neuropathic foot, occasionally of 
considerable severity. Increase in bone blood flow also occurs and may cause 
osteopenia, and this could underlay the development of the destructive bony changes of 
Charcot joints. 
Table 1.1 Possible consequences of vasomotor denervation in the neuropathic foot 
Arteriovenous shunting and increased Oedema 
peripheral blood flow 
Increased bone blood flow Osteopenia and Charcot joint 
Medial calcification Rigid arteries and high 
ankle/ brachial systolic pressure index 
Sympathetic denervation of the arteries to the foot also leads to increased 
vascular rigidity and medial calcification which is also commoner after lumbar 
sympathectomy (Edmonds et al., 1986). While there is no evidence that reduced blood 
flow results from this, Doppler examination of the foot circulation may give misleading 
results because of the incompressibility of the arteries. 
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Methods for diagnosis and assessment of diabetic neuropathy 
Clinical neurological tests 
Neurological status can be simply assessed in the clinic by detecting pain 
sensation to pinprick, light touch sensation to cotton wool and vibration using a 128 cps 
tuning fork starting distally from the foot up-wards to confirm a symmetrical stocking 
distribution of peripheral neuropathy. Absence of ankle jerks is evidence of peripheral 
neuropathy, although knee jerks are retained until surprisingly late. A dry skin with 
marked fissuring can be suggestive of a sweating autonomic deficit. Two investigations 
used in the clinic: vibrometry and nylon filaments are most useful to detect the patients 
susceptible to foot ulceration. 
Vibration perception threshold (VPT) 
This can be measured using a hand-held biothesiometer (Bio-medical Instrument 
Company, 15764 Munn Road, Newbury, Ohio 44065, USA). The vibration threshold 
increases with age, and values must always be compared with age-adjusted nomograms. 
A threshold for ulceration has been defined by Young et al.. (Young et al., 1994) who 
found that a VPT>25Volts is a good predictor for the risk of ulcer formation: Thus the 
measurement of the vibratory perception threshold is clinically useful in identifying 
those diabetic patients at high risk of foot ulceration (Boulton et al., 1986). 
Other tests of nerve function 
VPT is a measure of large fibre function, whereas other tests, such as thermal 
perception threshold (TPT) for cold and warm have been used to assess small nerve 
fibre function (Sosenko et al., 1988). However this is a less simple test than the VPT 
and more time consuming, being therefore recommended more for research purposes 
than for common use in the clinic. The same applies to motor and sensory nerve 
conduction velocity tests, which are probably the most exact diagnostic tests, but they 
require special equipment which is not always available in the clinic. 
An attempt was made to develop a device, the Neurometer, which would be a 
simple and comprehensive way of assessing peripheral nerve function (Masson et al., 
1989) by measurement of current perception threshold. Although the Neurometer 
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showed a degree of neuroselectivity, it also showed a large variability like all subjective 
sensory tests (Pitei et al., 1994). The motor and sensory conduction velocity tests are 
more precise measurements, but they are mainly used for research purposes and less so 
in the Foot Clinic. 
Semmes-Weinstein monofilaments 
The Semmes-Weinstein monofilaments (Hansen's Disease Foundation Inc., 
Carville, Louisiana, USA), which test the threshold to pressure sensation are much 
easier and quicker to use in the clinic. The nylon filament is applied to the foot until it 
buckles, when the patient should be able to detect its presence. Buckling of the 5.07 
monofilament occurs at 1Og of linear pressure and is the limit used to detect protective 
pain sensation. If the patient does not detect the filament, then protective pain sensation 
is lost. A study comparing Semmes-Weinstein monofilaments and VPT (Kumar et al. 
1991) in 182 subjects attending a national patients conference showed a good 
correlation between the two measures. The filaments were more sensitive (100%) but 
less specific (77.7%) in identifying patients who had foot ulcers compared to 
biothesiometry which was less sensitive (78.6%) but more specific (93.4%). In another 
study the accuracy of sensory-threshold measurements, VPT and TPT, for detecting 
diabetic foot ulcer patients was compared with that of cutaneous pressure perception- 
threshold in 314 non-insulin-dependent diabetic patients, of whom 91 had either a 
current foot ulcer or a history of foot ulceration. Pressure thresholds were highly 
accurate for identifying foot ulcer patients (Sosenko et al., 1990). The filaments are 
therefore reliable and may be superior to VPT and TPT in screening for patients at risk 
of foot ulceration since sensitivity is the more important parameter. In addition, they are 
inexpensive and are simple and easy to use as a screening device for identifying diabetic 
patients at risk of foot ulceration in the diabetic clinic or in general practice. 
Conclusion 
Diabetic peripheral neuropathy is an essential factor in the pathogenesis of 
diabetic foot ulceration. Its diagnosis can be made by clinical neurological and 
electrophysiological tests, of which vibration perception threshold and Semmes- 
Weinstein monofilaments are most suitable in the clinic for screening patients at risk of 
foot ulceration. 
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1.2.2. Epidemiological risk factors: History of foot ulceration, social status and race 
Previous foot ulcer and/or amputation have been shown to increase the ulceration/ 
amputation risk (Reiber, 1996), as well as a poor social situation especially if patients are 
elderly and live alone (Boulton, 1996). Ethnic differences in the incidence of lower 
extremity amputations secondary to diabetes have been demonstrated in the UK in 
Caucasians patients with a 14.2/10000 rate of amputation versus a 3.4/10000 rate in Asian 
patients (Gujral et at., 1993), who tend to be less likely to develop ulceration possibly 
related to their joint hypermobility and /or cultural trends in daily foot care (Toledano et 
at., 1994). An US study assessing the incidence of lower extremity amputations in Pima 
Indians with NIDDM has found their overall amputation rate to be 24.1/10000 person- 
years versus 6.5/10000 person-years for the general US diabetic population (Nelson et al., 
1988), whereas racial differences have been also demonstrated in black subjects, who tend 
to have increased subtalar joint mobility and lower foot pressures than the white ones 
(Veves et al., 1995) with effect on their risk of ulceration. 
1.2.3 Diabetic microvascular disease 
In the diabetic neuropathic foot 'histological evidence of microangiopathic 
changes can also be detected at the skin level (Faris et al., 1991) and abnormalities in 
skin local reflexes have been demonstrated by Tooke et al. (Tooke et al., 1996) as part 
of the microangiopathy associated with the diabetic foot and its ulceration. Physiological 
studies have been carried out in this thesis to explore this risk factor for ulceration and a 
summary of the relevant literature on this topic is described in the Chapter 7. 
1.2.4 Diabetes duration and long-term complications 
Diabetes microvascular complications, duration, and control have been shown to 
be independent predictors for amputation (Selby et at., 1995) in diabetic foot patients. 
Retinopathy has been associated with increased amputation risk (Reiber et al., 1992). 
Risk factors for foot ulceration in diabetic nephropathy are both ischaemia due to 
associated macrovascular disease, and neuropathy (Fernando et at., 1991). In patients 
with visual and renal impairment, as often found in those with renal transplant, the 
majority of foot lesions, both in soft tissue and bone, were related to neuropathy (Foster et 
al., 1995). 
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1.2.5 Diabetes control 
Glycated haemoglobin has been found to be higher in patients with ulcers than in 
those without (Croft et al., 1982). Furthermore the DCCT ( Diabetes Control and 
Complications Trial) established that patients who maintained lower levels of glycated 
haemoglobin have developed in time less diabetic complications including neuropathy 
(DCCT Study Group 1993), which has been shown previously to be associated with an 
increased risk of foot ulceration (Fernando et al., 1991). In diabetes an non-enzymatic 
glycation by which glucose molecules attach to structural proteins takes place leading to 
alterations in the physical properties of the protein. Therefore poor glycaemic control 
may be also associated with detrimental connective tissue changes (Yue et al., 1983). 
1.2.6 Soft tissue abnormalities 
Nonenzymatic glycosylation of collagen (Schnider and Kohn, 1980) and keratin 
(Delbridge et al., 1983) has been related to poor diabetic control, which is significant in 
that glycosylation of collagen produces an increase in intermolecular crosslinking making 
the skin and subcutaneous tissues rigid and inflexible (Hamlin et al., 1975). It is thought 
glycosylation produces a similar structural change in keratin (Delbridge et at., 1985). 
glycation of keratin may induce thickening of the skin, which becomes less elastic and 
more vulnerable to injury. Glycosylated keratin may also contribute to the build up of 
keratin and excessive callus formation, at the sites of weight-bearing which precedes 
and accompany ulceration. This changes in the properties of connective tissue may 
increase its vulnerability to high forces developed during gait between the different 
tissues of the foot, and between foot and ground. This may facilitate tissue breakdown, 
with formation of cavities and eventually ulcers. It has been hypothesised that rigidity of 
the skin and subcutaneous tissues and the build up of glycosylated keratin, callus, on the 
plantar surface in response to pressure, predisposes to ulceration through inadequate 
pressure distribution during walking (Frykberg, 1991). 
Conclusion 
Risk factors for ulceration, such as soft tissue abnormalities, diabetes duration, 
control and microvascular complications, are linked with the presence of diabetes per se, 
whereas epidemiological factors such as: social status, race and history of previous 
ulceration have been also shown to increase the ulceration risk. 
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Mechanical risk factors 
Despite the presence of predisposing factors such as neuropathy, a patient "at risk" 
may live for many years without developing an ulcer due to the avoidance of specific 
precipitating factors; for example, localised high pressure, by applying a high force on a 
small area, can lead to ulceration by disruption of tissue, such as stepping on a pin. 
Similarly, repeated mechanical trauma due to forces/pressures developed under the foot 
during walking could cause ulceration. 
1.2.7 Direct/extrinsic mechanical factors implicated 
in ulcer formation in the neuropathic foot 
Extrinsic mechanical factors are common in the foot with neuropathy. They 
occur mainly when patients with insensitive feet walk barefoot and step without 
noticing on sharp objects such as stones, pins or when those are inside their shoes, such 
as protuberant nails. 
Chemical injuries occur when using keratolytic agents, such as 'corn plasters', 
which contain concentrated salicylic acid and may cause liquefaction of the tissue, 
sepsis and necrosis. 
Thermal injuries, for example burns can lead to blisters which subsequently can 
become infected. Hot water bottle bums are the most frequent cause, also bathing in 
excessively hot water, or walking barefoot on hot sand during seaside holidays or 
keeping their feet too close to an open fire or resting on a radiator can lead to foot 
lesions. 
1.2.8 Biomechanical/intrinsic factors implicated 
in ulcer formation in the neuropathic foot 
Most commonly foot ulceration occurs due to abnormalities in the intrinsic 
biomechanical factors active during gait. Ulcers on the plantar surface of the foot appear 
to occur at sites of high normal (vertical) pressure (Ctercteko et al., 1981), although a 
shear component which acts not only at the shoe upper-foot interface, but also in the 
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depth of the soft tissues of the foot can not be excluded. Moreover repeated applications 
of `normal' pressures or shear stresses during activities of daily life (Brand et al., 1988) 
may lead to ulceration in an insensitive foot. When the total force, which is normally 
distributed on the whole plantar area, is concentrated on small areas such as prominent 
metatarsal heads in patients with neuropathy, this can increase the pressures 
dramatically. Therefore the plantar pressures would determine the amount of damage to 
the foot tissues and be implicated in the ulceration process. Hence the importance of 
measuring plantar pressures in the diabetic foot with neuropathy. 
1.2.9 Foot pressures 
Early foot pressure studies have shown that neuropathic feet with previous 
ulceration had abnormally high pressures at the ulcer site suggesting a correspondence 
between sites of high plantar pressure and ulceration. They also recommended the 
measurement of foot pressures as a predictive tool by determining specific areas under 
the foot that are prone to ulceration (Boulton et al., 1983). 
Attempts to determine a pressure threshold for ulceration have been made 
previously to allow an early identification of elevated stress and a timely therapeutic 
intervention, such as callus removal and footwear prescription, which can prevent many 
plantar lesions. 
Studies using pedobarography have confirmed that vulnerable areas of the 
neuropathic foot are those where pressure exceeds 10 kg/cm2 (Boulton et al., 1987). 
Later Veves et al.. (Veves et al., 1992) have reported that all of their ulcer patients had 
barefoot plantar pressures greater than 11.2 kg/cm2 (equivalent to 1.1 MPa). 
In-shoe pressure measurements are considered to give more information about 
the risk to ulceration, as they measure the forces developed in real life-conditions at the 
shoe-foot interface. Nevertheless no in-shoe threshold for ulceration has been defined 
yet (Hsi et al., 1993). However a variety of commercially available systems (see 
Chapter 3) for plantar pressure measurement are in clinical use at major diagnostic 
centres and different systems for measuring pressure distribution yield different results 
on the same patient (Cavanagh and Ulbrecht, 1991), so that results of one study 
cannot be easily extrapolated to another situation. This highlights the need for an overall 
understanding of clinical findings from plantar pressure studies. 
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Clinical findings from plantar pressure studies 
In foot pressure studies, diabetic patients have been the most extensively studied 
patient group. The apices of the toes and the plantar aspects of the first and third metatarsal 
heads are the most common sites of plantar ulceration in patients with diabetes (Holstein 
et al., 1976; Ctercteko et al., 1981; Edmonds et al., 1986; Veves et al., 1992). As a 
result, the forefoot has been the main area of interest in diabetic plantar stress studies. 
Barefoot measurements 
The supposition that plantar ulcers develop at sites of abnormally high pressure has 
so far been supported by one prospective study. In the period of follow-up of eighty-six 
patients, Veves et al.. (1992) noted that twenty-one plantar ulcers had developed; eight of 
which were at sites of abnormally high peak pressures (>12.3 kg/cm2) detected at the 
initial assessment. 
Several retrospective studies have found elevated peak pressures to be coincident 
with the sites of previous ulceration, and significantly higher plantar pressures in patients 
with neuropathy and healed plantar ulcers, compared to patients with neuropathy and no 
history of ulceration (Barrett, 1973; Stokes et al., 1975; Ctercteko et al., 1981; Boulton 
et at., 1983; Duckworth et at., 1985; Cavanagh et al., 1987; Smith et at., 1989). With 
these findings in mind it should come as no surprise then that re-ulceration is a common 
occurrence in these patients. 
Two groups have measured the forces beneath the feet of diabetic neuropathic patients. 
Stokes et al. (1975) used a forceplate consisting of twelve beams to make measurements 
beneath the feet of patients with a history of plantar ulceration. For the four feet studied, a 
range of "highest load" was given: from 175 N to 264 N (estimated from graph). 
Significantly lower toe loading and more lateral forefoot loading was also observed in this 
group compared to a group of asymptomatic subjects. 
Ctercteko et al. (1981) used a higher resolution forceplate consisting of one- 
hundred-and-twenty-eight, 15 mm x 15 mm loadcells for measurements. This system 
allowed the measurement of forces at sites of healed ulcers, which were found to be 
coincident with the sites of maximum load. For the twenty-four patients with a history of 
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plantar ulceration that were studied, the "mean peak force" was 228.7 N. Forces were also 
measured beneath the 
feet of patients with neuropathy and no history of ulceration and beneath the feet of 
asymptomatic subjects. In a comparison of all three groups, a considerable overlap in the 
ranges of the forces measured was found. Reduced toe loading in comparison to 
asymptomatic subjects was also observed in this study, but in contrast to the finding of 
Stokes et at. (1975) more medial forefoot loading was observed in patients that had 
previously ulcerated. 
When pressures were measured by Proano et al. (1992) under the toe, metatarsal, 
tarsal and heel areas, low values were obtained as a result of spatial averaging. Also 
considerable overlaps were found in the peak pressures measured under the previously 
ulcerated versus non-ulcerated feet of ten patients and ten asymptomatic subjects. 
However in an analysis of mean peak pressures, a significant difference was found 
between the pressures under the forefoot of patients that had previously ulcerated 
compared to the forefoot of asymptomatic subjects. Although it was not clearly stated, it 
appears that the sites of healed ulcers were predominantly under the forefoot, which 
accounts for this result. 
It is interesting to note that one group of workers has made a comparison between two 
systems for measuring plantar pressures (Young et al., 1992). In the study of 20 patients 
with diabetes, with measurements made using the Musgrave Footprint and the Optical 
Pedobarograph (OPG), no significant differences were found in the maximum peak 
pressures measured beneath the hallux and heel, but maximum peak pressures were 
significantly higher beneath the first and fifth metatarsal heads when measured by the 
OPG. One of the reasons for these disparities was wrongly attributed to the lower 
measurement range of the Musgrave system, but it was correctly noted that the lower 
pressures measured by the Musgrave system were due to the larger sensors which led to 
greater spatial averaging 
A number of researchers have measured peak plantar pressures in diabetic neuropathic 
patients and in asymptomatic subjects and have sought to define a threshold of 'normality' 
(Boulton et al., 1983; Smith et al., 1989) with the aim to determine which patients may 
be at immediate risk of plantar ulceration. 
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Table 1.2 Peak plantar pressures measured during barefoot walking. 
Source Peak pressures (kPa) 
Boulton et al. (1983) > 1100 
................................................................................ 
Boulton et al. (1984) 
.................................................................................................................................... 
920 to 3730 
................................................................................ 
Smith et al. (1989) 
..................................................................................................................................... 




200 to 500 
Cavanagh et al. (1987) 312 to 1895 
Conclusion 
With the wide range of reported pressures measured during barefoot walking under 
the sites of healed diabetic neuropathic ulcers (table 1.2), which in some cases overlap 
with the ranges reported for patients with diabetes and no foot problems and asymptomatic 
subjects, it is clearly difficult to define a foot pressure threshold for ulceration . 
In-shoe plantar pressure measurements 
Although diabetic neuropathic patients commonly ulcerate while wearing 
conventional shoes, there have been only few studies documenting the dynamic stresses 
beneath the feet of these patients inside such shoewear. 
In a study of six patients (seven feet) Pollard (1984) found maximum peak 
pressures at sites of healed ulcers ranging from 220 kPa to 500 kPa (2.2 kgcm 2 to 5 kgcm 
2) shod and from 200 kPa to 500 kPa (2 kgcnf2 to 5 kgcm 2) barefoot. Walking in shoes as 
opposed to barefoot resulted in lower peak pressures at five out of seven sites of previous 
plantar ulceration. In three out of five sites the highest peak pressure was found in barefoot 
measurements and remained so when shoes were worn. Pollard also measured pressures 
under areas free of ulceration, showing just a small decrease in pressures when wearing 
leather shoes versus barefoot walking (Table 1.3). 
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Table 1.3 Peak plantar pressures in diabetic patients with a history of plantar ulceration 
measured barefoot, shod and using walking casts by Pollard (1984, adapted) 
Site Peak pressure (kPa) 
barefoot leather shoes walking cast 
hallux 36 71 - 
mthl 336 327 129 
mth2/3 253 226 46 
mth4 201 187 64 
mth5 156 113 50 
heel 155 137 92 
Smith et al. (1989) was rather less thorough in his analysis of data in a study of 
eleven patients: a group average of the maximum peak pressure was quoted for seven 
plantar sites. This value was 610 ± 180 kPa (6.1 ± 1.8 kgcm2) for measurements made in- 
shoe and 670 ± 220 kPa (6.7 ± 2.2 kgcm 2) for barefoot measurements. From the standard 
deviation of the means it is apparent that there was a considerable overlap between the in- 
shoe and barefoot measurements. 
Conclusion 
These two groups have found in-shoe plantar pressures to be only slightly reduced 
when patients wore conventional leather shoes compared to walking barefoot. Foot 
pressures therefore remain high and it appears that shoewear among other factors, may 
influence the magnitude of plantar pressures. 
Factors associated with increased plantar pressures 
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in the diabetic neuropathic foot 
Loss of protective sensation predispose patients to ulcerate at sites where 
pressure is still 'normal' (Cavanagh et al., 1993), in addition to the link between 
diabetic neuropathy and high plantar pressures (Boulton et al., 1983). Thus, the foot 
that is already at risk of injury due to loss of protective sensation is placed at an even 
greater risk because of high mechanical stress due to biomechanical factors, many of 
which result directly from diabetic peripheral neuropathy. 
As plantar pressures in both walking and standing in normal feet are easily 
sufficient to occlude capillary blood flow (100mmHg is equivalent to 13.3kPa and 
typical pressures in the metatarsal area are around 400kPa (Rosenbaum et al., 1994), it 
may be that diabetics are different from controls in their ability to recover from 
occlusion, reflected by abnormalities in a number of local reflexes, including 
hyperaemic response which has been shown by Tooke et al.. (1996) in neuropathic feet. 
Diabetic microangiopathy is an important factor to be considered in the pathogenesis 
of foot ulceration as discussed in Chapter 7. 
1.2.10 Limited joint mobility 
Connective tissue contains a great percentage of collagen. The glycosylation of 
collagen which can occur in diabetes, results in less flexibility with subsequent 
limitation of joint mobility (LJM) and less resistance to the action of collagenases 
(Hamlin et al., 1975). Limited joint mobility was found to be related to both age and 
duration of diabetes (Lawson et al., 1983) and therefore to the duration of the non- 
enzymatic glycosylation process. 
Several studies have also shown a three to four fold increase in prevalence of 
microvascular complications in patients with LJM compared to those without 
(Rosenbloom et al., 1981). However a recent study has found that although LJM of the 
hands is associated with the presence of microvascular complications, does not predict 
their development (Arkkila et al., 1996). 
The normal foot has been described as a 'mobile adapter', and when this 
mobility is impaired (Birke et al., 1995) elevated plantar pressure during gait appears 
to result. 
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An association between abnormally high plantar pressures and limited mobility at the 
metatarsophalangeal and subtalar joints of the insensitive diabetic foot has been found by a 
number of researchers (Delbridge et al., 1987, Cavanagh et al., 1991a, Fernando et al. 
(1991). Glycosylation may also change the mechanical properties of the skin and other 
subcutaneous tissues, making them stiffer (Delbridge et al., 1985) and, therefore, more 
likely to transmit shear to the deeper, tissues. However in these patients, neuropathy is 
thought to be the critical factor in causing ulceration. This is backed by observing subjects 
who have limited joint mobility at the first metatarsophalangeal joint, i. e. having hallux 
rigidus, who have a tendency to develop an area of callus under the first 
metatarsophalangeal joint, but do not go on to ulcerate if they do not have neuropathy. 
1.2.11 Callus formation and its effect on soft tissue properties 
Callus formation is a frequent occurrence in diabetic patients; a study of 
prevalence of foot pathology and lower extremity complications has found that 51% 
patients of a diabetic outpatients clinic had plantar callus (Holewski et al., 1989). 
Furthermore clinical studies have reported ulcer formation to be invariably 
associated with plantar callus in diabetic patients with neuropathy (Edmonds et al., 
1986; Murray et al., 1996) and moreover, haemorrhages have been found within 
plantar callus in a study of 100 diabetic patients (Rosen et al., 1985). 
In addition a significant relationship was found between certain types of foot 
deformity known to be associated to callus formation, and the location of ulcer in 
neuropathic diabetic patients (Mueller et al., 1990): 6 out of 7 patients with Charcot 
joint had an ulceration at the midfoot, 9 of the 18 patients with compensated forefoot 
varus showed ulceration under the medial metatarsal heads, 15 out of17 patients with 
forefoot valgus showed ulceration at the first or fifth metatarsal head. 
However when the relationship between the loss of protective pressure sensation 
and the formation of plantar callus was assessed in patients with and without insensitive 
feet, equivalent number of areas and thickness of callus were found in both groups of 
diabetic patients suggesting that additional factors such as age-related changes in the 
foot and footwear should be considered in the risk assessment of the diabetic foot 
(Collier et al., 1993). 
Also limited joint mobility seems to be associated with callus formation. In 
patients with similar limited joint mobility, but no diabetes such as those with a 
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rheumatoid foot, it was shown that loss of motion at the hallux due to arthritis could 
lead to a hyperextension deformity and painful callus formation as a result of muscle 
spasm of the great toe intrinsic muscles in an effort to relieve and shift pressure from the 
metatarsal heads (Clayton et al., 1991). 
Callus formation is dependent on the amount of vertical and shear forces applied 
on the soft tissue of the foot during gait. Even moderate pressure applied repeatedly 
would lead to hypertrophic callus formation, which associated with an increase in foot 
pressures, can lead to tissue breakdown and ulcer formation. Brand et al.. (1988) have 
described an experiment in which the same moderate stress (20PSI) was applied 
repetitively to the paw of the rat. In the first day a flare response, oedema and an 
increase in skin temperature have occurred and these changes subsided when the stress 
was stopped. However in the second day of constantly applied stress, the changes did 
not subside so readily, and histological inflammatory changes plus hyperplasia of the 
skin occurred. By the end of a week of repeated stress on the paw, footpad necrosis and 
tissue breakdown occurred. In those rats in which the application of pressure was 
stopped for 2 days per week, the footpad skin became hypertrophic with a thick layer of 
keratin (Brand et al., 1988). 
During activity the foot is simultaneously subjected to pressure and shear. The 
simultaneous application of these stresses is thought particularly destructive to soft tissue 
in that the magnitudes required to produce damage are reduced when they are applied 
concurrently (Bennett et al., 1979). A theoretical analysis of soft tissue, which was 
initially compressed and then subjected to surface shear, has shown the effects of these 
stresses to be additive (Zhang and Roberts, 1993) 
The soft tissue needs to be able to adjust and to adapt to the sudden changes in 
pressure in order to absorb the shock and to dissipate the peak pressures applied to the 
body organs and the musculoskeletal system during gait. Similar to the suspension 
system of a motor car, the soft tissue acts as a spring which needs to lengthen and soften 
to decelerate -the body. Therefore the thickness and softness of the soft tissue are 
important in shock absorption. Subsequently skin hypertrophy leading to callus 
formation might occur to provide the necessary thickness. An illustration of this 
hypothesis is the occurrence of callus at the edge of the toes and heel, where the large 
changes in pressure and concomitant shear forces on the sole of the foot concentrate 
during gait. However if the soft tissue is not evenly distributed overall the area of the 
foot, the contrary is achieved, with concentration of force on small contact areas and 
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therefore increase in pressure (Thompson, 1988). This added to the effect of callus 
acting as a foreign body (Young et al., 1992) would lead to a further increase in plantar 
pressure followed by tissue breakdown and ulcer formation. 
1.2.12 Foot deformity 
The bones, fasciae and ligaments of the foot are very important in walking 
forming the longitudinal and transversal arches of the foot through which the load is 
distributed and transmitted to the ground. They change their shape and are flexible 
when under load. Atrophy of the interosseous muscles associated with peripheral 
neuropathy leads to abnormalities in their function to modulate the action of the long 
flexor and extensor muscles with added effect on the metatarsophalangeal and 
interphalangeal joints leading to foot deformity, such as claw or hammer toes. Since the 
submetatarsal fat pads are attached to the flexor tendons, the fat pad could move 
forward as the toes become clawed. Subsequently the metatarsals could be left with only 
a thin covering of skin, as noted frequently from clinical observation (Cavanagh et al., 
1994). This phenomenon may be implicated in elevation of plantar pressures and can be 
a reason why plantar ulcers tend to occur predominantly under metatarsal heads. 
Foot and nails deformities may also accelerate damage to the foot from repeated 
mechanical trauma. It has been noted that patients with diabetes who have a forefoot varus 
deformity, i. e. a fifth metatarsal head which is more plantar than the first, often ulcerate 
beneath the fifth metatarsal head (Mueller et al., 1990; Schoenhaus et al., 1991). Pes 
cavus, an abnormally high medial longitudinal arch can also be associated with claw 
toes and the abnormal distribution of weight leads to excessive callus formation under 
the metatarsal heads. Similarly hallux rigidus leads to stiffness of the first 
metatarsophalangeal joint with loss of dorsiflexion and results in excessive forces on the 
plantar surface. Recent reports by Cavanagh et al.. (1994) point to abnormalities in the 
bone structure and ligament function of the diabetic neuropathic foot with a history of 
ulceration, with possible subsequent abnormalities in the forces developed under the 
foot and in the foot function. 
Deformities due to previous surgery, such as ray amputations are normally very 
successful, but disturb the biomechanics of the foot, leading to high pressure under the 
metatarsal heads of the adjacent rays. Deformities of the hip and fractures of the tibia or 
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fibula can lead to shortening of the leg and an abnormal gait, which predisposes to 
abnormal pressure distribution and foot ulceration. 
Furthermore the bony and joint destruction commonly known as Charcot foot is 
characteristically associated with peripheral neuropathy. Bony damage in the metatarsal- 
tarsal region leads to two classical deformities: the rocker bottom deformity, and the 
medial convexity, which can concentrate the entire weight of the body on a few square 
centimetres of tissue. This leads to abnormal pressures under the foot, which if are not 
accommodated in properly fitting footwear, would result in ulceration at vulnerable 
pressure points. 
Conclusion 
High foot pressures are frequently a consequence of deformity which would alter 
the mechanics of the foot leading to abnormalities in the biomechanics of gait. These 
external precipitating factors acting on a neuropathic foot with loss of proprioception 
and abnormal neuro-vascular reflexes can lead to skin injury and ulcer formation 
(Apelqvist et at., 1990). As regards the degree of risk, the type of deformity can be 
classified as: 
- moderate: limited ankle and hallux motion, claw or hammer toes, hallux valgus, 
dystrophic nails, prominent metatarsal heads or other plantar bony proeminences and 
calluses associated with the level of activity. 
- severe: Charcot foot, greater toe or multiple ray amputations. 
A definite relationship has been shown between foot deformity and location of 
ulcers in 40 patients with diabetes and insensitive feet (Mueller et al., 1990). 
These findings support the hypotheses that 
- insensitivity, coupled with high, repetitive pressure, is a primary cause of ulceration 
- deformity is associated with characteristic pressure patterns and callus formation. 
Neuropathic oedema as mechanical factor 
Oedema leads not only to microvascular consequences, but it is likely to act as a 
foot deformity by increasing the pressures from poorly fitting shoewear, which should 
also be considered as an important mechanical factor. 
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1.2.13 Unsuitable shoewear 
Recently new methods such as F-Scan and Novel EMED-SF for dynamic plantar 
pressure measurements have been developed to assess the pressures inside the shoe. As 
they became validated and standardised, their value in quantifying the degree of foot 
pressure elevation in unsuitable shoes becomes clearer. High plantar pressures have 
been already associated with an increased risk of plantar ulceration (Veves et al., 1992). 
The dorsal ulcers seem to occur at the interface between the upper of the shoe 
and foot due to possible shear stresses developed inside tight or ill-fitting shoes. 
Therefore in-shoe pressure measurements can be useful aides in designing and assessing 
the efficacy of prescription footwear in reducing raised foot pressures (Cavanagh and 
Ulbrecht, 1994) and therefore in prevention of ulceration. 
1.2.14 Pattern of gait 
The pressure which is loaded on different parts of the foot varies with the 
patient's pattern of gait. In patients with unilateral amputation, the altered pattern of gait 
would lead to a predominant pressure distribution on the remaining limb, therefore 
increasing its risk of ulceration. Indeed high pressures were found under the remaining 
foot in diabetic amputees (Veves et al., 1992). Three-dimensional kinematic data and 
analysis of the plantar pressures revealed a significantly greater mean peak plantar 
pressure and altered kinematics in the feet of 10 diabetic neuropathic patients after 
transmetatarsal amputation suggesting that careful postsurgical footwear management is 
essential if ulceration is to be prevented (Garbalosa et al., 1996). 
The neuropathic patients have been shown to have a markedly increased postural 
instability (measured as the centre of force excursion) when standing with eyes open 
similar to non-neuropathic patients standing with eyes closed and head tilted back 
Simoneau et al., 1994), which is likely to increase their risk of falling and injury; 
especially as this significant increase in sway during standing and possibly during gait 
seems not to be compensated for by other sensory systems (Cavanagh et al., 1993). 
In contrast, it has been clinically hypothesised that the neuropathic gait would be 
characterised by a lack of variability, which would lead to a repetitive pressure load on 
the same areas of the foot with subsequent injury to the foot. However research findings 
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have not supported this hypothesis pointing to abnormal variability of uncoordinated 
gait in neuropathic patients (Cavanagh et al., 1992). 
The neuropathic subjects have also been shown to have less ankle mobility, 
ankle movement, ankle power, velocity, and stride length during walking than the 
control group. A significant decrease in ankle strength and mobility appeared to be the 
primary factor contributing to the altered walking patterns of the neuropathic group 
(Mueller et al., 1994). 
Further biomechanical assessments are needed to investigate the effect of 
peripheral neuropathy on gait; one attempt has been made in this thesis when comparing 
foot pressures in neuropathic and neuro-ischaemic patients (Chapter 4). 
1.2.15 Level of activity 
It is not unusual that patients remain ulcer free although they have apparently 
similar elevated plantar pressure and similar significant deformity to patients who go on 
to develop ulceration. Among other factors which probably contribute to the difference 
(possibly including vascular status, plantar tissue mechanical properties, etc. ) one that is 
frequently omitted, is the activity level of the patient. 
How mobile and active the patient is at home or at work should be a common 
question to be asked in the Diabetic Foot Clinic, when assessing the cumulative risk of 
ulceration. 
The level of activity can be an added factor to high foot pressures and deformity 
and correlates with the risk of ulceration: 
- low activity level is when the patient's daily ambulation is minimal being bed- or 
chair-bound. 
- moderate activity level is when the patient can move for more than 100 feet, similarly 
to when performing daily activities. 
- high activity level is when the patient's occupation requires prolonged standing, 
walking or running (Cavanagh, 1995). 
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Linking the risk factors 
The multiple risk factors interplay in the formation of foot ulceration in the 
diabetic patients; leading to a final cumulative risk for ulceration. The various 
interacting risk factors can be reduced or enhanced, and they need to be carefully 
thought about when methods for treatment or prevention of ulceration are considered, 
because the risk factors present in an individual would determine the treatment option; 
for example, in the management of the neuropathic foot prescribing shoewear has to 
take into account the presence of raised plantar pressures and deformity plus the level of 
activity of each patient. 
Linking the risk factors should also take in consideration the patient's 
psychological characteristics. Vileikyte et al.. (1996) have reported an association 
between the risk of foot ulceration and psychological factors, such as patient's interest 
for their own feet and in foot care, with effect on patient's (non-) compliance with 
treatment or prevention of ulceration. 
1.2.16 Management of the diabetic neuropathic foot 
Management of the diabetic neuropathic foot has three purposes: to prevent 
primary ulceration; to aid healing in patients who have ulcerated; and to prevent re- 
ulceration. All three of these processes may be aided by chiropody treatment and the use of 
special shoes that are often bespoke. 
Walking cast and chiropody treatment of diabetic neuropathic ulcers 
In the foot that has not ulcerated, callus is debrided regularly to reduce locally high 
pressures and minimise the risk of ulceration (Young et al., 1992). There are a number of 
ways in which the chiropodist can treat the diabetic foot that has ulcerated. In cases of 
primary ulceration due to continued weight-bearing, the initial treatment is in three stages: 
firstly, callus is removed from around the open site, as far back as soft pink skin; secondly, 
the area is cleaned with an antiseptic solution; and thirdly, a non-adhesive padded dressing 
is applied to protect and redistribute pressure at the site. At regular follow-up 
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appointments for chiropody, necrotic tissue is removed from around the wound to allow 
epithelisation from the edges and for the site to close. After the ulcer has healed, callus is 
debrided from the site regularly to prevent re-ulceration (op cit, Tindall, 1992). 
For some patients, ulcers may be long-standing because of continued weight- 
bearing at the site once the ulcer has broken through the skin. In such cases treatment with 
a below-knee plaster cast (or total contact cast) is indicated in preference to the expensive 
alternative of hospital admission. In cases where the chiropodist allows the patient to walk 
in the cast, a rubber heel is incorporated into the sole - this type of cast is referred to as a 
walking cast. Plaster casts have been found to be very effective in healing plantar ulcers 
(Lang-Stevenson et al., 1985; Laing et al., 1991) possibly because of the following 
reasons: (1) the weight of the cast immobilises the patient and the foot is not continually 
weight-bearing; (2) the infiltration of tissue with fluid (oedema) is controlled and reduced 
by the support provided by the plaster; (3) the patient is protected from further trauma by 
the hard plaster shell; and (4) plantar stresses are reduced by the total contact fit. 
The hypothesis that plantar stresses are reduced inside plaster casts has been 
investigated by three groups of workers in two studies of asymptomatic subjects and one 
study of patients with diabetes. Tests on asymptomatic subjects by Birke et al. (1985) and 
Novick et al. (1991), showed walking casts to reduce significantly the pressures beneath 
the forefoot in comparison to shoes. These reductions are attributable to the total contact 
support of the cast, which distributes pressure beneath the foot to reduce pressure peaks. 
In a study of six subjects, transducers were placed under four sites and significant 
pressure reductions were noted beneath the first and third metatarsal heads. Pressures were 
also reduced beneath the fifth metatarsal head and heel, but not significantly. 
Unfortunately the data recorded by these workers was not presented in units of pressure, 
but instead as millimetre deflections on a chart recorder. As a result, a comparison with 
pressures from other studies is not possible. 
Another study of 20 subjects showed walking casts to reduce significantly the 
pressures beneath the second and fourth metatarsal heads in comparison to shoes. 
Pressures were higher beneath the midfoot and only slightly reduced beneath the heel in 
the walking cast. The increase in pressure beneath the midfoot in the walking cast 
compared to the shoes is attributable to the total contact support of the medial longitudinal 
arch and the fact that weight-bearing occurs on the rubber heel beneath this area. The data 
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recorded in this study was presented in pounds force for each of the transduced sites. 
Converting this data via transducer area to pressure, the average peak pressures for the 
heel, midfoot and the second and fourth metatarsal heads when wearing shoes were 634 
kPa, 232 kPa, 832 kPa and 543 kPa, respectively. In the walking casts, the pressures 
beneath these same areas were 543 kPa, 311 kPa, 379 kPa and 289 kPa, respectively. 
In a study of seven patients with diabetes (eight feet), significant reductions in both 
pressures and longitudinal shear stresses were noted in walking casts compared to 
conventional leather shoes (Pollard, 1984) (table 1.3). Both the plantar and shear stresses 
were reduced in the cast possibly due to the fact that the foot was contained and its 
mobility was reduced. 
The total contact cast has become the standard method for mechanical unloading 
used in the treatment of active ulcers, which has been shown in a controlled clinical trial to 
heal 90.5% of ulcers in 42±29 days compared to 31.6% in 65+29 days for voluntary non- 
weight bearing and accommodative footwear (Mueller et al., 1989). 
Therapeutic shoewear 
Often the diabetic foot care starts with the treatment of the first ulceration. 
Different orthotic devices such as, centre-walking casts, walking splints and cut-out 
sandals, are of use to facilitate the healing of plantar ulcers in neuropathic conditions 
(Birke et al., 1991). In addition to the standard methods, a type of `half-shoes' has been 
used in the treatment of neuropathic forefoot ulcers by Chantelau et al.. (Chantelau et 
al., 1993). They showed that the `half shoe' cases reduced their overall healing time 
with 48 days and reduced their hospitalisation rate from 41 % to 4%. 
Clinics treating patients with diabetes have different approaches to the provision of 
special shoes. Some prescribe shoes to patients that are judged at risk of ulcerating, while 
others only provide shoes once ulceration has occurred and healing has taken place. 
Ideally, the shoes supplied to patients with diabetes should be made-to-measure 
and have: (1) low heels to reduce forefoot weight-bearing; (2) lacing to close the quarter 
and hold the foot back in the shoe; (3) uppers made of a breathable material, such as 
leather; (4) a high toe box, so that the upper does not rub against the dorsal surface of toes; 
and (5) adequate depth to accommodate a flat cushioning insole or an insole shaped to the 
contours of the sole (moulded insert) that distributes pressure and reduces pressure peaks 
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(Tovey, 1984). Bespoke shoes with the above characteristics are referred to as custom- 
made extra-depth shoes, while those bought off-the-shelf with these characteristics are 
referred to as stock shoes. 
Rocker-bottom or rocker-soled shoes are typically supplied to patients with a 
history of plantar ulceration. The outsole of these shoes is designed with a steep toe 
clearance that produces an axis beneath the ball about which the shoe can pivot. It is 
hypothesised that the axis about which the shoe pivots is critical in determining the sites 
beneath the forefoot at which plantar shear and pressure are reduced compared to 
conventional shoes. In-shoe plantar pressure measurement led Geary and Klenerman 
(1986) to advocate the placement of the rocker axis proximal to the line of the metatarsal 
heads. However, Pollard (1984) found higher pressures beneath the hallux and first 
metatarsal head in shoes with this rocker design, although longitudinal shear stresses were 
lower beneath the metatarsal heads compared to conventional shoes; while Schaff and 
Cavanagh (1990) found this rocker design to increase pressures beneath the heel, midfoot 
and the lateral aspect of the forefoot. 
Cushioning insoles (Chantelau, 1990) and moulded inserts have been also 
described in the literature and were considered therapeutic aids for diabetic foot, but only a 
few studies have used objective measurements to assess their pressure attenuating effects. 
Two materials are commonly used in the fabrication of shoe orthoses: PPT 
(Professional Protective Technology)®, a closed-cell foam; and Plastazote®2 a rigid 
open-cell foam. For flat cushioning insoles PPT is used; whereas for moulded inserts 
both PPT and Plastazote are used, typically in a sandwich construction of low-density 
Plastazote/PPT/high-density Plastazote to produce rocker inserts. The effectiveness of 
these and other insole materials in reducing peak pressures beneath the foot has been 
shown by several researchers (Boulton et al., 1984; Pollard, 1984; Brodsky et al., 
1988; Smith et al., 1989). Spence and Shields (1968) showed Neoprene®, a closed-cell 
foam (the material used to make wet-suits), to be effective in preventing blisters, 
calluses and ulcers beneath the feet of patients with neuropathy. Unfortunately the shock 
attenuation of PPT and Plastazote deteriorates in use, the Plastazote more-so than the 
PPT (Pratt, 1988). This deterioration in shock attenuation of the Plastazote is the result 
of "bottoming-out" compression with a consequent increase in stiffness, under repetitive 
2 
BXL Plastics Ltd. 675 Mitcham Road, Croydon, Surrey, CR9 3AL, UK. 
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high pressure, which can be detrimental to the insensitive foot. 
In summary, the prescription of fitted shoes in the management of foot ulcers aims 
mainly to accommodate, not to correct deformities and to distribute evenly the plantar 
pressures by transfer from high-pressure areas to areas of lower pressure, to provide 
shock absorption, to reduce friction and shear (Janisse, 1992). 
The shoes ought to have a proper fit matching the characteristics of the foot with: 
-a heat mouldable upper to accommodate any deformities 
-a long medial counter to control the heel and the medial arch and decrease the shear 
forces 
- easy entry to the shoe with laces or velcro 
-a shock-absorbing sole such as a rocker sole with an extended steel shank 
-a low heel to decrease pressures on the metatarsal heads and toes 
-a multiple-layer insert for the maximum cushioning and mouldability in an extra- 
depth. 
Assessment of preventative shoewear as regards efficacy in reducing high plantar 
pressures and accommodating deformity and as regards the life-time of the footwear 
ideally requires the use of in-shoe pressure measurement techniques such as F-Scan. 
Padded hosiery 
As fitted shoewear is usually worn with some type of hosiery, recent studies 
have considered the use of padded hosiery as another management approach for 
reducing plantar pressures in diabetic patients (Murray et al., 1993) or in rheumatoid 
arthritis patients (Veves et al., 1991). Veves and co-workers have shown that padded 
hosiery was able to significantly reduce the foot pressures in 27 neuropathic patients 
wearing only the padded socks and walking on the platform of an optical pedobarograph 
(Veves et al., 1989). 
When the effect of padded hosiery was followed-up at 3 and 6 months intervals 
the reduction in pressures was initially 31%, then 15.5% and 17.6% respectively (Veves 
et al., 1990). However when the effect of padded hosiery on plantar pressures was 
assessed inside the shoe (Flot et al., 1995) it was found to be limited at the forefoot and 
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hallux areas of the foot, but preserved after 4 hours of continuous activity or over a 
period of 8 weeks of wear. 
Patient education 
Education is of extreme importance (Edmonds et al., 1996) and includes attempts 
to improve the patient's understanding of foot problems and how to prevent them; for 
example, by improving patient's compliance with prescription footwear. 
However despite the accepted advantages of fitted shoewear, some patients still do 
not wear them (Chantelau and Haage, 1994): 
- because the shoes are expensive and the patients might not be able to afford them, if 
they are not provided free of charge by NHS but only a limited provision per year. 
- because the patients are unaware of the importance of the shoes in preventing foot 
damage. 
- because the shoes are unattractive and sometimes socially unacceptable. 
These points highlight : 
  the necessity to provide fitted shoes for all the patients, not only for those who 
can afford them, at reasonable prices; 
  the importance of the shoe design in their acceptability. Part of the surgical 
shoes effect is influenced by the length of time they are worn on or if they are 
worn at all or not. 
  the importance of education regarding the risk of foot ulcer and how this can be 
reduced by wearing the surgical shoes. Here comes the advantage offered by a 
dynamic in-shoe system for foot pressure measurement such as the F-Scan, 
which permits the visualisation of foot pressures on the screen allowing the 
patients to see for themselves the efficiency of fitted shoes in reducing the 
previously high foot pressures. 
An optimisation of both the design of the moulded insole and the materials used in the 
fabrication of the insole will lead to better preventative footwear. 
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Conclusion 
The development of ulceration needs to be anticipated and prevented. For 
successful preventative foot care, patients and physicians need to understand how and 
why ulcers form and the rationale for the types of footwear and care necessary to prevent 
ulcers (Miller, 1993). Proper care of diabetic foot problems should always include 
preventative measures such as regular callus removal, assessment and prescription of 
proper footwear and continuous education. 
In patients at high risk of ulceration, preventative measures are a necessity not an 
option. Therefore a variety of bespoke footwear is usually prescribed for 
accommodation of deformity and relief of high plantar pressures according to their 
history of ulceration, to the presence of deformity and their level of activity. 
For the footwear to be efficient it is important that patients are educated to 
understand that this is a permanent and continuous measure which requires their 
commitment in using and maintaining the footwear carefully. 
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1.2.17 Mechanisms for the development of ulceration 
in the diabetic neuropathic foot 
The forces developed under the foot are increased because of the effect of peripheral 
neuropathy on the intrinsic muscles leading to the clawing of the toes , which are 
unable to carry the normal load leading to a transfer into weight-bearing areas towards 
the metatarsal heads. This is added to the effect of the atrophy of small muscles of the 
foot which would result in increased prominence of the metatarsal heads. These 
abnormal pressures underneath the plantar surface of the diabetic neuropathic foot seem 
to play an important role in ulcer formation. 
In experimental studies, Brand (Brand 1978) has demonstrated that even moderate 
stress applied repeatedly to the foot causes inflammation, which takes more than 24 
hours to resolve, so that there is a reduced tolerance the next day to similar stresses. 
Daily exposure to these forces would produce continuos inflammation and eventually 
necrosis and ulceration of the affected area. 
A similar scenario would happen in the insensate feet of diabetic patients, who 
develop areas of increased loading due to neuropathy, deformity and callus formation. 
The inflammation in a normal subject is associated with pain and would lead to the 
subject relieving the stress by reducing the level of activity or developing an antalgic 
gait to reduce the load on the tender area. This does not happen in a neuropathic foot, 
which can not feel pain and continues to walk, while the inflammation may continue 
into necrosis and ulceration. 
Delbridge et al.. (Delbridge et al., 1985) has described how in response to these 
stresses a plaque of keratin develops, with callus formation at the areas of high pressure, 
which is considered to be a pivotal mechanical factor (Edmonds et al., 1986) in ulcer 
formation. 
TM', 
With excessive callus build-up, the compliant subcutaneous tissue between the 
metatarsal heads and callus becomes subjected to high local stresses during weight-bearing 
(Thompson, 1988), but the pain associated with this goes unnoticed by the patient (figure 
1.3) 
Breakdown of the trapped subcutaneous tissue results in a cavity filled with plasma 
and blood (figure 1.4). The sign of imminent breakdown is blood staining of the callus. 
The cavity gradually enlarges and eventually breaks through the skin to form the ulcer 








When the ulcer has occurred, there is secondary bacterial contamination and 
infection may result. For some patients, amputation becomes necessary if bone is infected 
from micro-organisms present on the skin or within footwear. 
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1.3 The diabetic neuro-ischaemic foot 
Although very little research has been conducted in the mechanisms of ulceration 
in the neuro-ischaemic foot, this section will describe its basic clinical features as a 
background to the research carried out in this thesis. As previously described, the neuro- 
ischaemic foot is characterised by ulceration along the margins of the foot and toes, and 
eventually gangrene due to a combination of peripheral neuropathy and vascular 
disease. 
1.3.1 Diabetic peripheral vascular disease 
Characteristics of PVD in diabetes and its relationship to foot ulceration 
Abnormalities of both micro- and macro-circulation have been implicated in the 
aetiology of foot ulceration. Microcirculatory disorders, are known to be associated with 
the diabetic foot and are described in further chapters. Furthermore macrovascular 
disease is more common in diabetes: peripheral vascular disease (PVD) occurs 20 times 
more frequently in diabetic patients than in patients with no diabetes (Ganda, 1984). 
Diabetic patients have been shown to be 22 times more likely to be admitted for skin 
ulcers/gangrene, 15 times more likely due to peripheral vascular disease, and 10 times 
more due to atherosclerosis (Jacobs et al., 1991). 
Macrovascular disease has the same main characteristics in diabetic as in non- 
diabetic patients: the atherosclerotic plaque contains lipids deposits, smooth muscle 
cells, monocytes, phagocytes and calcifications (Levin, 1995). However there are 
important differences in diabetes: the atherosclerosis tends to occur at a younger age and 
advances quicker, sex differences are lost and men and women are equally affected 
(Wilson et al. 1992) and also the vessels below the knee are predominantly affected. 
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Risk factors for PVD in diabetes 
The typical macrovascular risk factors such as, smoking, dyslipidemia, hypertension, 
obesity also predispose to PVD in diabetes. Furthermore specific risk factors such as 
duration of diabetes and hyperglycemia, hyperinsulinemia plus increased coagulability 
and thrombosis introduce an additional atherosclerotic effect. 
Diabetes, predominantly Type 2, is associated with insulin-resistance and 
hyperinsulinemia (DeFronzo et al., 1992) and insulin itself has been reported to be 
atherogenic (DeFronzo and Ferranini, 1991). The advanced-end products of glycation 
may play a role in accelerated atherogenesis in diabetes by interacting with the receptors 
of macrophages and endothelial cells with subsequent increase in matrix production and 
focal thrombosis (Brownlee, 1992) and/or with cytokines release promoting endothelial 
injury and plaque formation (Vlassara, 1990). 
The tendency for increased coagulability in diabetes is demonstrated by a threefold 
increase in tissue plasminogen activator inhibitor type 1 in obese and diabetic subjects 
compared to lean controls (McGill et al., 1994). 
Although both diabetic and non-diabetic patients with peripheral ischaemia can 
display similar clinical signs, such as intermittent claudication, rest pain and eventually 
foot ulceration or gangrene, different vessels tend to be affected in diabetic patients than 
in non-diabetic controls, who tend to have atherosclerotic involvement predominantly of 
the proximal vessels: aorta, iliac, femoral arteries. The most severely affected vessels in 
diabetes, are those below the knee, namely the tibial and peroneal arteries (LoGerfo et 
al., 1984). This feature is typical of diabetes mellitus (Strandness et al., 1993). 
These vessels are often calcified in the medial wall (medial calcification), which is 
also a feature of macrovascular disease in diabetic patients. However the relationship 
between medial calcification and atherosclerotic occlusive disease has not been yet fully 
investigated. 
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1.3.2 Medial arterial calcification 
This was described (Edmonds et al. , 1982) as a `pipe-stem' appearance on the X- 
ray films in diabetic patients with peripheral or autonomic neuropathy. The medial 
arterial calcification was found to be significantly more pronounced in the feet of 
neuropathic diabetic patients than the feet of non-diabetic or non-neuropathic control 
subjects (Young et al., 1993). 
The vibration perception threshold, duration of diabetes and serum creatinine were 
found to be independent predictors of the degree of medial calcification. The level of 
serum creatinine also can be related to the association of medial arterial calcification 
with diabetic nephropathy (Edmonds et al., 1986). As the medial arterial calcification 
seems to be associated with an increased risk prevalence of cardio-vascular mortality, 
this might be partly due to the association with diabetic nephropathy, which itself is an 
independent marker of increased mortality in diabetes (Jensen et al., 1993). 
However despite extensive vascular calcification, high peripheral blood flow at 
rest can be observed in the feet of patients with neuropathy (Gilbey et at., 1989) 
probably due to arterio-venous shunting, associated with autonomic neuropathy in the 
foot (Edmonds et al., 1982) 
Nevertheless medial calcification seems to have an impact on the distribution of 
peripheral vascular disease as shown by a study of 42 diabetic patients with PVD, which 
demonstrated that forefoot -medial arterial calcification predisposed to more severe 
below-knee PVD in diabetes (Chantelau et al., 1996) Furthermore, the medial arterial 
calcification can induce false readings of elevated ankle pressure in diabetic patients 
(Cutajar et al., 1973) 
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Methods for diagnosis and assessment of PVD in the clinic 
Palpation of pulses 
The main question in differential diagnosis of the diabetic foot ulcer is to 
recognise the neuropathic from the neuro-ischaemic foot, the important difference being 
the presence or absence of pulses detected by a simple and often undervalued 
manoeuvre, the palpation of foot pulses. If pulses of either posterior tibial or dorsalis 
pedis arteries are palpable, then significant ischaemia is unlikely. Absence of both 
pulses in the foot indicates a reduction in circulation, which ought to be confirmed by 
measuring the pressure index. 
Doppler assessment and measurement of the pressure index 
The ankle/brachial pressure index (A/B PI), which is the ratio of blood pressure 
measured at an ankle artery to that measured at the brachial artery is considered to be a 
useful tool in the assessment of lower limb ischaemia, by measuring the systolic blood 
pressure in the dorsalis pedis and posterior tibial arteries, and if carefully performed it 
reflects closely the intra-arterial pressure (Bollinger et al., 1976). The pressure index is 
<1 in the presence of ischaemia, whereas in normal subjects is usually A. Thus, 
absence of pulses and a pressure index of <1 confirms ischaemia. Conversely, the 
presence of pulses and a pressure index of 1 should rule out ischaemia. This would 
determine the ulcer management, namely that peripheral vascular disease is not present 
and the ulcer is treated as a purely neuropathic one, without considering angiography or 
angioplasty. 
However some diabetic patients have non-compressible peripheral vessels giving an 
artificially elevated A/B PI, even in the presence of ischaemia. Falsely elevated A/B PI 
measurements may be associated with medial calcification (Edmonds et al., 1986); thus 
they could lead to a subsequent high value despite the presence of peripheral vascular 
disease. In a study of 2092 patients referred for PVD assessment, Goss et al.. (Goss et 
al., 1989) have shown increased prevalence (18.3%) of a raised A/B PI(>1.5) in IDDM 
patients more than in NIDDM patients (4.5%), and in non-diabetic controls (2.8%). The 
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increase in prevalence of a raised A/B PI with duration of diabetes was found to be in 
agreement with the increase in prevalence of medial calcification with the duration of 
diabetes (Ferrier, 1964). These findings of elevated A/B PI might interfere with 
treatment decisions in diabetic neuropathic patients with concomitant peripheral 
ischaemia. 
It is thus difficult to assess the diabetic foot when the pulses are not palpable, but 
the pressure index is > 1. There could be two explanations. The examiner may have 
'missed' the pulses particularly in an oedematous foot and should go back to palpate the 
foot after the vessels have been located by Doppler ultrasound. If the pulses remain 
impalpable, then ischaemia probably exists in the presence of medial wall calcification 
(Edmonds et al., 1982). 
Considering these limitations of the ankle/brachial index other modalities for 
assessment of peripheral vascular disease have been proposed, such as a computer-based 
test using the A/B PI and a treadmill exercise for diagnosis of intermittent claudication 
(Goss DE et al., 1988). 
Toe systolic pressure 
In order to avoid errors of diagnosis of critical limb ischaemia additional methods 
are recommended, such as hydrostatic toe systolic pressure (Chantelau et al., 1995). 
Measurement of toe systolic pressure requires a toe cuff and a device for detecting toe 
blood flow. A toe pressure of 30 mmHg or less indicates critical ischaemia and suggests 
a very poor prognosis ( European Working Group on Critical Leg Ischaemia, 1992). 
Transcutaneous oxygen tension 
This has been also been proposed as a useful method with which to assess the 
functional status of skin blood flow. A recent study has demonstrated the value of 
measuring transcutaneous oxygen pressure on the skin of the dorsum of the foot in 
patients suspected of having critical ischaemia. The reduced values observed in diabetic 
patients have been interpreted as a consequence of peripheral vascular disease (Uccioli 
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et al., 1994). All patients with low oxygen pressure of less than 30 mmHg had clinical 
evidence of critical ischaemia (Jacobs et al., 1992). 
Angiography 
If critical limb ischaemia is diagnosed and serious lesions such as rest pain with or 
without gangrene develop, putting the limb at risk of amputation, angiography is 
performed with the possibility for angioplasty or by-pass if significant artery stenosis is 
detected ( Edmonds et al., 1986). 
Other vascular tests 
Recently a new method investigating the capillary circulation of the foot with 
99mTc-macroagregated albumin perfusion scanning was also proposed as an effective 
predictor for healing; it correlates findings of a poor tissue perfusion with failure of the 
ischaemic ulcer to heal (Moriartry et al., 1994). However this method has not been 
employed in general use. 
Laser Doppler measurements have also been used in assessing the micro- and 
macrovascular changes in patients at risk of foot ulceration, and their association with 
other non-invasive methods could be used in assessment of neuro-vascular reactivity in 
diabetic subjects with neuropathy. 
Conclusion 
A variety of vascular tests can be employed in the diagnosis of peripheral vascular 
disease in diabetes, of which the most commonly used for screening of neuro-ischaemic 
patients in the Diabetic foot Clinic at King's College Hospital are palpation of pulses 
and ankle-brachial pressure index. In the case of those with suspected calcified arteries, 
transcutaneous oxygen tension is also measured. 
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1.3.3 Neuro-ischaemic ulcer 
The initial presentation of the neuro-ischaemic ulceration is commonly as a area 
of superficial tissue necrosis which can be painful, surrounded by a rim of erythema, 
unlike the pure neuropathic ulcer which is not painful and presents frequently as a 
plantar lesion surrounded by callus. 
The neuro-ischaemic lesions occur mainly on the margins of the foot, such as the 
great toe or the lateral borders of the feet. The ulcers tend to be shallow, and not 
associated with callus. Foot pulses are usually absent. 
Claudication in a diabetic with PVD requires close and regular follow-up although 
claudication alone would rarely require surgical intervention. However rest pain when it 
develops in a pink, ischaemic foot is always serious. Digital gangrene may follow, and 
spread, and is much more serious than in a purely neuropathic foot. These changes in the 
neuro-ischaemic foot often lead to major amputation, if angiography, followed by 
angioplasty or by-pass are not performed immediately. 
1.3.4 Management of the neuro-ischaemic ulcer 
Medical management 
This is recommended for some of the patients with ischaemia who tend to be 
elderly, frail and/ or with other diabetes complication such as diabetic nephropathy or 
widespread cardiovascular or cerebrovascular disease, for whom reconstructive surgery 
is not feasible. Ischaemic ulcers may be painful and it may be necessary to prescribe 
opiates. 
Eradication of infection with prompt and specific antibiotic therapy in 
consultation with the microbiologist is recommended as in the purely neuropathic foot. 
However, severe sepsis in the ischaemic foot is an indication for emergency admission, 
first to control sepsis by intravenous antibiotics and surgical drainage, and secondly to 
assess the possibility of revascularization either by angioplasty or reconstruction. 
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Chiropodial treatment 
This is not aimed for removal of callus, as neuro-ischaemic feet tend not to form 
callus in excess, but toward removal of necrotic tissue from the ulcers and, in the case of 
subungual ulcers, cutting back the nail to allow drainage of the ulcer (Foster et al., 
1989). 
However if any lesion, however small and apparently trivial has not responded to 
conservative treatment within 4 weeks, then angiography and revascularization should 
be considered; and when critical ischaemia is present, this referral ought to be initiated 
much earlier (European Working Group on Critical Leg Ischaemia, 1992). 
The neuro-ischaemic foot with gangrene is treated differently than the 
neuropathic foot. When it is possible to improve the circulation by arterial 
reconstruction, then digital amputation can be performed in the ischaemic foot. 
When revascularization is not feasible, the amputation of a necrotic toe should not be 
performed because its healing is unlikely. However, regular debridement by the 
chiropodist along the demarcation line (Foster et al., 1989) could lead to successful 
autoamputation, as long as infection is controlled, in which the necrotic digit drops off 
to reveal a healed stump. 
Extensive gangrene in the neuro-ischaemic foot is either due to severe sepsis or 
complete occlusion of both the superficial femoral and deep femoral arterial systems. 
Sepsis should be controlled by surgical drainage and intravenous antibiotics. Then 
urgent angiography would be required to assess the possibility of arterial reconstruction. 
Surgical revascularization 
Techniques of revascularization of the diabetic foot years have been developed in 
recent years. Angioplasty in the iliac, superficial femoral and popliteal arteries is often 
performed in patients with localised disease, for example stenosis or short (< 10 cm) 
occlusions. However, diabetic patients tend to have lesions in the arteries below the 
knee, but advances in catheter and imaging techniques have made it possible to perform 
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angioplasty in these arteries, although the long-term results are still under appraisal 
(Bakal et al., 1990). 
Arterial bypass in the leg, and distal bypass either to the tibial or peroneal vessels 
is vital in cases of severe sepsis and necrosis to re-establish blood flow to the diabetic 
foot (Edmonds, 1987) and diabetes is not considered anymore a contraindication. 
Prescription footwear 
Footwear is frequently needed in the neuro-ischaemic foot. Unless there is severe 
deformity, when bespoke shoes are recommended, an extra-depth ready-made shoe to 
protect the margins and accommodate the foot should offer adequate protection and 
prevention of ulceration. 
1.3.5 Mechanisms for the development of ulceration in the 
diabetic neuro-ischaemic foot 
The pressure between some parts of the foot and the surface of the foot, on 
standing, could be sufficient to stop the blood supply to those areas. If the neuro- 
ischaemic foot, ischaemic necrosis may occur in the case of tight new shoes maintaining 
a pressure on the skin of the foot when worn for the first time. 
The forces required are not high (7-14kPa) but can lead to ulceration (Brand, 
1978) if maintained for several hours or by continuous friction with the shoe interface, 
especially if it is too tight. If the arterial blood flow is also reduced due to underlying 
peripheral vascular disease, then the skin perfusion could be stopped by an even smaller 
pressure. Thus arteriosclerosis is considered to be a predisposing factor for ulceration, 
especially in neuropathic patients with decreased sensation in their feet, who would not 
be able to identify the discomfort arising in shoes which are too tight. 
The response to such pressure is different in the neuropathic foot compared with 
the neuro-ischaemic foot. In the neuropathic foot, the response to pressure is 
hyperkeratosis and callus formation with eventual ulceration (Edmonds et al.. 1986) 
whereas in the neuro-ischaemic foot, pressure may lead to direct tissue damage. 
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1.4 Conclusion of introduction 
This introductory chapter has described the multiple risk factors involved in the 
aetiology of the diabetic foot of both neuropathic and neuro-ischaemic origin. 
One of the most important risk factors, present in both types of diabetic foot, is 
diabetic peripheral neuropathy. This along with other predisposing factors due to the 
presence of diabetes, such as diabetes duration and long-term complications, diabetes 
control and soft tissue abnormalities plus epidemiological risk factors: history of foot 
ulceration, social status and race, put the diabetic foot at considerable risk of ulceration. 
In the neuropathic foot, elevated plantar pressures are the other main factor 
which can precipitate ulceration. Extrinsic mechanical factors, such as stepping on a pin 
and biomechanical factors, such as foot deformity, limited joint mobility, abnormal 
pattern of gait and level of activity, plus the formation of callus and unsuitable footwear, 
are all factors associated with increased plantar pressures in the diabetic neuropathic 
foot. 
Thus the need to measure plantar pressures inside the shoe of the patient at risk and 
in normal walking conditions, requires the use of a methodology which would not 
interfere with any of the above mentioned mechanical factors. 
Furthermore a reproducible and sensitive technique of foot pressure measurement 
is needed for the quantitative assessment of therapeutic interventions used to reduce 
plantar pressures, such as removal of callus and provision of footwear. 
The neuro-ischaemic foot , which is characterised by the presence of diabetic 
peripheral vascular disease and neuropathy, has also a high risk of ulceration. From 
observational studies it is known that diabetic neuro-ischaemic patients tend to ulcerate 
on the margins of the foot and form less plantar callus. Nevertheless the other main 
factor involved in ulceration, the foot pressures and their pattern of distribution have not 
been studied in the neuro-ischaemic foot. 
Diabetic microvascular disease has been associated with the foot at risk of 
ulceration. Abnormalities in skin axon reflexes have been demonstrated in the 
neuropathic foot. However the effect of neuropathy on the function of microvascular 
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wall components, i. e. the endothelium and smooth muscle function, has not been 
previously investigated. 











Callus present absent 
Site of ulceration plantar margins of foot 
Foot pressures elevated unknown 
Pattern of pressure distribution variable unknown 
during gait 
It is surprising that relatively little research has been carried out in the 
investigation of factors leading to ulceration in the neuro-ischaemic foot, especially with 
regard to its distinctive characteristics from the neuropathic foot. 
Therefore research in determining the risk factors for the neuro-ischaemic as well 
as the neuropathic foot is needed. Exploring the intrinsic mechanisms through which all 
these risk factors interact and eventually lead to ulceration may provide a better 
understanding of the pathogenesis of foot ulceration, which then could be used in 
designing prevention and therapeutic strategies. 
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Chapter 2. AIMS OF THE THESIS 
The diseased diabetic foot especially if neglected and followed by gangrene and 
amputation, is one of the most important complications of diabetes in terms of 
morbidity and healthcare costs. 
Reducing its incidence by adequate prevention and treatment can only be done if 
the pathogenesis of ulceration in the diabetic foot is fully researched and understood. 
However the understanding of the multiple factors, such as foot pressures, diabetic 
neuropathy and vascular disease and their interactions in the pathway to neuropathic 
and/or neuro-ischaemic ulceration requires further research. 
The aims of this thesis were four fold: 
1. to establish a novel, practical and reproducible methodology for measurement of 
plantar pressures inside the shoe during normal walking conditions. 
2. to measure the plantar pressures under the neuro-ischaemic foot in comparison to the 
neuropathic foot using the newly established methodology, exploring the hypothesis that 
foot pressures may be responsible for the difference in the sites of ulceration in the two 
types of diabetic foot and in order to understand better the role of foot pressures and 
their interactions with other factors involved in the pathogenesis of ulceration in 
diabetes. 
3. to quantitatively investigate 
- the effect of formation and then removal of callus on plantar pressures, 
- the degree of plantar pressures reduction achieved with different types of 
footwear, exploring the hypothesis that therapeutic interventions, which are routinely 
used in the Diabetic Foot Clinic, are efficacious in reducing elevated foot pressures. 
4. to explore the effect of neuropathy on the endothelial and smooth muscle 
performance with the hypothesis that microvascular function is influenced by the 
presence of neuropathy in the foot prone to ulceration. 
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Chapter 3. FOOT PRESSURES MEASUREMENT 
3.1 Background 
The forces acting on the plantar surface of the foot which consist of two 
components: vertical forces or direct pressure normal to the surface, and shear forces 
tangential to the surface, play an important role in the aetiology of the foot. Therefore 
measuring these forces would be useful in diagnosis and assessment of foot disorders 
associated with peripheral neuropathy, Hansen's disease, spina bifida and orthopaedic 
conditions. In diabetic neuropathy, a relationship between high foot pressures and foot 
ulceration has been reported (Ctercteko et at., 1981; Veves et al., 1992). The 
abnormally high pressures occur in an insensitive foot which lacks the ability to detect 
and respond to noxious stimuli and therefore fails to redistribute these pressures leading 
to ulcer formation. The shear force has also been shown to have a cumulative effect with 
vertical force and contribute to ulcer formation (Bennett et at., 1979). Measuring the 
forces in the foot would allow preventative measures to be undertaken to reduce the risk 
of foot ulceration. 
The `ideal' system for foot pressure measurement as defined by Cavanagh et al. 
(Cavanagh et al., 1992) underlines the Kelvin's law: the act of measurement should not 
interfere with the characteristics being measured. Therefore an `ideal' device for plantar 
pressure measurement would cover a dynamic range of pressures from 0-2Mpa, with a 
linearity of <5% full scale, a sampling rate >50Hz, an amplitude resolution <lOkPa, a 
spatial resolution <1mm2, a hysteresis <5%, and a thermal stability <5% for 10°C 
change in temperature. The importance of spatial resolution in assessing peak plantar 
pressures has been stressed recently by Cavanagh (Cavanagh et al., 1996 ), but in 
clinical use it may not be necessary to assess the overall pressures but the localised areas 
under metatarsal heads most prone to ulceration, which describe an ellipse 
(approximately 1/0.5cm) and therefore it may be possible that small pad sensor or 
localised analysis of foot pressures would be more adequate for clinical use. Regarding 
the frequency of sampling, a high sampling rate is necessary if jumping or running 
measurements are done, but if neuropathic patients who walk slowly are to be assessed, 
lower frequencies are still acceptable. 
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However at the moment the results from different groups doing clinical research 
in foot pressures cannot be compared because of differences in sensor size affecting the 
resolution of devices and non-standardised collection of data protocols. Furthermore 
plantar pressure units are not standardised. 
In a recent paper from the Foot Pressure Interest Group, which is working 
towards standardisation in foot pressure measurement (Barnett, 1996) the need for 
standard user calibration, such as a standard sampling rate, was expressed. Also a spatial 
resolution of up to 5mm was considered to be acceptable. 
Likewise, considering the variety of methodologies used for foot pressure 
assessment, the need of standardisation arises once more in order to allow comparisons 
between studies. Some groups use long walkpaths, which allow 3 steps before and after 
the force plate, therefore measuring mid-gait pressures, whereas others use the' first 
step' pressures; however both methods are considered to be rigid and interfere with the 
`normal' walking. Therefore free walking is recommended. This would also preserve the 
patient's normal pace, whereas when a metronome is used to control the walking speed, 
this can induce alterations in the normal cadence. When analysing the measurements, 
the peak plantar pressures and pressure time integrals would be advisable to be 
quantified from a mean of 3-5 steps, which are considered to be suitable for 
interpretation of foot pressures. 
Several systems for barefoot and more recently for in-shoe measurement of 
plantar pressure are commercially available. They have enabled researchers to make 
clinical investigations which were hitherto impracticable. In-shoe sensors can make a 
potentially valuable contribution to the design and prescription of footwear and orthoses 
(Rose et al., 1992; Corbett et al., 1993; Albert and Rinoie, 1994; Lord and Hosein, 
1994), and in addition can enable further exploration of the causative factors of foot 
problems, notably those of diabetic ulceration, in realistic shod conditions (Cavanagh 
et al., 1985; Pitei et al., 1995). 
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3.1.1 Systems for assessment of shear forces under the foot 
Shear forces are thought to play a key role in pathogenesis of foot ulceration. 
The role of shear stresses in the aetiology of ulcer formation was stressed by Bennett et 
al. (Bennett et al., 1979) who showed that if shear forces act simultaneously with 
vertical ones, only 50% of vertical forces would be enough to occlude the blood flow in 
the foot. Reduced blood flow may decrease the tissue repair ability and lead to 
ischaemic lesions. However techniques for measurement of shear forces are not so well 
developed as those for the assessment of vertical forces. This is because of the technical 
difficulties arising from the fact that placing a transducer inside the shoe would interfere 
with the normal shear stresses by accentuating them. However one of the first attempts 
to develop a discrete shear transducer were made by Tappin and Pollard (Tappin and 
Pollard, 1980) and later by Lord and Hosein (Lord and Hossein, 1992). Both 
transducers used the same magneto-resistive principle: the movement of a magnet 
relative to a magneto-resistive element is proportional to the applied force and leads to a 
change in resistance. The maximum excursion of 0.6mm corresponds to a shear stress 
of 250kPa. The shear transducer developed at King's College School of Medicine and 
Dentistry was based on the same magneto-resistive principle, and was able to measure 
not only shear in two orthogonal directions but also direct pressure. It was aimed to 
place the transducer under the metatarsal heads. These were detected by direct palpation 
or by a novel approach, using a F-Scan pressure-measuring insole to detect the areas of 
maximum pressure on the map of the foot. The peak pressures measured under the 
palpated markers were on average only 50% of the true peak recorded by F-Scan 
suggesting that the method of palpation mislocated the area of peak pressure (Lord and 
Hosein, 1992). These findings highlight one of the problems occurring with discrete 
transducers, whether for assessment of shear or vertical forces, in placing and 
maintaining them in the correct position under the foot. Another clinical study (Pollard 
et al., 1983) using shear transducers in normal subjects was done barefoot and in a 
variety of footwear. They found the longitudinal shear under the first metatarsal to be 
the greatest in barefoot walking, whereas the walking cast reduced both the longitudinal 
and transverse components of the shear forces plus the vertical forces offering both a 
mechanical explanation for the healing of neuropathic ulcers in a plaster cast and an 
insight into a possible mechanism of ulcer formation. A study of relative timing of shear 
forces on the sole of the forefoot during walking (Tappin et al., 1991) has also 
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described the cumulative effect of shear and vertical forces in time: the maximum shear 
stress occurred at the same time as the maximum vertical stress under the first and 
fourth/ fifth metatarsal heads. 
The shear force transducers await further development (Laing, 1992). Recently a 
new type of shear transducer, the Kent shear system was introduced. It uses piezoelectric 
copolymer film for in-shoe biaxial shear force measurement: (Akhlaghi and Pepper, 
1996). This system using a lOx 10x3.6 mm copolymer film transducers has been 
developed to allow the simultaneous measurement of two orthogonal shear forces , at 
four sites under each foot over multiple footsteps in every day footwear. and it has been 
shown that this system successfully measures in-shoe shear forces. Further research is 
needed to demonstrate the effect of shear forces on the skin and soft tissues of the foot 
and their role in the foot pathology. 
3.1.2 Systems for assessment of vertical forces under the foot: 
barefoot and in-shoe measurements 
Barefoot measurements 
Force and load distribution measurement platforms have been used for static 
and dynamic measurements of foot pressures. The Kistler force plate (Kistler 
Instruments Ltd., Whiteoaks, The Grove, Hartley Wintney, Hants, UK) measures total 
vertical and shear forces with an accuracy greater than 1% and sensitivity to 0.05Pa, 
over full-scale ranges of 200kPa for vertical forces and +/- 50kPa shear forces. However 
the system is not able to measure plantar load distribution being mainly used for gait 
analysis. Nevertheless the high specification, good repeatability and long-term stability 
have recommended the Kistler force plate as the `Gold standard' for plantar loading 
measurements (Cobb and Clermont, 1995). 
The Musgrave Footprint system (Musgrave Footprint, Preston Communications 
Ltd., Llangollen, Clwyd, UK) is a method for the measurement of plantar load 
distribution under the barefoot. Its force-sensing resistors consist of two polymer sheets: 
one coated with pectinate electrodes, the other with semiconducting material. When the 
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force is applied, the contact area between the two layers increases leading to a 
logarithmic change in resistance. There are 2048 3*3mm sensors in a matrix 
distribution. A sensor's response to a load above 11OkPa can vary by 2% per loading 
cycle; above 1000kPa the variability increases to 15%. The temperature coefficient is 
load-dependent around 0.1% per Kg°C-1 and a possible clinical limitation could be the 
reduction in sensitivity with increasing load (Cobb and Clermont, 1995). In clinical 
studies a period of accustomisation was always necessary as demonstrated in a study on 
86 healthy subjects (Bennet and Duplock, 1993) or in another study assessing the 
effect of reconstructive surgery for different foot conditions (Roggero et al., 1993). 
The optical pedobarograph is a high-resolution technique for imaging the plantar 
load distribution being particularly advantageous for detection of sites of high pressure. 
This is extremely important, as highlighted by Lord and Reynolds (Lord and Reynolds, 
1986), in early detection of areas at risk of foot ulceration. 
The pedobarograph consists of a glass plate covered with an opaque material, 
typically a plastic sheet (Betts and Duckworth, 1980). When the force is applied, the 
change in the contact level between glass and plastic leads to a change in the amount of 
light propagated in the glass plate with a change in the refractive index, areas of contact 
showing as low-intensity regions (Franks and Betts, 1983). There is a range of 
transducer materials raising various problems such as adhesion to the glass plate, 
material deformation and wear, saturation within the range of interest, poor dynamic 
response time, dependence on the surface granularity, non-linearity, although the best 
transducer materials can reach a linear relationship between the pressure and light 
intensity (Franks and Betts, 1988). The pedobarograph is also dependent on 
temperature with a variation of 10-15% over 20-30°C. Numerous clinical studies have 
used the pedobarograph in orthopaedics (Betts et al., 1980)or in diabetic foot (Boulton 
et al., 1987). 
Another optical technique for high resolution imaging of foot pressure was 
developed by Rhodes et al. (Rhodes and Sherk, 1988) using an photoelastic sheet and a 
polariser bonded to a walkway, which is comparable to the pedobarograph with the 
advantage of temperature-independent responses (Cobb and Clermont, 1995). 
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In-shoe pressure measurements 
In-shoe foot pressure measurements have two main advantages over the barefoot 
measurements: they assess the forces developed at the shoe-foot interface, mostly 
implicated in the foot ulcer formation (Cavanagh et al., 1992), and it is possible to 
determine these forces during different gait phases (Hennig and Cavanagh, 1994). 
Discrete transducers for in-shoe pressure measurements 
The in-shoe discrete transducers which allow in-shoe pressure measurement at 
specific plantar sites introduce the risk of inadequate placement of the transducers in 
relation with the areas of interest (Lord and Hosein, 1992). However an accurate 
method of locating the discrete transducers was used by Akhlaghi et al. (Akhlaghi and 
Pepper, 1996) in a study highlighting the importance of using in-shoe pressure 
measurements of multiple steps in comparison to single-strike force plates, which give 
variable results. 
The capacitive pressure transducers respond to application of force with a 
change in capacitance; their sensitivity varies over the sensor area reducing from the 
centre, where this is ±5kPa, to ±3OkPa at periphery; therefore accuracy of the output 
depends on the load distribution. The frequency response is 12Hz, limiting measurement 
to slow walking speeds as described by Kothari et al. (Kothari and Webster, 1988), 
who proposed their use as an `electrotactile' feedback system to restore sensation to 
patients with diabetic neuropathy. 
The piezoelectric ceramic transducers are placed in a polyurethane case not only 
to protect them from moisture, but also to allow an even distribution of pressure and 
reduce the sensitivity to lateral strain (Gross and Bunch, 1988). The piezoelectric 
transducers using a copolymer film such as polyvinylidene fluoride (PVDF) were 
located into a 3mm thick lacquered cork insole at eight sites (Nevill et al., 1995). 
Although their technical characteristics were better than those of the ceramic ones (non- 
linearity 1.5% vs 3.4%, hysterisis <1.5% s 5.8%, frequency repines >20Hz vs >50Hz), 
the transducers using a copolymer film required periodic relaquering to reduce charge 
leakage arising from in-shoe humidity. These discrete transducers can still introduce 
errors by concentrating the load at the measurement site with consequent high readings 
70 
or saturation, ideally the thickness of the sensor should be below 0.5 mm to avoid these 
errors (Ferguson-Pell, 1980). 
The Electrodynagram system (Langer Biomechanics Group Ltd., The Green, 
Cheadle, Stoke-on-Trent, UK) uses seven sensors with a thickness of only 0.3 mm and 
contains an integrated circuit with a resistive bridge. It has been used in studies of 
diabetic foot ulceration (Smith and Plehwe, 1989) or in assessing the effect of heel 
height on foot function (Gastwirth and O'Brien, 1991) because it allows both in-shoe 
and barefoot pressure measurements. 
An electro-optical force transducer containing a spring mounted in an extra- 
depth shoe acts to occlude transmission of light between a LED and a photodetector 
(Maalej and Webster, 1988). However this would be difficult to use in clinical practice 
because it requires fitted footwear and it is difficult to align the sensors. 
In conclusion, although discrete transducers are advantageous by assessing the 
forces at the shoe-foot interface and allowing the correlation of load distribution with 
the different phases of gait, their mechanical properties such as thickness and size can 
also significantly affect the pressure distribution. 
Insole transducers for in-shoe pressure measurement 
A solution to the mechanical drawbacks of the discrete transducers can be to 
incorporate numerous transducers distributed in a matrix system in an insole, which 
would be placed inside the shoe with minimal effect on gait and pressure distribution. 
Insoles containing an array of piezo-electric transducers were developed. Hennig et al 
(Hennig and Cavanagh, 1982) constructed an insole with 499 piezo-electric ceramic 
transducers contained in a silicone rubber, with good technical characteristics: 0- 
1500kPa measurement range, 0.5kPa sensitivity with 1.5% variation over 10-40°C, non- 
linearity ±2% and hysterisis 1%, but requiring individual calibration for each sensor 
because of variation in their individual sensitivity. This type of insole can be difficult to 
build and can develop rapid mechanical fatigue, which can be avoided by using piezo- 
electric polymer (PVDF) film (Pedotti and Assente, 1984). Sixteen circular metallic 
discs were englobed into the film and the variability between sensors was much reduced 
±3%. 
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However for both types of piezoelectric insoles a few sources of error were 
discovered: additional charge generation due to lateral stretching, compressional heating 
and frictional heating during gait (Cobb and Clermont, 1995). 
The EMED Pedar system (Novel Gmbh, 80802 Munchen, Germany) has a 
capacitive sensor matrix. The insole consists of 99 sensors and it is 2mm thick, with 
individual sensors occupying an area of 17mm2. The sensor range is 30kPa-600kpa with 
a sensitivity of lkPa varying by ±5% over a temperature range of 10-40°C. It has a low 
hysteresis <3%, frequency response to 50Hz and good (intraclass correlation 
coefficient=0.84) day-to-day variability (McPoil et al, 1995). Due to its reliability the 
EMED has been used extensively in biomechanical studies and in clinical trials 
involving patients with diabetic foot ulcers (Cavanagh et al., 1992). 
Conductive and resistive technologies have been also employed in recent years 
in foot pressure analysis. An insole was developed by Peruchon et al. (Peruchon et al., 
1989) to measure variation in conductance of a conductive polymer when force is 
applied. Each sensor consists of a ground and an outer electrode, the current between 
electrodes increases with compression of polymer. The technical characteristics are less 
impressive; from 0-225kPa material compression is 15%, hysterisis is 12%, and non- 
linearity is 16%, after 225kPa nonlinearity increases to 26%. The measurement range is 
0-300kPa with a sensitivity of ±2OkPa, but the response is temperature independent for 
15-35°C. The Podo-Dyno-Gram system (PKS Electronics, Belgium) has been recently 
developed. It has an insole consisting of a mylar substrate which contains 64 circular 
sensors. They are force-sensing resistors with a measurement range of 0-800kPa and a 
sensitivity ±20kpa, non-linearity is less 10% (Cobb and Clermont, 1995). 
The F-Scan (Tekscan Inc., 307 West First Street, South Boston, MA 02127- 
1342, USA) is a system used fairly widely with a stated sensitivity of ±4%kPa. This is 
based on Force Sensitive Resistor (FSR) technology, which offers the advantage of very 
thin construction together with high spatial resolution. This concept was first 
introduced for medical application as a dental bite sensor (Podoloff and Benjamin, 
1989), and is now available for applications in gait analysis, prosthetic socket design, 
prosthetic knee joint design and seating. 
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Conclusion 
The in-shoe foot pressure measurements give valuable information about the 
forces developed at the foot/shoe interface, information which, the platform systems 
such as the Kistler force platform and the pedobarograph, although reliable, fail to do. 
The discrete transducers however are difficult to place and maintain at 
predetermined anatomical locations on the foot, because they can migrate due to the 
lateral stresses developed at the foot-shoe interface. This also means that the foot 
pressures cannot be assessed in the areas of the foot between the transducers. They also 
can act as foreign bodies in the shoe and alter the pressure measurements. 
However the matrix devices for in-shoe measurements, such as the F-Scan 
system, which consist of a large number of sensors evenly distributed permit an overall 
assessment of foot pressures and allow visualisation of pressure distribution inside the 
shoe. 
They also have the advantage in comparison with more traditional platform that 
the data can be collected from multiple steps without the risk of "targeting". Patients do 
not need to alter their walking pattern to make contact with the platform. 
Their disadvantages are related to the fact that they are more susceptible to 
mechanical breakdown as they are placed in and out of the shoe or subjected to repeated 
loading on the same area. They are more exposed to the in-shoe conditions of 
temperature and humidity and uneven contour. The position of the sensor relative to the 
floor influences the type of force measured, the true vertical forces are measured on the 
platforms whereas the in-shoe insole at its best, would probably measure the `normal' 
pressures because of its position to the ground (McPoil et al., 1995). 
Nevertheless the in-shoe pressure measurements are essential for the clinical 
understanding of ulcer formation and also for the design and assessment of prescription 
footwear to maximise its benefit to the patient. 
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3.2 F-Scan -a new method of foot pressures measurement 
One of the matrix systems for in-shoe foot pressure measurement is the F-Scan 
system which uses a pressure-sensitive insole placed inside the shoe, connected to a 
computer. The distribution of the vertical plantar pressures developed inside the shoe 
during normal walking conditions can be visualised instantly, recorded and analysed in 
order to detect the areas of peak pressures, the most prone to ulceration in a diabetic 
neuropathic foot. 
3.2.1 Description of the F-Scan system 
The system provides an ultrathin (0.16mm) and flexible pressure-sensitive insole 
to be placed inside the shoe. The insole was trimmed specifically to fit the shoe shape 
and size, by following the concentric tracings indicated on the insole which 
corresponded to different shoe sizes for men, women, girls and boys. The patients are 
asked to slip their foot inside the shoe very carefully because the insole can be easily 
creased. This is also why the handle extending from the side of the insole needs to be 
reinforced with sellotape at the points of insertion. 
Fig. 3.2.1 The F-Scan insole is placed inside the shoe and inserted directly in an 
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amplifier fixed to the ankle of the patient 
The handle connects directly into a cuff unit attached to the patient's ankle to 
provide preamplification and signal conditioning. A 9.25 m long coaxial cable links 
the amplifier to an IBM-compatible personal computer with an interface hoard, 
which runs F-SCAN Gait Analysis software version 3.65 to store and analyse the 
data. 
3.2.2 Recording technique 
The recording parameters can be set to suit the type of study undertaken: the range 
of frames to record is 1-285, the frequency expressed as frames per second is 0.000250- 
126.9Hz, the period range is 0.007878-4000.0 seconds per frame. Once the insole is 
placed inside the shoe and the patient is ready to start the test, the "recording" function 
visible on the screen is clicked and the F-SCAN displays `live' the map of the foot and 
the gait sequence on the screen. 
Fig. 3.2.2 Recording technique for the F-Scan system of in-shoe 
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foot pressure measurements 
Then the recording is processed by the computer and the data can be saved on 
the disk. `On the spot' or later the recording can be re-installed using a `Playback' 
function, when the F-Scan operates similar to a video-recorder. 
3.2.3 Calibration technique 
The subjects are weighed before starting the first run. Then their weight is 
entered into the system, which is to be calibrated against each individual weight. The 
subjects are asked to stand on a single foot for 2-3 seconds looking straight ahead and, 
taking a little support, if needed, to reduce sway and load their entire weight evenly on 
one foot. When the pattern of pressure loading is seen to be stabilised and distributed 
evenly on the screen, the calibration system is triggered. The procedure is repeated then 
for the other foot. 
3.2.4 Analysis of the recording 
F-SCAN data recorded from different runs can be recalled and analysed in one 
or two active windows side-by-side on the screen. The gait mode displays a two- 
dimensional representation of the plantar pressures sequentially from heel-strike to toe- 
off. The increase in pressure is seen as a change in colour of the pressure map from blue 
to red as a function of time. 
Fig. 2.3 \n; ilv ý1, ii the F-Scan recording of foot pressures 





When the "Average" function from the screen is activated a smoothing effect on 
the immediate surrounding cells occurs and reduces the possibility of artefacts. 
In order to measure the peak pressures at different locations on the plantar 
surface of the foot, the analysis allows up to four areas of interest (boxes) to be assessed 
by the operator. The boxes are adjustable to fit the area of interest from a minimum of 
10* 10mm (2cells*2cells) to a maximum of 300* 105 mm (60cells*2lcells) covering the 
entire field for one step. The boxes can also be moved in different locations on the map 
of the foot allowing the investigator to assess plantar pressures in a specific area of the 
foot, such as forefoot or heel. 
The F-Scan software enables analysis of the vertical ground reaction force versus 
time, the pressure versus time or the peak pressure versus time. The actual values can be 
obtained from the graphs for the areas of interest in each recorded step. 
The centre of force path, which is the path that the maximum pressure follows 
from the heel to the toes during a single gait cycle, can be also assessed. 
There is also the possibility to view the pressures developing sequentially from 
the heel strike to toe-off in a three-dimensional mode, which shows the pressures as 
peaks acting on the sensor at each moment in time. This can find use as an explanatory 
tool in the education of patients. 
Terminology 
When describing values of plantar pressure recorded, clinical significance is placed 
upon the highest value of pressure measured. In this thesis, strict definitions of the terms 
"peak" and "maximum" are adopted to provide clarity with respect to spatial and temporal 
factors. 
When looking at a snapshot of the pressure distribution beneath the foot at one 
instant in time (spatial analysis) there may be several discrete areas of peak pressure 
evident at that particular moment. 
When pressure is recorded at discrete locations beneath the foot against a timebase 
(temporal analysis) there will be a maximum value of pressure registered at each location, 
which describes the highest value observed in the time period. 
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3.3. Validation of F-Scan methodology in laboratory conditions 
Time-dependent behaviour of the F-Scan plantar pressure measurement insole 
3.3.1 Introduction 
The F-Scan system is a relatively new method for dynamic in-shoe foot pressure 
measurement which accompanies a software for gait analysis. The foot pressure 
assessment is based on the principle of a force-sensitive resistor, which provides a high 
resolution of measurement. The sensor is thin and unobtrusive in the shoe, the sampling 
rate (1-100Hz) is adequate for most clinical applications and the software is user 
friendly (Woodburn and Helliwell, 1996). Good reproducibility was reported in a 
study of static and dynamic foot pressures measurements by Rose et al. (Rose et at., 
1992). Fergusson-Pell and Cardi (1993) have demonstrated a high degree of linearity: 
coefficient of linear regression >0.99, although in the presence of creep (calculated as a 
percentage of the initial reading: 7.5% at 2 minutes and 13.5% at 10 minutes of 
100mmHg applied pressure) and hysteretic (calculated as the maximal difference in 
average measured pressure as a percentage of the applied pressure at the point of 
maximal difference: 22%) effects for the seating sensor. 
Therefore the technology is known to suffer from a number of drawbacks which 
are inherent in the polymeric inks used to lay down the printed circuit which forms the 
sensitive matrix. Rose et al. (1992) also indicated that calibration between separate 
sensors was poor and that sensor pads showed significant wear with use. 
Furthermore the variability of both F-Scan and EMED insoles was assessed by 
McPoil et al. (McPoil et al., 1995), through a series of bench tests in which known 
pressures were applied using a rubber bladder filled with compressed air. When the 
pressure was repeatedly applied, the measured pressure versus known pressure showed a 
linear behaviour in both insoles, though with larger variability in the F-Scan insole. The 
average error at 50kPa was 16% for EMED, and 4% for F-Scan and at 500kPa, it was 
0.8% for EMED and 24% for F-Scan. When a continual load of 150kPa was applied, the 
creep, which is the ability of the material used in the manufacture of insoles to resist 
change under an applied load over time, was found to be <3.4% and had a linear pattern 
for EMED, whereas the total creep for F-Scan was 11.6% and the pattern of creep did 
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not appear to be linear. When the F-Scan calibration was tested with an 
electromechanical testing machine (Instron 4505) by applying a known load and taking 
the output from the F-Scan system, the results showed a variability of 0-50% of pressure 
values between sensing cells. They also found a sensitivity of ±5kPa using static 
calibration, with day-to-day variability and test-to-test variability (10-20kPa for each 
cell and 4-100kPa between cells). The authors suggested as a solution to this problem to 
take an average pressure value of a number of elements which produce lower pressure 
values. (Nikolopoulos, 1996). Recent Tekscan reports on the new ink developed by 
them, have shown an improved cell-to cell variability of <5% if the sensor is calibrated 
prior to use and tested with the averaging option activated. 
3.3.2 Rationale and aims for the validation studies 
Considering that the F-Scan system was intended for clinical research and 
practice, these accounts of numerous impediments in the use of F-Scan highlighted the 
necessity for assessment of the technical characteristics of the insole and for validation 
of the version of F-Scan system in use in the Diabetic Foot Clinic at King's College 
Hospital. This version uses an improved software and the latest F-Scan insole, 
manufactured with a new conductive ink supposed to reduce creep and hysteresis. Thus 
it was aimed to test the insoles initially in laboratory conditions in order to characterise a 
number of aspects, particularly cell-to-cell variability, threshold, temperature sensitivity, 
sensitivity to bending, alleged initial 'bedding-in' and creep behaviour. Then a validation 
study in clinical conditions was planned in order to allow the development of a 
methodology for the use of F-Scan with reduced variability and increased reliability. 
Aim of the laboratory validation study 
The aim of the study was to evaluate the initial bedding-in and longer term time- 
dependent behaviour under cyclical loading. Pressures have previously been recorded 
for the seating sensor (Tekscan "Seat"), and showed an increase of 8-18% after 2 
minutes of steady loading, and 13.5-26% after 10 minutes, dependent on loading level 
(Ferguson-Pell and Cardi, 1993). This study has been performed to increase awareness 
of the behaviour of the system in order to allow selection of optimised calibration and 
trial procedures. This may help maximise the usefulness of this technology. 
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3.3.3 Method for creep tests 
F-SCAN system as described in the previous subchapter. 
Testing methodology 
The F-Scan insole is manufactured by sandwiching a printed circuit of force- 
sensitive resistive (FSR) material between two layers of Mylar substrate. The full-size 
insole (US men's size 14) consists of 960 pressure square cells spaced 5mm apart and 
evenly distributed in a grid-like configuration. Each cell acts as a force measuring 
device, the system software calculates the average pressure on each cell based on the 
measured vertical load and the cell area. 
Fig. 3.3.1 F-Scan insole 
An Instron model 1195 applied loads to the pressure sensitive insole, which 
was placed between two metal rectangular plates ( 310 mm x 120 mm). 
An additional layer (3 mm thick) of foam with small even pores, which is 
normally used in the manufacture of bespoke shoes, was inserted under the F-Scan 
insole for the following reasons: 
1. to spread the load, which is applied by the Instron plates in an uneven manner on 
a micro-scale: without the foam typically a mix of point and line contacts are seen. The 
foam provides additional compliance by producing local spatial redistribution. 
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2. Also in clinic, the insole would not be sandwiched between metal plates but 
between the soft tissues of the foot and the shoe insole. Thus the foam was also added to 
mimic as far as possible in this laboratory experiment, the in-shoe conditions. Unless the 
pressure is evenly distributed across each cell, errors will be introduced. 
applied load 
foam 
Fig. 3.3.2 The F-Scan insole and an additional layer of foam were placed between the 
two plates of the Instron machine 
3. the thickness (3mm) of the foam allowed redistribution of pressure without 
adding a significant movement of the Instron when compressing the foam. This 
movement could lead to notable delays in application of load by the Instron, if the foam 
is thicker. 
4. in order to mimic the pressure (cca. 200 kPa) developed under the foot in a good 
orthopaedic shoe, a high force (cca 6000N) has to be applied over an insole of 
approximately 300 cm2. When this high force is applied, the Instron plates despite their 
rigid construction, bend at the outer edges resulting in an uneven pressure distribution 
falling off from the central area towards the edges. 
In theory, with a layer of foam inserted, the variation in pressure from centre to 
edges is approximately proportional to (t2 -t 1)/t0, where to is the original thickness of 
the foam and ti, t2 are defined in Figure 3.3.2. With an even pressure distribution, plate 
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deflection will be solely determined by its stiffness, and hence (t2 - tl) is fixed; this 
condition of zero pressure variation can therefore only theoretically occur as to=-o. 
Hence inserting a thicker layer of foam causes the deflection of the plates at the edges 
to become less significant compared to the plate travel and the resultant pressure 
distribution is more even. However a very thick layer of foam can introduce viscoelastic 
delays, which can affect the dynamic response. 
Thus an acceptable foam thickness, such as 3mm, would allow for an even 








Fig. 3.3.3. Tridimensional representation of the F-Scan recording of pressures 
In cyclical tests, the plates were driven by a ramp displacement with reversal at 
a preset load; ramp velocity was varied to control the cycle time. Figure 3.3.3 shows a 
three dimensional representation of the F-Scan recording of pressures, achieved with a3 
mm layer of foam and a ramp velocity of 20 mm/minute between loads of 100 N and 
6400 N. 
In cyclical tests any creep behaviour of the insole could be a function of time or 
related to the number of cycles: to discriminate this the ramp velocity of the Instron was 
increased in some tests to 50 mm/minute. 
For static tests, a constant load of 3100 N was maintained this resulted in small 
oscillations of about 20 N around the set load level as the Instron periodically took up 
x compression of the foam to maintain the required load. 
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Procedure 
A single layer of closed cell foam of thickness 3 mm was cut to the size of the F- 
Scan insole. A new insole was then laid onto the foam and placed between the loading 
plates. 
During each trial, the F-Scan was set to record for 200 seconds at 5 frames per second. 
This was a compromise to achieve a reasonable length of trial at a sampling rate 
sufficiently high to capture data accurately during cyclic testing 
The response of the F-Scan system was (initially) calibrated against the load 
delivered by the Instron. A load of 5500 N was applied and held for 2 seconds and then 
the F-Scan response was scaled against the load. 
In the first series (A), a load cycle of 100 - 6400 N was applied in 6 trials each of 
20 cycles over 200 seconds. A5 minute rest period was allowed between trials, as 
preliminary observations showed a recovery phenomena, which seemed complete after 5 
minutes. In the last two trials, A7 and A8, the ramp velocity was increased from 20 to 
50 mm/minute, with the same cyclic load. The F-Scan rate of sampling was kept the 
same in A7 trial as in Al-6 at 5 frames per second for A7, but in A8 trial the rate of 
sampling was doubled (10 frames per second, for 100 seconds, for better time 
resolution. 
Another series of trials (B) were performed as for (A) but with the addition of a 
thermocouple to monitor the temperature at the interface between the insole and foam. 
In the first B trial (B 1), the Instron was set as for A 1-6 series; in the second B trial (B2) 
the Instron was set to apply double the load at double the frequency. A model H400 
Digital Thermometer (Hale Instruments Ltd., Cheshire, UK) with a miniature 
thermocouple was used to monitor temperature resolution of 0.1 °C and accuracy 0.5 
°C. 
In the final series of trials (series C), a steady load of 3100N was maintained for 
each 200 seconds trial period. The recovery period was again 5 minutes. 
Care was taken to start each series A and C, with a completely new insole. The insole 
used in series B had undergone a number of trial cycles prior to the series. 
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F-Scan pressure analysis 
In all trials, pressure analysis was done with the F-Scan `Average' function to 
reduce cell-to-cell variability; this function averages across any adjacent 3 by 3 matrix 
of cells. Pressures were displayed against time and the `Peak' function selected the 
highest pressure recorded in any specified loading cycle. 
3.3.4 Results 
Cyclical load trial 
An example F-Scan graph of pressure against time for a single trial in the A 
series (A3) is shown in Figure 3.3.4. There is an upward drift in apparent peak of 









Fig. 3.3.4 Loading profile recorded from F-Scan in cyclical loading 
In every trial, peak pressure rose during the 20 cycles: e. g. for series A, trial 3, 
the initial and final peak pressure readings were 272kPa and 316kPa respectively. 
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The mean increase for the first six trials in series A was: 14.712.1 (9.4-23.5)% 
from the first to the last peak; and respectively 8.5±1.7% when measured in the first 
peak after 30 seconds versus the last peak. 
In the fast speed trials A7-A8, the mean increase in measured pressures from the 
first to the last peak was 12.8±2.9(9.9-15.7)% and 4.3± 2.2 (2.1-6.6)% from the first 
peak after 30 seconds to the last peak. 










Fig. 3.3.5 Example plot of peak pressure 
per cycle; after an initial rapid rise, the plot is 
approximately asymptotic to a straight line 
An asymptote was determined for this latter part of the curve, as shown in Figure 
3.3.5. The rise period for the first rapid phase of the curve was estimated, taken to where 
the curve joined the asymptote. Accuracy of rise periods is ±5 seconds (i. e. one half 
cycle). 
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Trials conducted at the slower cycling rate (A1-A6 at 0.1 Hz) gave a mean rapid 
rise period of 74±6 (62-84) seconds: this can be compared to a rapid rise at the faster 
cycling speed (A7-A8 at 0.25 Hz) of 58-59 seconds. In terms of cycles, rapid rise 
periods were 8±1(7-9) cycles at the slower frequency and 14-15 cycles for the tests at 
higher frequency. 
Steady load trial 
For comparison, in the steady load trial pressures measured at 30 sec were taken 
as the first measurement, to avoid recording the transients during application of 
loading. The last pressure measurement was at 180 seconds. The mean increase for the 
six trials in series C was 7.3±2.6 (3.0-20.4)%. The increase in the cyclical peak pressure 
can be described as a more rapid rise occurring within the first 80 seconds, followed by 
a slower rise over the remainder of the trial. 
Effects during the series of trials 
The gradient of peak pressure rise against time was calculated (Figure 3.3.6). A 
decrease in the gradient was found progressively from Al to A6 suggesting that this 
characteristic reduces with continual use. 
The changes in cyclical peak pressures during series A, both from the first to the 
last cycle of each individual trial and of the variation from trial to trial, are represented 
graphically in Figure 3.3.7. It can be noted that recovery occurs between each trial and 
that the baseline of the initial pressure reading is not constant, but tending to increase 
over the series. 
In the first B trial (B 1) the temperature recorded at the beginning of the trial was 
21.2 °C and after the last cycle the temperature rose to 21.3 °C; in B2 trial when both 
the load and ramp velocity of the Instron were increased, the rise in temperature was just 
0.2 °C from 21.2 to 21.4 °C. 
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Fig. 3.3.6 Gradient of the asymptote 
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3.3.5 Discussion 
As expected, appreciable time-dependency has been demonstrated in F-Scan 
response to cyclical and sustained loading, in the form of increasing sensitivity to 
pressure over the course of the each trial. This continuation in change of sensitivity 
beyond 2 minutes has been observed earlier by Fergusson-Pell and Cardi (1993). The 
magnitude of the rise over 200 s trial varied considerably, for example from 9% - 24%, 
mean 15% in the first six trials in Series A. 
Two elements of this increased sensitivity can be observed: a rapid rise at the 
commencement of loading, and a more gradual steady increase over a period of several 
minutes. During cyclical loading, the rapid rise is substantially completed in 
approximately 70 seconds- 90 seconds, this representing 7-9 cycles ( figure 3.3.5) at the 
lower test frequency and 14-15 cycles at the higher frequency (utilised). This element of 
the response is therefore primarily sensitive to time under load and not the number of 
loading cycles. After the initial rapid rise, the response becomes approximately 
asymptotic to a straight line of positive slope over the remaining period of each trial. By 
plotting the gradients of these slopes over a series of trials, Figure 3.3.6, it can be 
observed that the slow increase gradually diminishes as the sequence of trials proceed. 
The increase in sensitivity appears to be largely recoverable between each trial 
following a rest of 5 minutes, Figure 3.3.7. However, there is an upward drift in the 
sensitivity with repetitive trials during a series, evidenced by the gradual rise in the 
starting and finishing peak pressure values. This represents an irrecoverable component 
in the response or a component which only recovers over a much longer time scale than 
the rest period. 
The curve of the starting peak pressure values in Figure 3.3.7 show that the 
irrecoverable increase is levelling out by the sixth trial, indicative of some initial creep- 
like or bedding-in phenomena which reaches a maximum value. Similarly the curve of 
slope gradient against trial number is also levelling out, Figure 3.3.6. This suggests an 
association between the slower steady increase and the irrecoverable component. It is 
proposed that the slower element of the sensitivity increase gives a permanent set due to 
creep-like behaviour which is complete over the first 20 minutes of loading (6 trials of 
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200 seconds); whereas the rapid element is recoverable, due to viscoelastic properties 
and occurs repeatedly in the first 80 seconds of loading following a rest period. 
It has been suggested previously that a new insole would show an initial change 
in sensitivity as flattening of the surface asperities of the ink induce lower resistance 
across each load cell. The results from these present trials, each commencing with a new 
insole, do not show evidence of this in the first trial as expected, but this could 
reasonably be proposed as the mechanism responsible for the slower irrecoverable 
creep-like component in the response. 
A comparison can be made between cyclical and static trials responses. In static 
tests, it was not possible to determine the rapid rise accurately; on this particular Instron, 
it took up to 30 seconds to apply the static load gradually under manual control. Hence 
for purposes of comparison to the increases during cyclical tests, the recorded pressures 
were registered at 30 seconds and 180 seconds in static tests. The mean increase in the 
six trials in series C was 7.3%, range 3.0%-20.4%. This is approximately half the 
increase found in the cyclical tests from first to last peak, but corresponds to the mean 
increase of 8.5 (3.7-15.0)% found from the first peak occurring after 30 seconds to the 
last peak. This again indicates that it is primarily the duration of loading and not the 
cyclical nature of the loading, which is responsible for the observed behaviour. 
In order to eliminate two possible explanations for the observations, we also 
recorded the temperature rise and the Instron loading profile during a series of trials. 
The F-Scan manufacturer reports temperature sensitivity of this particular ink to be 
1.8% perl°C, and hence the temperature increase recorded (0.2 °C) is insignificant. 
From the Instron force profiles, a small increase in loading magnitude can be observed 
at the start of a cyclical trial: this is due to initial compression of the visco-elastic foam 
inserted under the insole, which then allows higher forces to develop between the plates. 
However the rise occurs over the first two or three cycles and is also small, less than 
2%. 
From the point of view of the significance of these results to calibration of the F- 
Scan during clinical trials, we first note that the recommended life of an insole is 10 
walking trials. After this, rapid deterioration in the transducer response due to 
delamination from shear may render the insole unusable: such deterioration was not 
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noted in our trials where only vertical loading was applied. A calibration procedure 
must be appropriate to this expected life. Also because of the temperature sensitivity of 
the insole, care must also be taken to achieve equilibration with the foot in-shoe 
temperature before trials commence. 
The findings indicate that it is necessary to walk the patient on an insole for at 
least 60-90 seconds to overcome the initial rapid rise, after which the calibration against 
bodyweight and the trial walk should take place immediately. If the patient rests 
between walks, recovery will occur, and so a further 60 seconds of loading is necessary 
before each trial. The manufacturers recommendation for `bedding-in' an insole is 
supported for this reason, although it is noted from these experiments that this is not a 
one-off requirement. 
It is not practicable to overcome all the slower creep-like response by walking, 
since the 20 minutes required would frequently induce delamination: it might be 
possible to pre-condition the insoles with a static vertical load, although further research 
would be necessary to determine any longer-term effect of this treatment on `shelf life'. 
Notwithstanding, it would be beneficial for the patient to walk for several minutes on a 
new insole which will overcome a substantial part of the anticipated creep. 
Conclusion 
From these trials, it is suggested that there are two elements in the observed 
increase in sensitivity of this FSR insole transducer during loading. The rapid element 
demands that that the insole be conditioned by at least 60 seconds of loading prior to 
calibration, and that a trial walk be undertaken within a few seconds thereafter. Because 
of a permanent creep-like element of the response, sensitivity will continue to change 
slowly over several minutes even after the initial rapid rise is finished. This necessitates 
calibration at frequent intervals. 
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3.4 Validation of a clinical methodology for in-shoe 
pressure measurement using F-SCAN 
3.4.1 Background 
An accurate device to measure plantar pressures under the foot would play an 
important role in the diagnosis and treatment of foot conditions. 
Most of the previously reported studies of plantar pressures have measured a 
limited number of isolated, barefoot steps in a laboratory setting (Lord et at., 1986; 
Cavanagh et at., 1985). Such isolated snapshots of barefoot plantar pressures did not 
give us insight into possible step-to-step variations or information about plantar 
pressures which occur when wearing shoes, but it is also important to measure the peak 
plantar pressures within the shoe during normal walking conditions (Lord and Hosein, 
1994). In-shoe forces which occur during walking have not been well described, 
because standardised methods of in-shoe foot pressure measurement have not been 
developed until recently. Different types of equipment for in-shoe foot pressures 
measurement have different technical characteristics: the earlier discrete devices were 
able to detect pressures only under the area where they were placed and often they 
would be displaced due to the shear forces developed inside the shoe. Several systems 
using a matrix insole for in-shoe measurement of plantar pressure are now 
commercially available. They have enabled researchers to make clinical investigations 
(Pitei et at., 1995; Corbett et at., 1993) which were hitherto impracticable. Only a few 
studies have examined quantitatively in-shoe plantar pressures, using different systems 
of in-shoe foot pressure measurement during continuous walking by normal sensate 
control subjects and diabetic patients with neuropathy. In recent years, the two most 
used systems for in-shoe foot pressure measurement have been: the EMED system 
(Novel Gmbh, Munich, Germany) which uses a capacitance transducer and the F-Scan 
system (Tekscan Inc., Boston, MA) which uses a force-sensing resistor. 
Clinical comparisons were attempted to provide more information regarding the 
reliability of different types of foot pressure devices. When the F-Scan was compared 
to the Dynamic Pedobarograph (DPBG) (in one patient wearing the F-Scan insole 
attached to his foot while he was walking on a DPBG platform), it was interesting to 
note that the pressure pattern of the different anatomical points was identical in the two 
systems and the range of pressure was similar, with small intra-subject pressure 
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variability (Nikolopoulos, 1996). However the author also described a 
`preconditioning' effect stabilised after the initial ten cycles with the F-Scan insole. In 
comparison with the platform systems of foot pressure measurement, which are reliable, 
but do not allow assessment of forces developed inside the shoe, the in-shoe insole 
devices are ideal for characterising the forces at the shoe-foot interface, but they have 
certain technical problems as regards reliability. In-shoe pressure measurement raises 
potential problems because the sensor has to acclimatise to the in-shoe conditions of 
temperature, moisture, shape and size of the shoe which will influence the pattern of 
loading of the vertical forces due to body weight as well as the shear forces expressed 
when the foot slips inside the shoe. 
Furthermore the F-Scan was compared to the EMED system in a dynamic study 
in four healthy subjects (McPoil et al., 1995). The F-Scan insole was found to have a 
good to fair level of reliability between different days of testing, different trials, 
different steps for the first peak of force during the contact phase of the stance, whereas 
the reliability was found to be poor for the propulsive phase of the stance. However the 
EMED reliability proved to be good over all the stance phases. However they were able 
to measure only forces, not pressures because the spatial resolution is much higher in 
the F-Scan insole with its 966 FSR sensors, than in the EMED insole with its 99 
capacitance transducers (Cobb and Clermont, 1995). 
Also the F-Scan insole is ultrathin (0.16mm), flexible and can be trimmed to the 
size and shape required to fit the footwear. In comparison the EMED insole is rigid, is 
2mm thick and comes in standard sizes and shape. However the F-Scan insole is 
disposable and therefore it has a limited life-time, whereas the EMED insole is 
supposed to last for longer and is also much more expensive. Also the recording 
parameters such as sample rate, analysis time, number of frames, can be adjusted 
through the software facilities to suit the characteristics of the experiment and 
sometimes may account for different results found with different systems. 
Therefore the differences in the technical characteristics of the various 
equipment could influence the results and the comparisons made between them. They 
also seem to recommend different systems for different roles in the diabetic foot care: 
the EMED would be suitable as a screening device due to its reliability, whereas the F- 
Scan which benefits from a high spatial resolution and adjustability, seems to be more 
appropriate for the assessment of therapeutic measures for plantar pressure reduction, 
such as chiropodial treatment and prescription footwear for the diabetic foot. 
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However in order to use the F-Scan system, which was still in prototype stage 
when it arrived in the laboratory of the Medical Engineering and Physics Department, 
King's College Hospital, for clinical research or practice in the Diabetic Foot Clinic, its 
technical limitations needed addressing in order to validate and standardise a reliable 
method of plantar pressures assessment. 
The technical characteristics of the F-Scan sensor obtained in laboratory 
conditions of repetitive loading (imitating the normal gait) and details of the behaviour 
of the insole in these circumstances are described in the previous subchapter. The 
conclusions drawn would help improve the calibration procedure and the 
accommodation of the insole inside the shoe to overcome a substantial part of the 
anticipated creep. However these tests were done in laboratory conditions when a 
constant vertical load was repeatedly and evenly applied. In the clinical setting, the real- 
life conditions inside the shoe in which the F-Scan insole is to be used, are very 
different. It means putting the insole in contact with curved and uneven contours, 
especially in a diabetic foot characterised by deformity which would develop high 
pressures under certain areas whether other areas would not be loaded at all. Also 
placing the insole in the shoe and taking it out will induce a degree of manipulation, 
which might affect its longevity. Likewise the conditions of humidity and temperature 
developed inside the various shoes of various groups of patients may have a different 
effect on the behaviour of the insole. All these variables plus the variables introduced by 
walking such as, step-to-step and test-to-test variability need assessing in, a clinical 
setting in order to minimise the deficiencies and develop a valid methodology for foot 
pressure measurements with suitable accuracy and reproducibility. 
Aims of the clinical validation study 
The aim of our study was to develop an optimal clinical procedure in order to 
obtain reproducible results with the F-Scan taking in consideration its technical 
limitations. 
The clinical validation study was designed in two parts: 
1. methodological studies of the characteristics of the F-Scan insole inside the shoe 
in order to acquire validation of the research studies for clinical practice. The reliability 
of the insole in consecutive runs, the life-time of the insole and the temperature change 
inside the shoe during a F-Scan test were studied. 
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2. a clinical pilot-trial, whose aim was to validate the F-Scan technique 
recommended by the previous methodological experiments, in a clinical setting 
involving two groups of patients: diabetic patients with neuropathy and a history of foot 
ulceration and non-diabetic controls. 
The diagnosis of these two groups is only relevant because they represent likely 
clinical conditions of diabetic neuropathic patients with insensate feet, who have a high 
risk of developing foot ulceration. The methodology was particularly aimed at 
neuropathic diabetic patients with insensate feet which can interfere with the behaviour 
of the F-Scan insole by creasing it and thus reducing its life-time. Also the sensitivity of 
the insole to the in-shoe conditions of temperature and humidity can be different when 
in contact with a neuropathic foot, which is characterised by higher plantar pressures 
and higher skin temperature, but less moisture due to sympathetic denervation 
manifested as a decrease in sweat secretion. Also abnormal shape due to deformity, 
claw toes and Charcot joint could be present in the neuropathic foot and potentially 
increase the degree of manipulation of the F-Scan insole, reducing its durability. A 
control group was included in the study, in order to observe any differences in the 
behaviour of the insole. The variability between runs, the inter-step variability and the 
reproducibility tests were assessed. 
Methods and patients 
Two groups of subjects were studied. They were known from previous work 
(Boulton et al., 1987) to be characterised by significantly different ranges of pressure: 
Group A: 11 neuropathic patients with a previous history of foot ulceration, no 
history of intermittent claudication and foot pulses palpable bilaterally. Neuropathy was 
defined by the presence of neuropathic symptoms and the absence of ankle reflexes 
accompanied by abnormal vibration perception threshold (VPT>20 Volts) measured 
from the tip of the great toe using a Biothesiometer (Biomedical Instruments, Newbury, 
Ohio, USA) (Guy et al., 1985). This test was performed six times and the mean value 
was calculated. Vibration perception is a function of large myelinated fibres, which may 
be damaged at a later stage in the neuropathic process than the smaller fibres conveying 
thermal sensation (Guy et al., 1985). 
Group B: 11 non-diabetic controls of whom none had a family history of diabetes. 
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Measurement of foot pressures 
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Each subject used a new insole. Recording of a subject walking on a flat surface 4 
metres long, at his/her normal speed is referred to as a `run'. Subjects were tested in 
standard shoes (Clarks trainers `Swing Low') to avoid variation of foot pressures with 
different types of footwear. They were also given standard nylon knee-high hold-ups 
because hosiery can also alter the foot pressures (Rose et al., 1992; Veves et al., 1989). 
Analysis of the recorded pressures was done with the `Average' function on, in 
order to activate a smoothing effect on the immediate surrounding cells. Peak plantar 
pressures were measured as they are an accepted parameter to describe the pressures 
developed at shoe-foot interface (Cavanagh et al., 1996). 
Statistical analysis 
The analysis of variance for pressure was done considering the run, the step and 
the site where pressure was measured as main effects and their interactions were 
calculated. Data are presented as Mean ± SEM and where appropriate as median 
(range). Data were analysed using the paired Student's t-test to compare pressures 
measured in similar anatomical locations in neuropathic patients versus control 
subjects. 
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3.4.2 Reliability of the insole in consecutive runs 
Procedure 
The reliability of pressure readings was not known with continuos repeated runs. 
Therefore we investigated the behaviour of the insole with repeated runs, without any 
break between them, by observing variations and discrepancies in the recorded 
pressures in two patients each wearing the same insole during consecutive runs without 
any break. 
Results 
Peak pressures recorded indicate that the insole was liable to fail after the 4`h 
continuous run. 












- C]-- Patient 1 
-ý Patient 2 
Table 3.4.2 Foot pressures (kPa) measured in continuos consecutive runs 
Patient lrun 2run 3run 4 run 5 run 
A 103 221 231 274 140 
B 238 269 274 277 147 
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Therefore in order to avoid any interference it was decided that every test would 
consist of a maximum of 3 consecutive runs. 
Furthermore, the very first run of a insole produced always a smaller reading 
than the subsequent ones suggesting that a "bedding-in" process was still happening. 
Therefore the patients were asked to perform a first run on the insole without 
recording it, in order to allow them to acquaint themselves with the recording 
conditions and also to allow the "bedding in" process. 
3.4.3. Life-time of the insole. Creasing and drop-out of the insole 
during non-consecutive runs 
Procedure 
The durability of the insole was not known and therefore it was uncertain as to 
the maximum number of runs each individual insole could be used without errors or 
artefacts. 
The life-time of the insole was assessed in 3 patients, each using a new insole, 
by repeating the measurements until failure of pressure readings was noted as shown by 
tracks missing on the screen corresponding to the areas of creasing of the insole. 
The runs were carried out with breaks between them, when the insole was taken 
out from the shoe and then placed again inside the shoe, before the following run was 
started. This procedure imitated the clinical conditions which the insole undergoes, 
including manipulation both inside and out the shoe, which can induce the creasing of 
the insole. 
Results 
This test of insole durability was carried out in the 3 subjects and the results for 
one patient are shown in the Fig. 3.4.2. 
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Number of runs 
The insole failed after 24 runs. Results in the other two patients were similar, the 
insole having a mean life time of 25 ±3 runs. 
Therefore it is recommended to use one insole for less than 20 runs in total and 
ideally it is advisable to use one insole per patient, especially in longitudinal studies. 
3.4.4 Variability between runs 
Procedure 
In all 11 patients of both the control group and diabetic neuropathic group the 
foot pressures were recorded in two runs and results from the first run were compared to 
those from the second run. 
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Results 
There was no statistically significant difference between the pressures developed 
in the first run versus the second run neither in controls (p=0.83) or in neuropaths 
(p=0.42) (Table 3.4.3) 
3.4.5 Inter-step variability 
Procedure 
Each run lasted for 4 seconds and at a F-Scan sampling rate of 5 frames/second, 
approximately 3-4 steps were recorded per run in each subject. Foot pressures measured 
in successive steps were compared. 
Results 
The pressures measured in each step of the same run did not differ significantly from 
step to step (p=0.18, in controls and p=0.73, in neuropaths) - see Table 3.4.3. 
Table 3.4.3 Comparisons between the pressures measured in different runs 
and between the steps of the same run 
Non-diabetic 
control subjects 
RUN 1 vs RUN 2 141.7±25.3kPa vs 149±28.8 kPa 
p=0.83 
STEP 1 vs 2 139.3±35.6kPa vs 146.3+31.4kPa 





296±19.9kPa vs 300.8±15.5kPa 
p=0.42 
281.6+25.7kPa vs 307+19.3kPa 
vs 306.7+18.5kPa 
p=0.73 
Therefore any step of any run could be chosen for foot pressure analysis, but in 
order to standardise the procedure the use of the second step of the second run or the 
mean value of all steps of one run is recommended. 
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3.4.6 Reproducibility tests 
Procedure 
Reproducibility was assessed in every group by calculating the coefficient of 
variation of the peak foot pressures with repeated measurements. 
The control subjects (n=2) were tested in the morning and then in the afternoon 
of the same day. 
Then the measurements were repeated a day later in the morning. 
A week later the same patients were asked to come back and foot pressures were 
measured once again. 
The neuropathic patients (n=3) were tested in two separate occasions, at 4,5 and 
6 weeks interval. 
Inter-observer variability in reading the values of the pressures on the screen of 
the computer was also assessed by asking 2 observers to make an independent analysis 
of the pressures measured in one patient. 
Results 
Reproducibility was assessed in every group by measuring the coefficient of 
variation of the peak foot pressures. The coefficient of variation (CV) was measured in 
the two control subjects in three separate occasions at different time intervals: in the 
morning versus afternoon the CV was 5.3 ± 1.5 %., at 1 day interval the CV was 12.4 ± 
0.9 %; and at 1 week interval the CV was 10.3 ± 1.3 %. 
The three neuropathic patients who were tested in two separate occasions at 
5±0.5 weeks interval showed a coefficient of variation: CV=18.9±4.1%. 
Inter-observer variability in reading the values of the pressures on the screen of 
the computer was also assessed: CV=1.4±0.3% 
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3.4.7 Temperature change inside the shoe during a F-Scan test 
Procedure 
The change in temperature was measured in one control subject during a routine 
F-Scan test. A model H400 Digital Thermometer (Hale Instruments Ltd., Cheshire, UK) 
with a miniature thermocouple was used to monitor temperature at the interface 
between the subject's foot and the insole, where was secured with sellotape. The 
thermometer was attached at the ankle of the subject when walking. 
Results 
The temperature measured initially inside the shoe was 28.6°C and after the F- 
Scan test comprising of three runs of three steps, the temperature inside the shoe was 
29.7°C, resulting in an increase in temperature of 1.1 °C. 
3.4.8 Clinical pilot-trial assessing foot pressures in control subjects 
and diabetic neuropathic patients 
Procedure 
In order to investigate the location of the peak pressures of the foot, these were 
measured under the big toe and respectively under each metatarsal head. Also in order 
to characterise the pressure distribution under the main areas of the foot (Rose et al., 
1992), pressures were evaluated under the medial and lateral side of the forefoot and 
under the heel.. 
The size of the box which defined the areas of interest was adjusted 
accordingly: 
2.25 cm2 for the big toe 
1 cm2 for each metatarsal head, 
11.25 cm2 for each side of the forefoot, which was thus divided in the medial 
and lateral forefoot 
11.25 cm2 for the heel. 
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Results 
The foot pressures were significantly higher under the hallux and the first, 
second and fourth metatarsal head in the neuropathic patients than in control subjects 
(Table 3.4.4). 
Table 3.4.4 Peak foot pressures (kPa) in control I 
subjects and neuronathic natients 
AREA CONTROLS NEUROPATHS 
Big toe 162.8±54.6 268.2 ± 52.9 p< 0.05 
1 metatarsal head 253.6 ± 51.8 433.2 ± 90.0 p< 0.005 
2 metatarsal head 226.8 ± 36.2 338.8 ± 65.0 p< 0.05 
3 metatarsal head 269.8 ± 17.0 287.2 ±123.1 NS 
4 metatarsal head 128.0 ± 46.6 208.8 ± 61.6 p< 0.05 
5 metatarsal head 124.5 ± 13.4 150.1 ± 60.8 NS 
Heel 271.4 ± 52.2 397.3 ± 220.2 NS 
Medial forefoot 254.5 ± 18.9 386.0 ± 107.2 p< 0.01 
Lateral forefoot 126.2 ± 28.1 179.5 ± 66.2 NS 
MEAN±SD 
4 
When the pressures were measured under the main areas of the foot, the 
pressures were significantly elevated in neuropathic patients versus non-diabetic 
subjects under the medial side of the forefoot, but not under the lateral side of the 
forefoot or under the heel (Table 3.4.4). 
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3.5 Discussion 
This technology to measure in-shoe foot pressures has been only recently 
developed and it has been important to investigate this method in detail with particular 
regard to the characteristics of the insole. 
In this study we have established a method for measurement of in-shoe foot 
pressures in order to achieve acceptable reproducibility necessary for the study of foot 
pressures in clinical practice and the following technique is recommended: 
Recommendations for the use of the F-Scan 
If a new insole is used, the patient (wearing standard shoes and socks) will be 
asked to walk normally on a flat, even surface for 2 minutes in order to reach a suitable 
level of "bedding-in". If an insole had been used previously, the patient will be asked to 
walk only for 1 minute in order to acclimatise the insole to the in-shoe conditions. 
Then the insole will be calibrated against each individual body weight by asking 
the patient to load all the body weight on one foot, whilst concomitantly on the screen 
the pressure is checked to be evenly distributed and then the `Calibration' function is 
triggered. 
Then the initial run will be done immediately. It is recommended that an F-Scan 
test consists of 3 runs. The initial run will be a learning one. The next two runs will be 
recorded. It is advisable not to record consecutively more than 3 runs in a patient. 
Calibration again at the end of the F-Scan test is recommended to check for 
major artefacts in insole sensitivity. 
It is not recommended to use an insole for more than 20 runs in total, especially 
if tracks are missing persistently on the screen. It would be advisable to use an insole 
per foot per patient, especially if longitudinal studies are to be done. 
In the analysis of pressure, it is advisable that the second step of the second run 
or the mean of all the steps in a run to be considered in. order to standardise the 
assessment of peak pressures. 
Also it is advisable to keep constant the size of the window containing the gait 
sequence to be analysed and to place the box constantly on the same location on the 
image, which will correspond to the same anatomical site. 
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The process of "bedding in" observed in the simulated walking test and in the 
test of insole reliability, dictated the recommendation for asking the patient to walk on 
the insole before the calibration. The necessity for a "bedding-in" process in the insole 
resulted also from the laboratory tests of cyclical loading (Pitei et al., 1995), which 
showed that the insole should be conditioned by at least 60 seconds (and for further 60 
seconds if using a new insole) of loading prior to calibration and that a trial walk be 
undertaken within a few seconds thereafter. This procedure aims to reach the plateau of 
the recoverable creep and allows the recordings to be made in the this part of the creep 
curve, which was shown to have a variability in the range of 3-4% (Pitei et al., 1995; 
McPoil et al., 1995). 
The pre-conditioning of the insole was also considered to overcome the initial 
creep. In the manufacturer's literature, Tekscan undertake 100% acceptance testing of 
insole on their bladder device, with two cycles up to 700kPa checking for track loss. 
Hence the insoles have already undergone two cycles at a high pressure, increasing the 
number of cycles would have an effect on the long-term irrecoverable creep behaviour, 
but there would not have a pre-conditioning effect on the recoverable dynamic creep. 
Also pre-conditioning of the insole before each trial in a bench top device might 
account for the long-term creep or separation, but it can not account for the temperature 
sensitivity or the recoverable creep. Therefore the F-Scan transducer was not pre- 
calibrated in a jig because of the drift in the sensitivity; nevertheless the manufacturer's 
recommendations for calibration were followed with due regard to the creep-like effect. 
Therefore the initial walk before calibration serves several purposes such as 
reaching a plateau of the original non-recoverable creep, allowing the insole to conform 
to the curved shapes of the foot and temperature equilibration inside the shoe. This 
comes in agreement with another study recommending to place the insole inside the 
shoe for up to 5 minutes prior to calibration to allow the sensors to be loaded repeatedly 
and the temperature to stabilise to the environment of the shoe (Koch, 1993). Lord and 
Hossein' study (1994) also supports our recommendations showing that temperature 
stability was gained over 3 minutes of use of the insole. The temperature sensitivity of 
the insole reported by the manufacturer was 1.8 % for 1 °C and in our study we found 
1.1°C temperature change during a three run trial in a control subject, which is unlikely 
to influence significantly the level of recorded pressure. However the diabetic 
neuropathic patients with high foot pressures and a history of ulceration are 
characterised by higher skin temperature due to the presence of arterio-venous shunts in 
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their foot (Edmonds et al., 1986), but reduced vasodilatatory reactivity (Newrick et al., 
1988) which would decrease the variations in their skin temperature. Therefore this may 
help avoiding variability of the insole due to changes in temperature. Also the 
neuropathic patients have dry skin and reduced sweating due to a concomitant 
sympathetic deficit, which would help avoid the effect of excessive moisture inside the 
shoe, which can infiltrate the margins of the insole giving false, although localised, high 
readings. 
The calibration procedure against body weight would also take account of 
hysteresis and initial variability in insole manufacture, the temperature at which 
equilibration is gained, the long-term creep and the long-term degradation allegedly due 
to shear. However certain sources of error ought to be considered such as the hysteresis 
or different cells being pre-conditioned to different load levels, therefore increasing 
inter-cell variability. As regards hysteresis of the insole, reported by manufacturers to be 
typically in a range of 10-15%, ideally the body weight would be always loaded in the 
same direction for calibration. This was a reason for recommending the use of an insole 
per foot per patient, which would allow to place the insole always in the same position 
in the shoe, although the manufacturers describe that both sides of the insole as equally 
sensitive. As regards inter-cell variability, manufacturers have reported the individual 
cell variation being as much as 15% from the average and the amount of these single 
cells that could be seen across the 966 cell-sensor is estimated at 5. In order to 
overcome the problem of inter-cell variability it is recommended to calibrate over a 
large area to get the best average. This is attempted by asking the patient to load all the 
body weight on one foot, whilst it is checked concomitantly on the screen that the 
pressure is evenly distributed and then the `Calibration' function is triggered. 
Once the system is calibrated, it is advisable to start the first run immediately in 
order to take account for the recoverable (dynamic) creep seen in the laboratory 
experiments. However it is recommended not to record the first run, but to employ it as 
a learning curve run which would allow the patient to get used to the recording 
conditions as well. During this initial run it is also aimed to reach a suitable level of 
accommodation of the insole with the foot inside the shoe and to complete the 
"bedding-in" process. However sensitivity will continue to change slowly over several 
minutes even after the initial rapid rise is finished because of a irrecoverable, permanent 
creep-like element of the response. This necessitates calibration at frequent intervals 
namely at the beginning and at the end of the F-Scan test, in order to check for any 
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major sensitivity artefacts such as temperature or shear sensitivity. Nevertheless these 
variables highlight the importance of limiting the number of runs per one F-Scan test, 
which also resulted from the insole reliability trial: no more than 3 consecutive runs are 
recommended per patient: the first run for equilibration of the insole and patient's 
learning curve and the following two to be recorded. 
The change in sensitivity during one F-Scan test, found in the laboratory 
experiments and in the simulated walking trial was shown to partially recover during 
the rest period. A minimum of 15 minutes break, which is feasible in clinical 
conditions, between tests using the same insole was found to be necessary for a suitable 
recovery of insole sensitivity. 
The test of creasing and drop-out of the insole during un-consecutive runs 
highlighted another limitation of the insole regarding the total number of runs which 
one insole could undertake before an irrecoverable loss of sensitivity occurs. The mean 
life-time of an insole was shown to be of approximately 20-25 runs. Although for 
longitudinal studies one insole per patient would be recommended, the insensitive and 
often deformed diabetic foot could increase the wear-off factor by increasing the degree 
of manipulation and creasing, hence reducing the life-time of the insole. Mylar film is 
practically inextensible, so that local dynamic cross-talk effects are minimal. However, 
the long term effects of shear are to cause separation of the two layers of mylar from the 
ink layer. As this happens, the insole suffers a gradual degradation in sensitivity over a 
period. This would be a limiting factor on the life of the insole. This may support the 
findings of Rose et al. (1992) showing that the pressures measured decreased by the 
20.5% at the twelfth trial and Birke et al. (Birke et al., 1994) reported an apparent 7% 
reduction in pressure after seven trials of walking 20 feet. 
From the tests of run-to-run variability and inter-step variability, it was clear that 
there was not a significant difference between the pressures measured in different runs 
or in different steps of each run, in both the control group and the in neuropathic group. 
Therefore any step of any run could be used for analysis. In order to standardise the 
procedure, the second step of the second run or the mean of all steps are recommended 
to be considered. This suggestion is in agreement with the findings of Rose et al. 
showing that that F-Scan measurements were remarkably similar (mean 810, 
SD=20kPa) between subsequent steps within a trial (Rose et al., 1992). Mueller et al. 
have also shown that acceptable reliability can be obtained on a single day of testing 
with as few as three steps, using the calibration suggested by manufacturer (Mueller et 
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al., 1996). Other studies also have suggested using a mean of three trials when using 
pressure measures from the EMED system (Hughes et al., 1991) and the 
Pedobarograph (Holmes et al., 1991). 
When measuring the foot pressures at different sites under the plantar surface in 
the control group and in the neuropathic group, higher pressures under the medial side 
of the forefoot and under the hallux were found in the neuropathic group, which seem to 
be characteristic for neuropathic patients even in early stages of neuropathy (Boulton et 
at., 1987) and are associated with an increased risk of foot ulceration (Veves et al., 
1992). Similar studies of foot pressures have shown also that most of the lesions of the 
neuropathic foot are secondary to excessive pressures on the forefoot (Mueller et at., 
1994; Cavanagh et at., 1992). Also from the study of the coefficients of variation, a 
larger variation in plantar pressures was demonstrated in neuropathic patients during 
continuous walking: 18.9% versus 10.3%, which was the highest coefficient of variation 
found in controls. In controls the variability of measurements on different days was 
found by others (Rose et al., 1992) to be similar to that of the measurements done on 
the same day, although they do not give the coefficients of variations, but the standard 
deviations of the measurements: SD=28. OkPa on the same day, SD=41.3kPa on separate 
days. Koch (1993) reported a intraperson coefficient of variation <23%, which was 
reduced to 15% if the sensor was allowed to `warm-up' in the shoe for 5-10 minutes 
prior to testing. Also in another study (McPoil et at., 1995) when compared to EMED 
insole, the F-Scan insole was found to have a good to fair level of reliability between 
different days of testing, different trials, different steps for the first peak of force during 
the contact phase of the stance, whereas the reliability was found to be poor for the 
propulsive phase of the stance. Unfortunately there is no description in their 
methodology about any procedure regarding the insoles customisation to the conditions 
inside the shoe. These findings suggest that the F-SCAN offers an acceptable 
reproducibility in assessing the foot pressures during gait if the insole is accommodated 
to the conditions inside the shoe. 
However, the greater variability found in neuropathic patients requires caution in 
interpreting the data from isolated steps when studying neuropathic patients. Another 
group (Zhu et al., 1993) using a portable, insole data-acquisition system consisting of 
seven pressure sensors placed in each insole under the pressures under posterior and 
anterior heels, the metatarsal heads and hallux demonstrated similarly an increased 
variability of walking in the neuropathic group and higher plantar pressures under first 
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metatarsals and posterior and anterior heels in the neuropathic group compared with the 
control group. Cavanagh and his group have also shown that there is an increased 
variability of loading in the forefoot compared to the rear foot in neuropathic patients 
(Cavanagh et al., 1994). Therefore all these findings support the theory of increased 
variability in diabetic neuropathic patients which might play a role in the aetiology of 
plantar ulceration. 
The inter observer variability of only 1.4% is in agreement with another study 
where the observer was compared to the computer's ability to pick up areas of peak 
pressure. The study found minimal differences (1-2%) providing that a consistent area 
was used to determine pressure and there was a consistent placement of the box 
(Mueller et al., 1996). This supports our recommended technique to keep the area of 
the window constant and to place the box constantly on the same location on the image, 
which would correspond to the same anatomical location. 
To be useful for clinical or research purposes, an in-shoe pressure system must 
be capable of providing reliable measures over time. The F-Scan linearity is comparable 
with other methods of foot pressure measurement: such as, the EMED-E barefoot 
measurements (r=0.85) (Birke et al., 1994) or when compared to the force platform 
(r=0.96) (Mueller et al., 1996) and the pedobarograph which showed that the pressure 
pattern of the different anatomical points was identical in the two systems and the range 
of pressure was similar, with small infra-subject pressure variability (Nikolopoulos, 
1996). The F-Scan reliability has been reported to be good (Mueller et al., 1996; 
Mueller et al., 1994) especially if a methodology to stabilise the insole inside the shoe 
is used, as proven in this chapter and by other studies (Koch, 1993; Lord and Hosein 
1994). 
Conclusion 
A method for measurement of in-shoe foot pressures which achieves acceptable 
reproducibility in the study of foot pressures has been established and presented in this 
chapter. Foot pressure measured by analysis of in-shoe dynamic peak pressure using the 
F-SCAN is now feasible and adequately reproducible and should enable further 
exploration of the causative factors of foot problems, notably those of diabetic 
ulceration, in realistic shod conditions. A future use of in-shoe foot pressure 
measurements resides in the assessment of efficacy (Chantelau and Haage, 1994; 
Albert and Christensen, 1994) and design of bespoke footwear for diabetic patients. 
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Chapter 4. FOOT PRESSURES ASSESSMENT IN NEURO- 
ISCHAEMIC DIABETIC PATIENTS VERSUS NEUROPATHIC PATIENTS 
4.1 Introduction 
The aetiology of foot ulceration is multifactorial (Murray and Boulton, 1995) 
involving a complex series of factors of which some of the most important are 
peripheral sensory neuropathy and peripheral vascular disease (PVD). 
Lower extremity arterial disease has been shown to have a high incidence in the 
diabetic population with up to 50% increase in the number of absent pulses in both 
diabetic men and women (Abbott et at., 1990). Furthermore PVD is an important factor 
implicated in the aetiology of foot ulceration leading to an increased risk of amputation 
(Pecoraro et at., 1990). However PVD is rarely on its own but more frequently there is 
a combination of PVD and neuropathy in the neuro-ischaemic foot (Boulton, 1996). 
4.1.1 Types of foot ulceration in diabetes 
Although ulceration has been described in detail in Chapter 1, the main features 
of ischaemic and neuropathic ulceration are summarised below. 
Ischaemic foot ulceration 
Vascular disease is a significant factor in over 60% of diabetic foot ulcers 
(Walters et al., 1992) and the ischaemic foot ulcer leading initially to gangrene of the 
toes, puts at risk of amputation the entire foot or leg. Various factors lead to reduced 
blood flow in the ischaemic foot: 
- Atherosclerosis obliterans with thrombus formation and stenosis of the artery, 
which requires urgent assessment of the site and size of stenosis by angiography and 
concomitant angioplasty if possible, or surgical tibial-peroneal by-pass. This is achieved 
by using the patient's own saphenous vein and by connecting the vessels above the knee 
to the pedal vessels which frequently are unaffected (Allen et al., 1993). This would be 
followed-up regularly in the Diabetic Foot Clinic until complete healing and re-gain of 
the arterial function. 
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- infection leading to microthrombi formation which can close the digital arteries 
of the toes with resulting septic vasculitis and gangrene. This would be treated with 
intensive intravenous antibiotic therapy according to the organisms found in the wound 
and their sensitivity. 
- rarely, microemboli from the ulcerated plaques in the proximal vessels can 
occasionally cause the `blue' or `purple' toe syndrome, characterised by sudden pain and 
discoloration of the toes with a sharp demarcation between the ischaemic area and the 
area with normal perfusion. If the skin and/or muscle small arteries are blocked by these 
microemboli, painful petechiae or muscle pain can occur. If these symptoms are 
bilateral, the origin of the emboli is in the aorta or higher; if they are unilateral, the 
origin is in the iliac artery or below. The treatment requires removal of the source of 
embolization by vascular surgery (Levin, 1995). 
Vascular assessment 
Different techniques of diagnosis and assessment of peripheral vascular disease 
have been described in detail in the introductory Chapter 2. The methods routinely used 
in the Diabetic Foot Clinic at King's College hospital are described as follows: 
-a trained technician assesses all patients with clinical peripheral vascular 
disease, using Doppler ultrasound to measure the ankle blood pressure, which also 
permits recognition of an altered wave-form such as damping of the pedal artery 
waveforms caused by arterial narrowing. In patients with absent pulses but high ankle 
pressures, transcutaneous oxygen tension measurements are done in the clinic and then 
the patient is referred for further investigation to the Vascular Laboratory at King's 
College Hospital, which assesses the waveform pattern. Furthermore the patients 
diagnosed with critical limb ischaemia will be referred for arteriography in order to 
detect the areas of arterial stenosis. 
Neuropathic foot ulceration 
Peripheral neuropathy is present in over 80% of diabetic patients with foot 
lesions (Caputo et al., 1994). Neuropathic foot ulcers occur at areas of pressure, due to 
high plantar pressures found in neuropathic patients at risk of ulceration (Veves et al., 
110 
1992) or to repetitive moderate stresses on an insensitive foot with diabetic neuropathy, 
limited joint mobility, deformity (Fernando et al., 1991). 
When the foot is well perfused, the repetitive stress and increase in pressure 
stimulate callus build-up, which further increases local pressure acting as a foreign body 
(Young et al., 1992) leading to ulceration from pressure necrosis, usually under the 
metatarsal heads or hallux on the plantar surface of the foot (Levin, 1995). Most of the 
neuropathic ulcers develop under the plantar surface of the foot. 
Neuro-ischaemic foot ulceration 
When the perfusion of the foot is not satisfactory, the possible complication of 
vascular dysfunction is added to the sensory loss and increases the risk of foot ulcers in 
diabetic patients. (Boulton, 1991) with the occurrence of another type of lesion, the 
neuro-ischaemic ulcer. 
Most of the foot ulcers are due to a combination of neuropathy and ischaemia 
(Walters et al., 1992). The neuro-ischaemic foot ulcer is the commonest manifestation 
of ischaemia in the diabetic neuropathic foot, often manifested as failure of lesions to 
heal or ulcer recurrence. Such non-healing ulcers may occur over not very high pressure 
points, such as the medial aspect of the first metatarsophalangeal joint, over a malleolus, 
or at sites of pressure between the toes. However the callus formation is less prominent. 
Furthermore the ulceration tends to occur less on the plantar surface, and more at sites 
of shear stress, as described previously (Jeffcoate et al., 1993) due to ill-fitting shoes 
and the resulting ischaemic pressure necrosis. 
However the pressure loading in the shoes of patients with neuro-ischaemic 
ulcers has not been studied previously; neither regarding the shear, horizontal 
component of the forces acting on the foot, nor regarding the vertical forces developed 
inside the shoe. 
The shear transducers still await modernisation, whereas the new methods for 
dynamic in-shoe foot pressure measurement such as F-Scan have been developed and 
allow assessment of the pressures developed at the shoe-foot interface. This would be 
predominantly the normal force although a small component of shear force can be 
detected at the margins of the insole. 
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4.2. Aims of the study 
The aims of the present study were to apply the methodology established in the 
previous chapters for the use of F-Scan, in order to assess the pressures developed at the 
shoe-foot interface in diabetic neuro-ischaemic patients. In contrast to neuropathic 
patients who develop ulcers under the plantar surface of the foot, the diabetic patients 
with peripheral ischaemia (who also have a degree of neuropathy and impaired 
sensation) develop ulcers on the margins of the foot. 
Neuropathic ulcers develop at sites of high pressure on the plantar surface 
(Boulton et al., 1983). High plantar pressure seemed to be a multifactorial condition 
relating mostly to the limitation of joint mobility in the foot and to neurological 
dysfunction. Most of the current foot pressure studies (static or dynamic) have been 
performed barefoot (Veves et al., 1992; Fernando et al., 1991), but it is also important 
to measure the peak plantar pressures within the shoe during normal walking conditions 
(Cavanagh et al., 1985; Lord and Hosein, 1994). However plantar pressures have 
never been measured in neuro-ischaemic patients. The hypothesis could be that their 
plantar pressures are lower than in neuropaths. 
Therefore the aims of our present study were to measure vertical in-shoe foot 
pressures during walking in neuro-ischaemic diabetic patients and to compare them to 
diabetic patients with neuropathy alone. 
The study was divided in two parts: 
" the first part aimed to measure the in-shoe plantar pressure distribution during 
walking in neuro-ischaemic diabetics and compare them to diabetic patients with 
neuropathy alone and also to two control groups, such as diabetic patients without 
neuropathy and non-diabetic subjects. 
" the second part of the study aimed to analyse the way the pressure was loaded during 
walking in each group. Was the pattern of pressure loading consistent from step to 
step or was there variability between steps? 
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4.3 Patients and methods 
4.3.1 Selection and characteristics of patients 
Four groups of patients were selected to take part into the study: 
Group A: 18 neuropathic patients with a previous history of foot ulceration, no 
history of intermittent claudication, foot pulses palpable bilaterally and a brachial-ankle 
pressure index equal or higher than 1. Neuropathy was defined by the absence of ankle 
reflexes accompanied by abnormal vibration perception threshold (VPT>20 Volts) 
measured with a Biothesiometer (Biomedical Instruments Co., Ohio, USA). 
Group B: 14 neuro-ischaemic patients with a history of ulceration on the margins 
of the foot. Peripheral ischaemia was defined as a pressure index less than 0.8, absent 
foot pulses. They also had a degree of neuropathy as their mean VPT was 29.3±13.5 
Volts, which was not significantly different from the mean VPT of the neuropathic 
patients. None of the neuro-ischaemic patients complained of ischaemic pain. 
Group C: 11 diabetic controls without complications. All of them had present 
ankle reflexes and bilateral foot pules palpable. The mean VPT was 9.9±2.7Volts and 
their pressure index was equal or higher than 1. 
Group D: 15 non-diabetic controls of whom none had a family history of 
diabetes. 
Table 4.1 Clinical details of patients 
Diabetes Diabetes 
No. Age duration type VPT 
(years) (years) 1/2 (V) 
Controls 15 49.6±11.9 - - 7.0+ 0.5 
Diabetic Controls 10 57.6±10.8 9.2±9.7 4/6 9.9± 2.7 
Neuropathic patients 18 55.4±16.0 21.5±12.7 8/10 38.7±12.7 
Neuro-ischaemic 14 63.5± 9.8 17.4±14.4 6/8 29.3±13.5 
The VPT was not statistically significant (NS) different between control subjects 




Foot pressures measurement was performed as recommended in the previous 
chapter. 
Recording 
The patient was asked to walk at his own normal pace, on a flat surface. The 
recording of foot pressures was done concomitantly for 4 seconds. All the recordings 
were done in the same direction of walking. The recording of foot pressures was 
performed in standard shoes (Clarks `Swing Low' trainers) which were used because of 
the reported variation with different types of footwear. The patients were given standard 
pop socks because hosiery can also alter the foot pressures (Veves et al., 1989). 
Analysis of pressure recording 
F-SCAN data recording from different runs were recalled and analysed in two 
active windows on the screen. The gait mode displayed a two-dimensional 
representation of the plantar pressures sequentially from heel-strike to toe-off. The 
increase in pressure was seen as a change in colour of the pressure map from blue to red 
as a function of time. The "Average" function from the screen was activated, in order to 
allow a smoothing effect on the immediate surrounding cells and to reduce the 
possibility of artefacts. 
In order to determine the distribution of pressures under the foot and detect if 
there is any tendency towards a pattern of pressure distribution in different groups of 
patients, the analysis investigated four areas of interest under the four main areas of the 
foot: the big toe, the medial and lateral side of the forefoot and the heel. The size of the 
box was adjusted accordingly with the area of interest: (15mm*15mm) for the big toe 
and an area of (45mm*45mm) for the medial or lateral forefoot and heel. 
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Fig. 4.0 Peak plantar pressures analysed under the four main areas of the foot 
on a F-Scan recording 
The peak plantar pressures were obtained from the pressure-time graphs for the 
areas of interest by moving the cursor along until the peak of each graph representing 
the pressures developed under a specific area during each step, was reached. A mean of 
all pressures measured in each step of each run was calculated for a patient. 
The highest peak plantar pressure in a patient was calculated as the greatest 
pressure value observed under a specific area during all steps of all runs. 
As a new version of F-Scan software (3.8) was received recently (1996), the 
recordings were re-analysed regarding the maximum plantar pressure developed by a 
patient during a gait stance. A standard box (10*10mm) was applied automatically by 
the programme on the area of highest pressure detected by the computer under the foot. 
Analysis of pattern of pressure 
In order to investigate if the pressures were loaded on the plantar surface 
consistently in every step of every run, their interactions in different steps of different 
runs were analysed in all groups of patients to describe the pattern of pressure loading. 
The interactions between the first and second step in the first and second runs 
were calculated in order to find out if the pressures of the first step in the first and 
second runs were loaded in a similar way to the second step in the first and second runs, 
referred to subsequently as the interaction for run by step. 
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4.3.3 Statistical analysis 
Data are presented as Mean ± SEM. Data were tested for normality and then 
were analysed using the parametric Student's t-test to compare pressures measured in 
similar anatomical locations in the four groups of subjects: neuro-ischaemic patients 
versus neuropathic patients versus the two groups of control subjects. The plantar 
pressures were measured under the big toe, under the medial and lateral side of the 
forefoot and under the heel. 
The pattern of pressure loading was analysed as the interaction for run by step in 
the four groups of subjects: 
- non-diabetic controls 
- diabetic control patients 
- neuropathic diabetic patients 
- neuro-ischaemic diabetic patients. 
The one-way analysis of variance for measured pressures was used considering 
the run and the step as main effects and their interactions were calculated in the pattern 
of pressure analysis. 
4.4 Results 
4.1.1 Mean peak plantar pressures in the four groups of subjects 
The diabetic controls manifested a slight trend to higher peak pressures than 
non-diabetic controls, although this was not statistically significant, except under the 
hallux (Table 4.2). 
The neuropathic patients showed significantly increased plantar pressures when 
compared to both control groups under the lateral and medial sides of the forefoot, 
although the diabetic controls had pressures under the hallux and the heel which were 
not statistically different from the neuropathic patients. However the neuro-ischaemic 
patients showed significantly greater pressures than all the other three groups (Fig. 4.1) 
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Table 4.2 Mean peak plantar pressures (kPa) measured under hallux, lateral and 
medial forefoot and heel in the 4 grouts of subiects 
Lateral Medial 
Patients Hallux forefoot forefoot Heel 
Controls (C) 115.0±12.8 127.3±17.8 151.7±19.6 134.4±15.7 
Diabetic Controls (DbC) 170.0±22.8 138.9±15.9 139.0±20.5 148.9±22.3 
Neuropathic patients (Np) 171.2±16.5 182.0±16.2 211.8±20.1 217.3±24.9 
Neuro-ischaemic patients 272.5±35.7 263.9±30.5 267.1±34.5 245.8±32.3 
(Neuro-Isch) 
Comparisons between groups 
C vs DbC p=0.04 p=0.63 p=0.66 p=0.60 
Np vs C p=0.02 p=0.03 p=0.05 p=0.02 
Np vs DbC p=0.96 p=0.017 p=0.02 p=0.07 
Neuro-Isch vs C p=0.001 p=0.001 p=0.008 p=0.005 
Neuro-Isch vs DbC p=0.02 p=0.001 p=0.004 p=0.02 
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Fig. 4.1 Graphic comparison of the mean peak plantar pressures measured in the four 
groups: non-diabetic and diabetic controls, neuropathic and neuro-ischaemic patients 
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Table 4.3 Highest peak plantar pressures (kPa) measured under hallux, lateral and 
medial forefoot and heel in the 4 groups of subiects 
Lateral Medial 
Patients Hallux forefoot forefoot Heel 
Controls (C) 162.5±28.4 156.0±22.1 204.6±37.8 188.2±33.0 
Diabetic Controls (DbC) 190.8±28.1 158.9±17.5 167.0±26.4 166.1±22.8 
europathic patients (Np 195.3±19.3 212.0±19.2 242.0±25.1 240.1±28.1 
euro-ischaemic patients 344.0±49.2 331.6±45.7 349.1±49.5 301.0±39.1 
(Neuro-Isch) 
Comparisons between groups 
C vs DbC p=0.48 p=0.92 p=0.43 p=0.59 
Np vs C p=0.32 p=0.06 p=0.03 p=0.24 
Np vs DbC p=0.89 p=0.06 p=0.06 p=0.07 
Neuro-Isch vs C p=0.01 p=0.002 p=0.02 p=0.03 
Neuro-Isch vs DbC p=0.01 p=0.002 p=0.004 p=0.007 
Neuro-Isch vs Np p=0.003 p=0.01 p=0.04 p=0.21 
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Fig. 4.2 Graphic comparison of the highest peak plantar pressures measured in the four 
groups: non-diabetic and diabetic controls, neuropathic and neuro-ischaemic patients 
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Table 4.4 Maximum peak plantar pressures (kPa) and their location 
in the four groups of subjects 
Number of subjects which had their 
Patients Maximum maximum pressure located under 
pressure 
(kPa) Hallux Ist 2nd 3rd 4th 5th 
MTH MTH MTH MTH MTH 
Controls (C) 365.1±49.8 2 4 6 3 0 0 
Diabetic Controls (DbC) 310.2±34.7 5 2 3 1 0 0 
Neuropathic patients (Np) 482.8±68.6 6 6 3 2 0 1 
Neuro-ischaemic patients 757.6±135.9 5 2 2 1 4 0 
(Neuro-Isch) 
Comparisons between groups 
C vs DbC p=0.3, NS 
Np vs C p=0.04 
Np vs DbC p=0.03 
Neuro-Isch vs C p=0.007 
Neuro-Isch vs DbC p=0.008 
Neuro-Isch vs Np p=0.04 
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Fig. 4.3 Graphic comparison of the maximum plantar pressures measured in the 4 
groups: non-diabetic and diabetic controls, neuropathic and neuro-ischaemic patients 
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4.4.2 Highest peak plantar pressures in the four groups of subjects 
Again the highest peak plantar pressures in each area of the foot were 
significantly elevated in the neuro-ischaemic group when compared to the other 3 
groups (Fig. 4.2). 
In the neuropathic patients a trend was found towards greater pressures than in 
the control groups. However this was not statistically significant, except for the medial 
side of the forefoot. 
The highest measured pressures in the control subjects did not differ from the 
pressures measured in the diabetic control patients (Table 4.3). 
4.4.3 Maximum plantar pressures in the four groups of subjects 
The maximum pressures developed under the plantar surface by the neuro- 
ischaemic patients were the greatest, significantly higher than those found in the 
neuropathic group and both the control groups (Fig. 4.3). 
The neuropathic patients had also significantly increased maximum pressures 
when compared to healthy subjects and diabetic controls (Table 4.4). 
The location of the maximum pressure developed by a patient under the plantar 
area was found to be predominantly central (under 2nd and 3rd metatarsal heads) in 9 
out of 15 (60%) non-diabetic controls, medial (under hallux and Ist metatarsal head) in 
7 out of 11 (63%) diabetic controls, also medial in 12 out of 18 (66%) neuropathic 
patients and marginal in 11 (7 medially and 4 laterally, under the 4-5th metatarsal 
heads) out of 14 (78.5%) neuro-ischaemic patients. 
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4.4.4 Pattern of nressure loading in the two control srouns of 
diabetic and non-diabetic subjects 
The pattern of nressure loading in diabetic and non-diabetic control 
suhiects was consistent: in both grouns the nressures behaved in a similar wav 
between stens from the first to the second run. The nressures decreased from 
first run to the second run for both first and second stens (Fig. 4.4). There way 
not a statistically significant difference between the interactions for run by sten 
in either the non-diabetic control groun (n<O. 79) and neither in the diabetic 
control groun (n<O. 56). 
Fig. 4.4 Interactions for run 
fiten in: 
Control group p= 0.79 NS 
Diabetic control p= 0.56 NS 
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158 nattern of nre, csure loading 
FOOT l Ste 
PRESS 







I RUN 2 RUN 
4.4.5 Pattern of nres ure loading in neuronathic diabetic natients 
In the grout) of diabetic neuronathic patients the pattern of nressure loading 
was found to he inconsistent. The nressures decreased from the first run to the 
second run for only the first step. whereas the second sten showed an increase 
nressure from the first run to the second run (Fie. 4.5). Althouwh the actual 
'ariation in nressure was minimal and not statistical significant. what was found 
to he statistically significantly different was the interaction hetween the two 
trends (n<D. 05) suegestinQ that the pressures were loaded in an inconsistent 
manner hetween steps and runs. 
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4.4.6 Pattern of pressure loading in neuro-ischaernic diabetic patients 
However the neuro-ischaernic group presented a similar consistent 
pattern of pressure loading, to the control groups: the interaction for run by 
step was found to be not statistically different (p=0.19). The pressures 
decreased between the first and second runs for both steps (Fig. 4.6). 
Foot pressures 
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4.5 Discussions 
This study has shown that the neuro-ischaemic patients had the highest plantar 
pressures, higher even than the neuropathic patients and also increased when compared 
to diabetic control subjects and non-diabetic control subjects. However the pattern of 
pressure loading in neuro-ischaemic patients was consistent and similar to the pattern of 
pressure loading of the controls groups, whereas the neuropathic patients have 
demonstrated an inconsistent pattern of pressure loading. It is interesting to note that 
despite having increased plantar pressures and a comparable degree of neuropathy, the 
neuro-ischaemic patients did not have a history of ulceration on the plantar surface. We 
believe these observations may have relevance to the mechanism of ulceration in the 
neuro-ischaemic and neuropathic foot. 
Neuropathic ulceration has been studied extensively and its multifactorial 
aetiology has been detected (Boulton AJ, 1994). The measurement of foot pressures 
was considered to be essential when characterising the risk of neuropathic ulceration 
considering their important role in its pathogenesis. However there were no similar 
studies assessing the foot pressures in the neuro-ischaemic diabetic patient. These 
patients have also a high risk of ulceration, firstly, because of their peripheral vascular 
disease and secondly, because most of them have an underlying degree of neuropathy. 
The majority of neuropathic foot ulcers develop under the plantar surface, 
predominantly under the metatarsal heads or other areas of high pressure, such as 
deformity. However from clinical observation, the neuro-ischaemic patients tend not to 
develop ulcers on the plantar surface but more on the sides of the foot (Edmonds, 1987) 
or on the upper margin or in between the toes (Jeffcoate et at., 1993). In a study of 148 
ulcers in neuro-ischaemic feet, 88(59%) were found on the toes, 7 were interdigital, 14 
on the lateral surface of the 5th metatarsal head, 12 on the medial side of the Ist 
metatarsal head and only 4 on the plantar aspect of the Ist metatarsal head (Edmonds, 
1987). 
Also considering that high plantar pressures have been implicated in the 
aetiology of neuropathic ulceration, the hypothesis regarding the foot ulceration in 
neuro-ischaemic patients was that they would have lower vertical pressures, as they tend 
not to develop ulcers underneath the foot. This hypothesis was not confirmed by the 
present findings, which actually has shown that the mean plantar pressures under all 
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areas of interest on the plantar surface: the hallux, the medial and lateral sides of the 
forefoot and the heel were higher even than those in the neuropathic patients. By 
meaning all the peak pressures recorded in all steps of all runs in each patient we 
attempted to obtain a value of pressure which represents the overall, constant loading on 
the foot as a method for the assessment of one of the causative pathways in neuropathic 
ulceration, the constant and repetitive stress. 
However by meaning the pressure values, we might have missed the highest 
peaks of pressure, which are the ones more likely to lead to ulceration in the neuropathic 
foot with a history of ulceration, characterised by increased plantar peak pressures 
(Boulton et at., 1984). In another study by Boulton et al.. all the feet with a history of 
ulceration had abnormally high pressures at the ulcer sites (Boulton et at., 1983). 
Therefore we also analysed the highest peak pressures under the four areas of interest in 
the four groups. Again the highest peak plantar pressures were present under the neuro- 
ischaemic foot, whereas the neuropathic patients had lower pressures than the neuro- 
ischaemic patients did, but higher than both control groups. The highest plantar 
pressures developed by the neuropathic patients were significantly increased only under 
the medial side of the forefoot, which has been recognised as the area most prone to 
ulceration in neuropathic patients (Boulton et at., 1983). The pressures measured under 
the other areas of the foot showed a trend to increase without statistical significance. 
Nevertheless they could be clinically significant if applied repetitively on an insensitive 
foot. 
Another similar experiment in progress in the Diabetic Foot Clinic has used the 
Musgrave platform to assess the barefoot dynamic plantar pressures in diabetic patients 
with ischaemia versus diabetic neuropathic patients and non-diabetic controls using a 
protocol similar to the one used in the present study. The preliminary results obtained 
with this different method of plantar pressure assessment, have shown that the neuro- 
ischaemic patients had the highest pressures when compared to neuropathic diabetic 
patients and non-diabetic controls. The results have been presented at the International 
Diabetes Federation Congress, Helsinki, 1997 (Pitei, 1997). 
Recently a new version of the F-Scan software has allowed the assessment of 
maximum pressure developed by a patient under the entire plantar area and the site 
where this is located. Therefore on re-analysis of the data obtained in all patients, it was 
found that the neuro-ischaemic patients had developed indeed the highest maximum 
pressures, significantly higher than all the other groups, but not statistically different 
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from the neuropathic group who also developed increased maximum plantar pressures. 
Furthermore when analysing the location of the maximum pressure, 78.5% of neuro- 
ischaemic patients developed the maximum plantar pressures towards the margins of the 
foot, whereas 66% of neuropathic patients loaded their maximum pressures under the 
medial side of the forefoot. These results supported the clinical observations regarding 
the areas where foot ulceration tends to occur in neuropathic or neuro-ischaemic 
patients. Likewise these findings would suggest that the maximum plantar pressure 
measurements could be a useful parameter in detecting the location of high plantar 
pressures in patients at risk of foot ulceration. 
Another significant parameter regarding characterisation of pressure distribution 
during gait has been highlighted in recent literature, namely the pressure-time integral 
(Shaw, 1995). The total stress depends on the amplitude of pressure inside the shoe and 
the length of time the pressure was applied for. Therefore it is not only important to 
know how high the pressures inside the shoe are, but also for how long have they have 
been loaded. It must be said that in this study the pressure-time integrals were not 
measured, because the F-Scan methodology was not set up to do so initially, and the 
primary question of the study concerned purely the amplitude of plantar pressures 
developed inside the shoes of the four groups of patients. Also the facility to measure 
pressure-time integrals was not available to us from the manufacturer until a late version 
of F-Scan software, which was not totally validated by the time this thesis has been 
written. However further studies assessing the pressure-time integrals and the time 
characterisation of the foot pressures in the neuropathic and neuro-ischaemic patients 
versus the control subjects and diabetic controls are needed. 
Thus, although the neuro-ischaemic patients did not develop ulcers under the 
plantar surface their vertical plantar pressures were consistently high, and even higher 
than the neuropathic patients who tend to develop ulcers underneath the foot. It must be 
noted that the neuro-ischaemic patients had also a degree of neuropathy, which was not 
significantly different from that of the neuropathic patients. The degree of neuropathy 
was above the vibration perception threshold considered to be of risk for ulceration, as 
described by Young et al.. (Young et al., 1994). Therefore some increase in the plantar 
pressure could have been expected considering that these neuro-ischaemic patients did 
have a degree of neuropathy. However if their pressures were higher than those of the 
neuropathic patients, why did they not develop ulcers underneath the foot? 
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A possible explanation may be regarding the level of activity. This aetio- 
pathological factor implicated in the ulcer formation was considered to be essential by 
Cavanagh et al. (1994). As an added factor to the level of activity, the type of activity is 
also important when assessing the foot pressures as the amount and the type of activities 
during daily living may affect the foot (Rozema et al., 1996). It is important to know 
how often and for how long an area on the plantar surface is subjected to a repetitive and 
high stress. In our study, it is possible that the neuropathic patients simply continued to 
walk on areas of quite high pressure, whereas the neuro-ischaemic patients simply 
walked less because of possible intermittent claudication and general frailty, which 
prevents them from actively walking on these areas of high pressure. 
The neuropathic foot, in response to continuous repetitive stress and high 
pressures, develops `hot' spots and callus build-up (Levin, 1995) which itself has been 
implicated in the aetiology of ulcer formation, acting as a foreign body and increasing 
further the pressures (Young et al., 1992). In contrast, the neuro-ischaemic foot, which 
is defined by both ischaemia and a degree of neuropathy, tends not to build-up so much 
callus, possibly because of the poor blood supply. This is in contrast to the neuropathic 
foot which in the presence of a good blood supply develops callus at the sites of high 
pressures and this has been proven to be a forerunner of ulceration on the plantar surface 
(Edmonds, 1987). The findings of high pressure in neuro-ischaemic patients seem not 
to be related to the callus formation. 
Furthermore in the neuro-ischaemic foot there is possibly reduced subcutaneous 
tissue due to poor blood supply. This may reduce the cushioning effect of the soft tissue 
and may account for the high pressures found in these patients. Likewise, it may be that 
the properties of the soft tissue in neuro-ischaemic patients are altered in comparison to 
the pure neuropaths who have a good blood supply with palpable pulses. It might not 
only be that the soft tissue is thinner but its intrinsic compressibility, and elasticity are 
altered as the tissue is suffering from `malnutrition' because of the continuos ischaemic 
process. Observations on amputated neuro-ischaemic legs indicate that their muscles 
can be atrophic-(Personal communication. Edmonds, 1996). The properties of the soft 
tissue have just recently been considered as important in the aetiology of ulceration. The 
thickness of the soft tissue and the alignment of bones were measured from standing 
weight bearing X-rays and they have been shown to be useful predictors of elevated 
plantar pressures under metatarsal heads in walking (Cavanagh et al., 1994). 
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Furthermore Brink has shown in ten neuropathic patients with a history of 
ulceration that soft tissue at the sites of previous ulceration over the metatarsal heads, 
was significantly harder than at other sites in the same feet or in the control feet, 
although the degree of limited joint mobility was similar in neuropathic patients to that 
in the older controls. He also found that the peak plantar pressures were significantly 
higher at this areas of induration of the plantar pad and concluded that the induration of 
the soft tissue may predispose to recurrent foot ulcers in diabetics by decreasing the 
shock absorption capacity of the plantar pad (Brink, 1995). Future studies are awaited 
to elucidate the role of soft tissue in the diabetic foot ulceration and specifically in the 
neuro-ischaemic foot. 
An atrophic, thin skin on the foot may be more vulnerable to the shear forces 
developed on the margins of the foot. Ischaemia of the superficial layers of the dermis 
allows cleavage to occur in response to shear stresses with subsequent formation of 
blisters (Goodfiled et at., 1986). The shear forces developed at the shoe-foot interface 
have been implicated, although the exact mechanism still awaits elucidation - as 
discussed in the previous chapter, in the aetiology of foot ulceration in neuropathic 
patients with concomitant vascular disease. The neuro-ischaemic foot has a decrease in 
the blood flow with subsequent tissue ischaemia, which makes the soft tissues of the 
foot more sensitive to stresses developed inside the shoe from ill-fitting shoes, which 
would lead to localised areas of pressure due to the shear stresses (Jeffcoate et al., 
1983). This might lead to the necrosis of the ischaemic tissue at the sites of friction with 
the tight shoes (Edmonds, 1987) before there is time for the high vertical pressures to 
act on the plantar surface and lead to ulceration, especially if the level of activity is 
reduced (Cavanagh, 1995). 
In the absence of a clinically available shear transducer, attempts to determine a 
relationship between anterior-posterior shear and maximum plantar pressures were 
made in 30 subjects (Cornwall et at., 1995). The results of this study have shown that 
by complex analysis of a combination of peak force, time to peak pressure and stance 
duration time, the anterior-posterior shear can be predicted. However this theoretical 
attempt underlines once more the need for technologies to be developed and for further 
studies to measure the shear forces inside the shoe, with special interest in the neuro- 
ischaemic patients who possibly are the most vulnerable to shear stress. 
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Another possible explanation of the study findings may be that different groups 
of subjects may have different ways of loading the pressures on the plantar surface. 
Therefore an attempt was made to find a way to analyse the pattern of pressure loading 
in different steps of different runs by describing the interactions between the steps and 
runs of the patients in the four groups. Both the control groups: diabetic patients 
without neuropathy or ischaemia and non-diabetic control subjects, had a consistent 
pattern of loading. The neuro-ischaemic patients also showed a similar consistent way of 
loading the pressures on the plantar surface of the foot. These findings suggest of a 
repeatable, uniform gait. However the only group showing a significant interaction 
between the pressures developed in each step of each run, was the neuropathic group, 
which developed an inconsistent pattern of pressure loading: they increased or decreased 
the pressures of the first step from the first run to the second run, with a contrary 
tendency for the pressures of the second step. For example, if the pressures of the first 
step were increased in the second run, the pressures of the second step were decreased 
in the second run. Although the change in pressure actually was not statistically 
significant, what was significant was the interaction between the direction of change 
(increase/decrease) of the pressures developed in the steps of the first and second run. 
Therefore, it seems that the neuropathic patients have a higher variability of gait 
and of pressure loading. This is in agreement with other findings reporting problems 
with gait and posture in neuropathic patients, who were 15 times more likely to report 
injuries, these results being strongly indicative of an effect of neuropathy on gait 
(Cavanagh et al., 1992). Furthermore increased unsteadiness, and uncertainty in 
neuropathic patients were reported as biomechanical consequences of diabetic 
neuropathy, which leads to loss of large fibre proprioception and somatic feedback from 
receptors in the feet (Cavanagh et al., 1993). Also Boulton et al.. have shown that 
important changes in the distribution and level of pressures under diabetic neuropathic 
feet occur during a relatively short time in the natural history of foot pressure 
abnormalities in neuropathic diabetic subjects (Boulton et al., 1987). 
As regards variability of pressure loading, the neuro-ischaemic patients behaved 
similarly to the control groups suggesting a less variable gait than the neuropathic 
patients. This may be somehow surprising as the neuro-ischaemic patients also had a 
degree of neuropathy, although this was less advanced. 
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A possible explanation may be that the neuropathic patients with an advanced 
degree of neuropathy had lost their proprioceptive sensitivity almost entirely and they 
were more likely to be unsteady when walking and to traumatise their feet easier. 
However the neuro-ischaemic patients who had a lesser degree of neuropathy, may have 
been more congruous in the way they loaded the pressures and may have still been able 
to develop an antalgic gait in a consistent manner, as a normal control would do. 
Conclusion 
The neuro-ischaemic patients who tend not to develop ulcers under the plantar 
surface, but on the margins of the foot, have been shown to have abnormally high 
vertical foot pressures, but a consistent pattern of loading suggestive of a constant, 
normal gait in the presence of a comparable degree of neuropathy to the pure 
neuropathic patients. However this was not associated with plantar ulceration. This 
pattern of gait was similar to the diabetic controls and non-diabetic controls that had 
lower foot pressures. However the neuropathic patients, who tend to develop ulcers on 
the plantar surface of the foot, had high pressures, although lower than the neuro- 
ischaemic ones, but an inconsistent pressure loading pattern suggestive of a variable 
gait. 
These findings may indicate different mechanisms of ulcer formation between 
neuro-ischaemic and neuropathic diabetic patients, possibly linked among other factors 
to the pressure distribution pattern. 
Therefore the whole issue of ulceration in neuro-ischaemic patients raises new 
questions for future research as regards the time characterisation of pressures 
distribution inside the shoe, the size and role of shear stresses in foot ulceration, and the 
role of soft tissue characteristics in the aetiology of foot ulceration. 
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Chapter 5. THE EFFECT OF REGULAR CALLUS REMOVAL 
ON FOOT PRESSURES 
5.1 Background 
Clinical studies have reported ulcer formation to be invariably associated with 
plantar callus (Edmonds et al., 1986). A clinico-pathological study of diabetic foot 
ulcers in 54 patients during a 32-month period suggested that abnormal pressures 
contributed to all lesions occurring in areas of callus (Jones et al., 1987), which also 
took longer time to heal than traumatic lesions. 
Haemorrhages have been found within plantar callus in a study of 100 diabetic 
patients with neuropathy (Rosen et al., 1985). Furthermore recent studies of magnetic 
resonance imaging in diabetic patients with a history of foot ulceration found artefacts 
or `drop outs' on the image of the foot. These are thought to represent accumulation of 
haemoglobin degradation products in the soft tissues of the foot. Although the vertical 
plantar pressures were not different in patients with or without these soft tissue 
haemorrhages, the presence of such soft tissue haemorrhages might be a result of 
increased shear forces (Brash et al., 1995). Likewise they might reflect intrinsic 
capillary fragility which is associated with microangiopathy, highlighting once more the 
interaction between the microcirculation defects and the other risk factors implicated in 
the aetiology of foot ulceration such as callus formation and foot pressures. Furthermore 
the diminished hyperaemic response to noxious stimuli due to a reduced axon reflex in 
neuropathy plus abnormal neuro-vascular responses are likely to delay healing of 
lesions precipitated by minor or major trauma easily unnoticed by an insensitive foot 
due to neuropat iy. 
The reduction in dynamic plantar foot pressures, when the callus was removed 
in diabetic neuropathic patients, has proven also that the callus may act as a foreign 
body elevating the plantar pressures (Young et al., 1992) and predispose to foot 
ulceration. It also has highlighted the necessity of regular chiropody in the care of 
diabetic foot, which is of extreme importance in preventing foot ulceration and 
amputation according to the St. Vincent Declaration. Moreover a study evaluating a 
structured teaching and treatment programme including chiropody has shown the 
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significant decrease in the number of patients with callus formation and poor nail care, 
which was associated to a concomitant reduction in the health care costs due to the 
prevention of major health problems (Pieber et al., 1995). 
Therefore chiropody has been proven to be an essential aide in the care of the 
diabetic foot. The question arising next was: 
- how often chiropody treatment should be performed, as the optimum frequency 
of callus removal is unknown. 
Patients come on a regular basis to the Diabetic Foot Clinic in King's College 
Hospital for callus removal on the advice of the chiropodist treating them, who takes 
into account the different clinical variables such as history of ulceration, individual rate 
of callus formation and level of activity in each patient. However none of them are 
quantitative variables. 
One way to assess quantitatively the effect of callus removal is to measure the 
plantar pressures, and most important inside the shoe, where the ulceration is more 
likely to occur in real-life conditions. Only one single study has been done previously, 
which tested the effect of callus removal on foot pressures, but it was performed 
barefoot. Nevertheless it has found an important reduction in plantar pressure of 25% 
when (Young et al., 1992) the callus was removed. However follow-up studies have 
not been performed, and it is important to elucidate what happens from the time when 
callus is removed until the patient presents again at the Diabetic Foot Clinic. 
Aim of the study 
Therefore the primary aim of this study was to quantify the change in plantar 
pressures before and after callus removal. In a pilot follow-up study the change in 
plantar pressures when the patient comes back next time for regular chiropody was 
measured in order to assess the efficiency and the necessity for frequent chiropody. 
The F-Scan system of dynamic measurement of foot pressures inside the shoe 
was used in the study in an attempt to establish its value for determination of the 
suitable frequency of callus removal. 
Also by weighing the callus and recording the time interval between chiropodial 
treatments we made an attempt to quantify the effect of chiropody. 
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5.2 Methodology and study conditions 
Foot pressures assessment as described in the previous subchapter. 
5.2.1 Protocol 
The patients' feet were inspected for the presence of callus before the test and 
the area was noted for the attention of the chiropodist and to enable the investigator to 
locate it for F-Scan analysis. Patients had an F-Scan test before and after the callus was 
removed. 
The amount of callus removed was placed in a sterile container labelled with the 
name of the patient, the date and the site where the callus was removed from, plus with 
the name of the chiropodist. The callus removed was kept in a dry container and 
weighed as dry-substance, at least 1 month after removal. In a preliminary pilot-study 
we found that the weight of callus at 1 month, 3 and 6 months after removal remains 
constant if kept in the same dry container. 
5.2.2 Recording 
Each patient walked wearing standard trainers on the same even area, for three runs, the 
last two runs being recorded. One new insole was used per patient. 
5.2.3 Analysis 
The plantar pressures were measured as peak pressures. The pressures were read 
from the pressure-time graphs for the area of interest by moving the cursor along the 
graph and choosing the point of maximum pressure. This was the area visible on the 
map of the foot which corresponded to the area where the callus was identified at foot 
inspection and from where the callus was subsequently removed. On the screen this area 
of interest was selected by placing the standard size (0.25cm2) box on it and this was 
followed sequentially before and after callus removal and then again at follow-up. 
The peak pressure was calculated as a mean of the three steps of the second recorded 
run, as a method to standardise the analysis at each visit. 
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Standard trainers were Clarks `Swing Low' trainers with a standard inlay molded 
Plastazote (Polyethylene) foam with a small heel cup and arch support laminated to a 
woven nylon sock. A second layer of Polyurethane was used to improve the cushioning. 
5.2.4 Neuropathy assessment 
The presence of nerve damage was assessed in both lower limbs by clinical 
examination of the ankle reflexes and foot pulses, together with recording the vibration 
sensory threshold (VPT). Thermal sensory thresholds (TPT) were also recorded with a 
Thermal tester (Somedic, Stockholm, Sweden) from the dorsum of the foot and the 
response to five warm and five cold stimuli delivered at random time intervals was 
recorded. 
53 Patients 
The selection of patients was made taking into account 24 consecutive patients 
who came to the Diabetic Foot Clinic for regular callus removal. These patients were 
divided into three groups after the time interval between two visits at the clinic for 
callus removal: 
Group 0-6 patients who presented for the first time ever for callus 
removal and who did not have a history of ulceration. 
Group A-9 patients who required chiropody treatment on a regular basis, at every 6-8 
weeks and had a history of ulceration. 
Group B-9 patients who needed more frequent chiropody, at every 3-4 weeks and had 
a history of ulceration. 
The assessment of plantar pressures was done in the 24 patients on the day of 
chiropody treatment before and after the callus removal. In 20 patients we were able to 
quantify the callus by weighing it as dry substance. 
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t adre z. 1 unnicai ana neuro painy aetaiis of patients 
Group 0 Group A Group B 
Patients n=6 n=9 n=9 
Age (years) 50.8±5.7 61.2 ± 3.9 69.2 ± 2.5 
Diabetes duration (years) 11.3±4.4 24.6 ± 6.3 15.8 ± 4.3 
Vibration perception 15.8±3.6 36.8 ± 3.7 31.7 ± 3.4 
threshold (V) 
Thermal perception 8.5±0.6 12.2 ± 1.0 13.0 ± 0.9 
threshold for hot (°C) 
Thermal perception 2.5±0.6 11.4 ± 1.8 9.9 ± 1.8 
threshold for cold (°C) 
HbAlc (%) 8.1±0.7 9.2±0.9 9.8±0.5 
Weight (kg) 79.1±6.2 86.5±6.5 76.3±2.0 
Time interval between never before 6.7±0.3 4.0±0.2 
chiropody treatment 
(weeks) 
Mean ± SEM 
In Group 0: 2 patients had callus under their first metatarsal head, 3 patients 
under the 2nd-3rd metatarsal heads, 1 patient under 4th metatarsal head. 
In Group A: 5 patients had callus under their first metatarsal head, 2 patients 
under the 2-3 metatarsal heads, 1 patient under 5th metatarsal head and 1 patient under 
the Charcot deformity. 
In Group B: 4 patients had callus under their first metatarsal head, 2 patient 
under the 3rd metatarsal head, 3 patients under 4-5th metatarsal heads. 
137 
Characteristics of the patients 
All patients in Groups A and B had peripheral neuropathy and a history of 
neuropathic foot ulceration, whereas the patients in Group 0 had less neuropathy and no 
history of neuropathic foot ulceration. All groups of diabetic patients had a long 
duration of diabetes, although those in Group B had the longest duration of diabetes. 
The diabetes control was similar in all groups (Table 5.1). All the patients included in 
the study were free from major peripheral arterial disease: foot pulses were easily 
palpable and ankle: brachial ratios were > 0.8. 
5.4 Follow-up pilot study methodology 
In an attempt to prolong the interval between treatments 5 patients from Group 
B, who previously used to come at 3-4 weeks interval, were followed-up and the 
interval was increased to 6 weeks in 3 of them and 8 weeks in two of them. This was 
done in an attempt to assess if they needed frequent chiropody or longer time intervals 
may be a feasible and more cost effective, but still a safe option for callus removal in 
prevention of ulceration. 
The plantar pressures before and after callus removal were re-assessed at the 
follow-up visits to the Diabetic Foot Clinic in order to correlate the increase in pressure 
with the built-up of callus after the initial removal. 
5 patients from Group B were followed-up closely: 2 patients (W. G. and S. T. ) 
were followed-up for 2 consecutive visits and 1 patient (W. J. ) was followed-up for 3 
consecutive visits; 2 patients (BD and J. I. ) were followed-up for 4 consecutive visits. 
3 patients were allowed to go 6 weeks, instead of their regular 3 or 4 weeks 
before chiropody. In 2 patients the subsequent interval was prolonged to 8 weeks in 
order to assess if longer time intervals lead to a proportional increase in pressure. 
5.5 Statistical analysis 
Mean and SEM were calculated using the statistical analysis Statwork package. 
Comparisons between plantar pressures before and after callus removal were made 
using the paired Wilcoxon Signed Rank non-parametric test and the Mann-Whitney test 
was used for comparisons between groups. 
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5.6 Results 
Comparisons were made between the plantar pressures before and after callus 
removal in all patients (Figures 5.4 and 5.5). 5 patients from Group B were followed-up 
closely after their initial session of callus removal. In 3 patients who were allowed to go 
6 weeks, instead of their regular 3 or 4 weeks before chiropody, the plantar pressures 
increased with 36.3±4.0%. In the 2 patients whose subsequent interval was prolonged to 
8 weeks, the peak pressures have risen with 34.3±3.1 %. 
The follow-up patients from Group B were not included subsequently in the 
analysis of plantar pressures before and after callus removal of Group A. 
5.6.1 Plantar pressures before and after callus removal in Group 0 
The plantar pressures in patients who presented for the very first time to the 
Diabetic Foot Clinic were 374.8±69.9 kPa (Mean±SE) before callus removal and 
251.0±56. OkPa afterwards, which indicates a decrease in pressure of 31.8±8.3%, 
p=0.014 with 341±156.5 mg callus removed. Figure 5.1 
5.6.2 Plantar pressures before and after callus removal in Group A 
The comparison between plantar pressures before and after callus removal in the Group 
A of patients who received regular chiropody at 6-8 weeks interval indicated a 
significant reduction of 29.0±4.2%, p<0.005. The peak pressures were 351.7±71.7kPa 
before the callus was removed and 240.5±48.4kPa afterwards. The callus weight was 
467.8±83.6 mg. Figure 5.2 
5.6.3 Plantar pressures before and after callus removal in Group B 
When the plantar pressures before callus removal (241.0±29.9kPa) were compared to 
those (176.2±19.9kPa) after callus removal in the Group B patients who received 
frequent chiropody at 3-4 weeks interval, the mean reduction in pressure was 
30.7±7.1 %, p =0.006 and the weight of the callus removed was 276.5±75.9 mg. Fig 5.3 
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5.6.4 Comparisons between plantar pressure reduction 
in Group 0 and A and B 
Although there was a different time interval between chiropody treatments there 
were no statistically significant differences between the percentage reduction in plantar 
pressures in the three groups. The weight of the callus removed was not statistically 
significant different in any of the three groups. 
Table 5.2 Comparisons between the four groups of patients who had 
chironodial removal of callus 
Group 0 Group A 
vs Group 0 
Group B 
vs Group 0 
Group A 
vs Group B 
Patients n=6 n=9 n=9 n=9 
Vibration perception 15.8±3.6 36.8 ± 3.7 31.7 ± 3.4 p=0.49, NS 
threshold (V) p=0.006 p=0.004 
Thermal perception 8.5±0.6 12.2 ± 1.0 13.0 ± 0.9 p=0.44, NS 
threshold for hot (*C) p=0.047 p=0.01 
Thermal perception 2.5±0.6 11.4 ± 1.8 9.9 ± 1.8 p=0.48, NS 
threshold for cold (*C) p=0.05, NS p=0.05, NS 
Plantar pressures (kPa) 374.8±69.9 351.7±71.7 241.0±29.9 p=0.4, NS 
before callus removal p=0.69, NS p=0.10, NS 
Plantar pressures (kPa) 251.0±56.0 240.5±48.4 176.2±19.9 p=0.49, NS 
after callus removal p=0.70, NS P=0.22, NS 
Callus weight (mg) 341.5±156.5 467.8±83.6 276.5±75.9 p=0.43, NS 
p=0.63, NS p=0.78, NS 





Fig. 5.1 Peak plantar pressures in 
Group 0 of patients who received chiropody 
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5.6.5 Plantar pressures at follow-up visits after initial callus removal 
Case studies 
Follow-up for 2 consecutive visits (Fig. 5.6- see Page 151) 
Patient WG was seen both at the first and second visit after a4 week interval, 
his pressures increased only with 1% during the 4 weeks. 
Patient ST was seen initially after 4 weeks interval and second time after 6 
weeks interval, when the pressures increased with 34.4%. 
Follow-up for 3 consecutive visits (Fig. 5.7) 
Patient WJ came at his first assessment after a3 weeks, then he was followed-up 
for 4weeks when the pressures increased by 44%, then he received chiropody and was 
Fig. 5.7 Peak plantar pressures in patient W. J. 
when callus was removed 
at 3 consecutive visits to the 
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followed for another 6 weeks when the pressures increased by 30.6%. 
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Follow-up for 4 consecutive visits (Fig. 5.8) 
Patient BD came for the first assessment after 4 weeks interval, received 
chiropody and was followed-up for 8 weeks when the pressures increased with 37.5%, 
the callus was then removed urgently and she was followed-up for 6 weeks when the 
pressures increased by 28.1%, then she received chiropody and was followed-up for 
another 4 weeks when the callus did not build up. 
Patient JI came after 4 weeks interval, received chiropody and was followed-up 
for 6 weeks when the pressures built-up by 44%, then for another 6 weeks when the 
pressures increased by 25.1 %, then for 8 weeks during which the pressures increased by 
31.2%. 
5.7 Discussion 
Plantar callus is a common occurrence and is probably associated with high 
vertical and shear forces in neuropathic patients with insensitive feet. Shear stresses at 
these areas of high foot pressure could ultimately result in ulcer formation. Therefore 
the removal of callus by chiropody treatment is important in prevention of foot 
ulceration. Moreover methods to diminish callus formation are sought as an early 
preventative measure: a study assessing the use of orthotic devices to correct plantar 
callus in diabetic patients has shown the beneficial effect of orthotic devices in reducing 
the callus formation presumably by redistribution and reduction of pressure (Colagiuri 
et al., 1995). 
It is accepted that conventional regular chiropody is extremely important in 
preventing ulceration. The present study has shown that chiropody is an essential tool 
in callus removal leading to a significant reduction in plantar pressures of 31.8±8.3% in 
patients at their first ever visit to chiropodist, of 29.0±4.2% in patients requiring regular 
chiropody at 6-8 weeks time interval and of 30.7±7.1 % in those coming more frequently 
at 3-4 weeks interval. Therefore independent of the time interval between treatments, 
the actual chiropodial technique of callus removal has an overall decreasing effect on 
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This is in agreement with a previous study of callus removal in 17 diabetic 
neuropathic patients which showed that the peak pressures under 43 areas of callus in 
the forefoot fell by 26% after callus was removed. It was also demonstrated that the 
pressures under the heel were unchanged, highlighting the importance of assessment of 
specific areas of pressure as callus tends to be more localised in the forefoot. 
Furthermore the present study has found that areas of callus were predominantly 
localised under the medial area of the forefoot plantar surface (5 out of 6 patients in 
Group 0,7 out of 9 patients in Group A, 6 out of 9 patients in Group B). 
The patients in Group 0, who were coming for the first time to the Diabetic Foot 
Clinic to have their callus removed, showed the biggest reduction in plantar pressures 
with callus removal (32%). Their plantar pressures before chiropody were also the 
highest, in the presence of heavy callus. Paradoxically this group of patients did not 
have a history of ulceration, but interestingly they also had less neuropathy than the 
other two groups with a history of ulceration. Therefore heavy callus alone or high 
plantar pressures alone do not seem to lead to foot ulceration, but the coexistence of 
other factors is needed, of which probably the most important factor is peripheral 
diabetic neuropathy. 
These findings support those of Fernando et al. (1991), who also showed that 
abnormal plantar pressures alone do not lead to foot ulceration. Furthermore they come 
into accord with the multi-factorial theory of diabetic foot ulcer aetiology (Boulton, 
1994) including: neuropathy, limited joint mobility, high foot pressures, trauma, 
improper shoe wear and callus formation (Murray et al., 1995). 
In contrast to Group 0, the patients in both Group A and Group B had a history 
of ulceration and a more advanced degree of neuropathy as assessed by TPT for cold 
and hot temperatures and VPT, which was in both groups above the threshold of risk for 
ulceration, namely 25 Volts (Young et al., 1994). The percentage reduction in plantar 
pressures with callus removal in Group A(at 6-8 weeks) was similar to that in Group 0, 
whereas the percentage reduction in plantar pressures with callus removal in Group B 
(at 3-4 weeks) was smaller although not statistically significant. Accordingly, the 
baseline pressures were smaller in group B (241.0±29.9kPa ) than in group A 
(351.7±71.7kPa) and as a consequence the plantar pressures after callus removal were 
smaller in Group B (176.2±19.9kPa) than in group A (240.5±48.4kPa). Furthermore the 
weight of the callus removed was higher in Group A. 
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Although not statistically significant, these differences in pressure might highlight the 
clinical importance of the absolute levels of pressure attained by regular chiropody in 
prevention of ulceration and suggest the 3-4 week interval between visits as being 
suitable for control of callus formation and prevention of ulceration. 
The trend towards higher pressures and the higher values of callus weight in 
Group A receiving regular chiropody at 6-8 weeks interval might suggest that these 
patients simply needed more frequent chiropody. 
However with no recurrence of ulceration in this, admittedly small, group of 
patients seen at 6-8 weeks interval, another explanation could be that: those patients 
coming at 3-4 weeks might be coming too often to the chiropodist, with no real benefit. 
They could be asked to come at longer time intervals allowing a better use of the time 
and staff resources in the Diabetic Foot Clinic. Alternatively, it could be argued that the 
higher range of pressure at 6-8 weeks interval is still safe regarding ulceration, but only 
in those patients characterised by a slower rate of callus formation. 
In the follow-up case studies, the rate of callus formation varied in different 
individuals probably related to their level of activity and mobility. In two instances in 2 
of our follow-up patients (diagrams ) there have been no significant increase in pressure 
at 4 weeks after callus removal, whereas another patient increased his pressures with 
44% in 4 weeks. However as the increase in plantar pressures after 8 weeks was not 
much higher than that after 6 weeks, from these observations it seems that the rate of 
callus formation rises sharply initially in the first 4-6 weeks and then the rate of callus 
formation and pressure increase slows down. However it has been demonstrated that 
even moderate stress, if it is repetitive could lead to soft tissue breakdown and 
ulceration (Brand, 1988), with the necessity of callus removal sooner (at 6 weeks) than 
later (at 8 weeks). 
This may be of importance in the Diabetic Foot Clinic in deciding how frequently 
a patient ought to be seen in correlation with his plantar pressures. Although now 
empirically determined by chiropodists by the absence of recurrent ulceration, the 
frequency of callus removal might be dictated by the individual rate of callus formation 
which can be now quantified by measuring the increase in plantar pressure with the built- 
up of callus. In addition from our follow-up cases it was clear that although the pressure 
decrease with callus removal tended to be in a certain range per patient (e. g. patient BD: 
14-15-17% or patient JI: 21-17-26%), there is some variability in the amount of callus 
removed and sometimes in the actual pressure reduction (BD: 7.3% or JI: 4%); all these 
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are probably related to differences in the operating techniques of the chiropodists. These 
would influence the immediate result, the weight of callus removed, which previously 
was thought to be a useful indicator of the efficacy of callus removal. However the 
measurement of plantar pressures has proven to be a more functional and objective 
indicator valuable in the assessment of chiropodial treatment. 
Conclusion 
The F-Scan methodology can provide the facility to follow-up the callus 
formation until it reaches the upper limits of acceptable pressure and requires removal. 
This might prove of benefit for reducing the costs of foot care by reducing the frequency 
of chiropodial treatment and making it more cost-effective. 
Using this relatively recent technology, longitudinal studies of plantar pressure 
in correlation with chiropodial follow-up are needed now in a larger number of patients. 
Previous longitudinal measurements of plantar pressure have shown a change in the 
pressure distribution but with no significant rise in the peak forefoot pressure when 
performed barefoot (Boulton et at., 1987) or in contrast, an increase in vertical 
pressures was reported in neuropathic patients with high plantar pressures which were 
considered to be highly predictive of subsequent plantar ulceration (Veves et al., 1992). 
The measurement of foot pressures may prove to be useful first for the `on the 
spot' assessment of the efficacy of the callus removal and secondly in the chiropodial 
follow-up of the patients. Diagrams such as those drawn for our follow-up case studies 
could be included in the notes of the patients coming to the Diabetic Foot Clinic in 
order to provide the necessary documentation regarding the change in plantar pressure 
before and after chiropody at each visit. 
These observations of plantar pressures are of interest, but further close follow- 
up of a larger number of patients is required, preferably a weekly measurement of 
plantar pressures to assess the rate of callus formation and to define in a larger number 
of patients the threshold of pressure for the removal of callus in order to keep the 
diabetic foot free from ulceration. 
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Chapter 6. THE EFFECT OF FITTED SHOEWEAR ON FOOT PRESSURES 
6.1 Introduction 
Footwear is an important aspect of the treatment of diabetic foot and the aim of 
this study was to assess the quantitative effect of different types of footwear on foot 
pressures. 
6.1.1 Role of prescription footwear in prevention of foot ulceration 
The role of prescription footwear in prevention of recurrent ulceration is 
achieved by counter-acting the mechanical factors involved in ulcer formation; namely 
by accommodating the deformed foot, supporting the insensitive foot with limited joint 
mobility and decreasing the high foot pressures. 
The moulded inserts of the prescription shoes are thought to have two main 
effects on plantar pressures: 
- first to reduce the foot pressures directly through the cushioning effect of 
different types of materials used for their inserts, 
- secondly to redistribute the pressures through the moulding process of inserts to 
fit the characteristics of the foot. Therefore the vertical forces would be dispersed from 
small areas of high pressure on the larger surface of the sole with a subsequent 
reduction in pressure. 
6.1.2 Characteristics of prescription footwear 
Tovey's (Tovey, 1984) guidelines regarding the role of prescription footwear 
require that the shoes should be able: 
- to accommodate foot deformities 
- to stabilise foot deformities 
- to limit aberrant joint motions 
-- to relieve the excessive foot pressures 
- to reduce shock and shear 
The shoes ought to be of sufficient depth to accommodate the foot to avoid undue 
pressure from the upper side of the shoe. The actual process of shoe fitting requires that: 
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- both feet should be measured 
- shoes should be fitted on both feet during weight bearing 
- the proper position of the first metatarsal should be checked 
- the correct length and width should be provided 
- the heel should be supported 
-a proper fit over the instep should be checked. 
Most orthotists and surgical shoes manufacturers tend to use soft leather for 
prescription shoes with a large upper to accommodate the often deformed foot, and an 
extra strip of leather around the heel to keep it secure. Inside the shoe, seams are 
avoided in the areas prone to friction. More recently elasticised bands (Recco) or 
materials such as Dupont material, which has elastic and stretch properties are used to 
accommodate the toes. In the case of the hammer toes, some manufacturers heat the 
leather according to the position of the hammer toe in order to stretch out the upper and 
allow more space and flexibility (Uccioli, 1996). As usual the sole has a shank to make 
it rigid and able to support an insensitive foot with wasted interosseous muscles. 
Ultimately the prescription shoes offer a way to accommodate both the 
deformity and the insert. The latter is the most important component of the shoe as 
regards provision of necessary cushioning. The insert is often multi-layered and can be 
up to 8 mm thick (Tovey, 1984). 
Prescription shoewear can be divided into two groups: stock shoes or bespoke 
shoes. Therefore prescription shoes although coming in a large range of styles and 
designs, have usually extra-depth, whether they are manufactured stock shoes such as 
the `New Style TM' with a Poron insert (Ken Hall Ltd, Kettering, Northants. ) or 
bespoke shoes such as those provided by the Orthotic Dept. at King's College Hospital 
and containing ethyl-vinyl acetate (EVA) inserts. 
Similarly there is an enormous variation between the type of inserts and the 
materials used in their manufacture, with different characteristics as regards their 
amount and rate of mouldability and permanent deformation and hence in their ability to 
provide cushioning, and/or shock absorption (Brodsky et al., 1988). Some inserts are 
made of resilient, semi-rigid materials (Poron) good for shock absorption (Pratt et al., 
1986) and foot control, but they are usually flat and not moulded on the sole of the foot. 
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Other inserts are made of soft materials such as EVA polymer, which are comfortable, 
inexpensive, easily adjusted being mouldable and allowing better cushioning 
(McKenzie et al., 1985), but there is the risk of flattening of the material (Garcia et al., 
1994). The ideal insert represents a combination of materials to achieve both durability 
and mouldability (Brodsky et al., 1988). The actual design of the inserts could also 
have a direct effect on foot pressures. For example the mid-sole construction often 
found in running shoes (trainers) with moulded inserts has a beneficial effect by 
redistributing and reducing the plantar pressures. 
Prescription of fitted footwear still involves a series of empirical stages (Lord, 
1989). When shoes are to be fitted, the physician suggests a standard design or 
individually designed bespoke shoes. Matching the surgical shoes to the individual 
characteristics of the foot requires special insoles designed with the skills of an 
orthothist, which makes them expensive. The shoes -are produced through a series of 
fitting sessions with costly materials and the demand of fitted footwear on the hospital 
budget can be substantial. From the £38 million annual NHS budget, 30% is spent on 
foot orthoses and footwear (Fox et al., 1994). Thus, in the past, the absence of 
techniques for in-shoe foot pressure measurements have made the assessment of 
footwear difficult. 
The F-Scan system is particularly advantageous for assessing the effect of 
different shoes on plantar pressures because it has an ultrathin insole, which can be 
placed inside any shoe and trimmed to the size and the shape of the shoe without 
interfering with the foot pressures. 
6.1.3 Technical limitations of in-shoe plantar pressure assessment 
in relation with prescription footwear 
Attempts to measure the effect of different footwear on foot pressures have been 
made previously, but they have had to take into account the technical limitations of the 
systems used for the assessment of plantar pressures. The limitations of the 
instrumentation with cumbersome techniques, measurement variability and inadequate 
durability, are the most important factors which have delayed the quantitative 
assessment of a variety of shoe wear on the foot pressures. 
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The in-shoe pressure transducer used to assess the effect of the rocker-bottom 
shoe on foot pressures had a number (72) of pressure-sensitive elements which could 
not cover all the areas of the foot and therefore certain areas of the foot were not 
monitored (Cavanagh, 1990) 
In another study, using a smaller number of sensors (15 pressure-sensor insole) 
to measure the plantar pressures in 13 different shoes, considerable variability in the 
measurements of forefoot pressure was reported (Schaff et al., 1986). These studies 
with discrete transducers have produced a variety of results when comparing 
prescription to conventional footwear ranging from 50% reduction to no change or to 
actual increase in some locations. 
This highlights the necessity for a pressure-sensitive device containing 
numerous sensors to cover the entire area of the foot. This would not only provide the 
required spatial resolution, but also the possibility to detect the areas of highest pressure 
on the map of each individual foot. From this point of view, the F-Scan could be 
advantageous: its insole consists of 960 individual sensor cells, in a grid-like 
configuration, allowing a high spatial resolution. It is also ultrathin (1.8mm) and can be 
cut to the size and shape, often unusual, of the diabetic prescription shoes. However the 
fact that the insole has a limited life-time as described in the previous subchapter and 
there is a variability between the ability of different insoles to measure pressure (Rose 
et al., 1992; Brown, 1996) , limits its use. Nevertheless if one insole is used per patient 
useful comparisons can be made, especially in a study comparing the pressures of the 
same patient in different footwear. Therefore the design of the present study followed 
the methodology developed previously to reduce variability and provide reliable 
measurements. 
A previous study using the F-Scan for in-shoe pressure measurements in diabetic 
patients with at-risk feet and in healthy subjects showed that the in-shoe pressures are 
significantly lower than the barefoot ones and that the shoes of diabetic patients 
provided a higher pressure reduction than did those of the control group; it concluded 
that the F-scan system can be particularly useful in assessing and designing footwear 
suitable for diabetic patients with at-risk feet (Sarnow et al., 1994) 
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6.2 Aim of the study 
The primary aim of the present study was to assess the quantitative effect of 
different types of footwear on foot pressures in patients with recurrent ulceration, in a 
clinical situation characteristic for the Diabetic Foot Clinic in King's College Hospital. 
The dynamic in-shoe foot pressures were measured in patient's own shoes, in 
standard trainers and in prescription shoes fitted with moulded ethyl-vinyl-acetate 
(EVA) or Poron inserts. As it is not possible to standardise what it is routinely done in 
the Diabetic Foot Clinic, we had to accept that patients commonly wear a wide range of 
shoes. Also the bespoke shoes could not be identical in all patients, being individually 
designed and made to measure for each of them. In an attempt to reduce the variability, 
all the assessed bespoke shoes were newly fitted, the standard trainers were nearly new, 
being used just for testing and not showing any signs of wear. However the patients' 
own shoes had different degrees of wear. 
In a pilot study, 3 patients who were prescribed bespoke shoes with EVA inserts, 
were followed-up over 2 further visits. 
Therefore our aim was to establish the value of different types of footwear in a 
group of patients with recurrent foot ulceration in the clinical setting of routine diabetic 
foot care as they presented to the Diabetic Foot Clinic. 
6.3 Patients and methods 
6.3.1 Selection of patients 
The selection of patients was made by taking 25 consecutive patients attending 
the Diabetic Foot Clinic for whom prescription shoes or trainers had been 
recommended. These patients wore a highly varied mixture of their own shoes: 
including High Street shoes, patients' own trainers, used bespoke shoes with EVA 
inserts and used stock orthopaedic shoes with Poron inserts. 
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The assessment of plantar pressures was done in 21 patients on the day they 
received newly fitted prescription shoes (17 containing EVA inserts and 4 containing 
Poron inserts). 
In the 21 patients: 
- two did not have their 'own shoes' (which consisted of used prescription shoes left in 
the Orthotic Department to be repaired). 
- two others had very deformed feet and they were unable to use the standard trainers 
provided by the Diabetic Foot Clinic. 
Therefore a group of 19 patients could be used for comparison of new 
prescription shoes to own shoes and another (overlapping) group of 19 patients would 
be used for comparison of new prescription shoes to standard trainers. 
In 17 patients common to the two groups, the plantar pressures measured in 
standard trainers were compared to those in patient's own shoes. In a further 4 patients 
who were considered but not provided with fitted shoes, plantar pressures were 
measured in their own shoes, and compared to those in standard trainers. 
Patients in the follow-up pilot study 
Three patients wearing prescription shoes with EVA inserts were taken into the 
follow-up pilot study. Details in Table 6.5. 
In one patient (IT), a 54 years old male, with insulin-dependent diabetes of 50 
years duration; weight of 81kg, height 186cm, the foot pressure measurements in 
bespoke shoes with EVA inserts were done in three occasions. 
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6.3.2 Characteristics of the patients 
All patients had peripheral neuropathy and a history of neuropathic foot 
ulceration. Their mean age was 59.3±2.5 years. Two patients who did not have diabetes, 
but had spina bifida with a history of recurrent neuropathic ulceration were also 
included. Table 6.1 
Table 6.1 Clinical details of patients 
Patients n= 25 
Age (years) 59.3 ± 2.5 
Diabetes duration (years) 19.6 ± 3.7 
IDDM/ NIDDM 9 IDDM / 14 NIDDM 
2 non-diabetic neuropaths 
Vibration perception 35.3 ± 2.7 
threshold (V) 
Thermal perception 10.3 ± 1.0 
threshold for hot ( °C) 
Thermal perception 8.2 ± 1.1 
threshold for cold ( °C) 
Mean ± SEM 
The 23 diabetic patients had a long duration of diabetes, 19.6±3.7 years. 
There was a predominance of NIDDM patients. The patients included in the study were 
free from major peripheral arterial disease: foot pulses were easily palpable and ankle- 
brachial ratios were > 1. 
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6.3.3 Methodology and study conditions 
Dynamic in-shoe foot pressures measurement using the F-Scan system was done 
as described and recommended in Chapter 3. 
Protocol 
All the pressure measurements in a patient wearing different types of shoes were 
done on the same day. Patients taking part in the follow-up pilot study were also tested 
during consecutive visits to the Diabetic Foot Clinic. 
Recording 
Each patient walked on the same even surface, for three runs, the last two runs 
being recorded in each type of shoe. The recording in each type of shoe was done in no 
particular order. One new insole was used per patient and it was placed inside the shoe 
of the foot, which had suffered recurrent ulceration in the past. 
Analysis of pressure recording 
The pressures in the three different type of shoes were measured as peak 
pressures. The area of interest was selected by placing the (0.25cm2) box on the area of 
highest pressure visible on the map of the foot, which was followed sequentially in 
different types of shoes. 
The pressures were read from the pressure-time graphs for the area of interest by 
moving the cursor along the graph and choosing the point of maximum pressure. The 
peak pressure was calculated as a mean of the three steps of the second recorded run, in 
order to standardise the analysis in each type of shoe. 
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Shoes 
Patient's own shoes were tested. They come in a variety of styles and shapes. 
Patients came to the Diabetic Foot Clinic wearing 4 main types of own shoes: 
- High Street shoes with leather sole 
- used bespoke shoes with EVA inserts 
- used New Style TM' (Ken Hall, Kettering, Northants. ) stock shoes with Poron 
inserts 
- own trainers 
Bespoke shoes fitted with ethyl-vinyl-acetate inserts were moulded by the 
Orthotics Company after the cast taken by the hospital Orthotics Department according 
to the individual characteristics of the foot. Layers of EVA, each having a different 
density were placed as follows in order to match the cast and provide adequate 
cushioning: the top layer had a Low Density EVA, followed generally by 2-4 layers of 
Medium Density EVA, finally the base layer was made of High Density EVA, the most 
dense and rigid layer aimed to fit a flat soled shoe. 
Fig. 6.0 Example of bespoke shoe fitted with ethyl-vinyl-acetate (EVA) insert 
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In some instances if an extra internal rocker was needed, a layer of High Density 
black Plastazote was added. The number of layers of EVA were determined by the 
shape of the foot and its contours i. e. a cavus foot will need more layers than a less 
deformed foot to match the cast. 
`New Style' stock shoes (Ken Hall, Kettering, Northants. ) were stock extra- 
depth shoes manufactured in different sizes and fitted with a flat 2*3 mm Poron insert. 
Standard trainers used in this study were Clarks `Swing Low' trainers with a 
standard inlay moulded Plastazote (Polyethylene) foam and a second layer of 
Polyurethane used to improve the cushioning, with a small heel cup and arch support 
laminated to a woven nylon sock. 
Methodology of follow-up pilot study 
In order to assess the behaviour of EVA insert with time, repeated peak 
pressures measurements were performed in 3 patients. 
The initial assessment was done when the patients received their newly fitted 
bespoke shoes with EVA inserts. The second assessment was at their next appointment 
in the Diabetic Foot Clinic. 
Neuropathy assessment 
The presence of nerve damage was assessed in both lower limbs by clinical 
examination of the ankle reflexes and foot pulses, together with recording of the 
vibration perception threshold (VPT). 
Thermal sensory thresholds (TPT) were also recorded with a Thermal tester 
(Somedic, Stockholm, Sweden) from the dorsum of the foot and the response to five 
warm and five cold stimuli delivered at random time intervals was recorded. Clinical 
and neuropathy details in Table 6.5 
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6.3.4 Statistical analysis 
Mean and SEM were calculated using the statistical analysis Statwork package. 
Comparisons between different types of shoes were made using the paired West and 
Wilcoxon test for a non-parametric distribution, in order to calculate the significance 
between groups. 
6.4 Results 
Comparisons were made in four groups of circumstances: 
1. in prescription shoes versus patients' own shoes 
2. in standard trainers versus patients' own shoes 
3. in prescription shoes versus standard trainers. 
4. in newly fitted versus worn-in prescription shoes with EVA inserts, at follow-up. 
6.4.1 Comparison between peak pressures in prescription shoes and 
patients' own shoes (Table 6.2 and Fig. 6.1) 
The peak plantar pressures (Fig. 6.1.1) measured in High Street shoes which had 
predominantly leather soles (437.8 ± 148.5kPa) were much higher than those in 
prescription shoes newly fitted with EVA inserts (286.4 ± 76.3kPa). This significant 
difference (p<0.01) was equivalent to a reduction in pressure with EVA inserts of 26.5 
± 4.9% (Fig. 6.2). From the individual graphs (Fig. 6.1.1) it was noticed that the 
percentage fall was the greatest in the two patients with the highest plantar pressures. 
When patients were tested in their own trainers (187.4 ± 43.1kPa) and compared 
to prescription shoes (156.0 ± 31.3kPa), very little difference was detected (Fig. 6.1.2) 
and the small improvement (10.2 ± 18.5%) was not significant (p=0.47, NS) (Fig. 6.2). 
However the patients with the highest pressures did benefit again from prescription 
shoes (Fig. 6.1.2). 
Plantar pressures actually increased significantly (Fig. 6.2) with 21.5 ± 9.2% 
(p<0.05) when patients were given new prescription shoes (210.7 ± 35.1kPa) compared 
to used prescription shoes (167.4 ± 28.3kPa). (Fig. 6.1.3). 
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6.4.2 Comparison between peak pressures in standard trainers versus 
patients' own shoes (Table 6.3 and Fig. 6.3) 
The effect of trainers varied accordingly to the type of shoes the patient was 
already wearing (Fig. 6.4). 
When compared to leather sole High Street shoes (489.2 ± 108.4kPa) the 
standard trainers (397.8 ± 110.2kPa) were a clear advantage (Fig. 6.3.1), reducing the 
plantar pressures by 19.2 ± 8.0% (p<0.05) (Fig. 6.4.1). 
However when compared to used and worn prescription shoes (149.0 ± 
37. OkPa), the new standard trainers (205.4 ± 40.9kPa) actually proved worse (Fig. 
6.3.3), showing a trend to increase the pressures with 25.7 ± 14.0% (p = 0.07, NS). (Fig. 
6.4.3). 
New standard trainers (217.2 ± 40.7kPa) and used patients' own trainers 
(214.6± 37. OkPa) showed no statistical difference (3.3 ± 6.6% p=0.45, NS) in the 
plantar pressures (Fig. 6.4.2) 
6.4.3 Comparison between peak pressures in new prescription shoes 
and standard trainers (Table 6.4 and Fig. 6.5) 
The effect of prescription shoes varied accordingly to the type of inserts the 
shoes were fitted with (Fig. 6.6). 
In prescription shoes newly fitted with EVA inserts (228.4 ± 40.9kPa) the peak 
plantar pressures proved to be lower (Fig. 6.5.1) than those in standard trainers (376.4 ± 
77.2kPa). This significant difference (p<0.001) was equivalent to a reduction in 
pressure with EVA inserts of 32.1±4.3%. (Fig. 6.6.1) 
However when compared to standard trainers (171.2 ± 15.7kPa), the new 
prescription shoes fitted with Poron inserts (199.0 t 30.2kPa) had higher pressures (Fig. 
6.5.2) showing a trend, although small and not statistically significant (10.5 ± 8.8%, p= 
0.14, NS) to increase the pressures (Fig. 6.6.2). 
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6.4.4 Comparison between peak pressures in newly fitted and worn-in 
prescription shoes with EVA inserts at follow up 
The plantar pressures in EVA inserts showed a trend to decrease in time, from 
the first to the second visit to the Diabetic Foot Clinic which was at a mean interval of 5 
± 0.5 weeks (Table 6.5). The coefficient of variation of the repeated measurements was 
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In 3 patients the initial peak pressures in newly fitted bespoke shoes with EVA 
inserts (434.0 ± 137.5kPa) were higher than those measured (344.0 ± 127.4kPa) when 
the patients attended their next appointment to the Diabetic Foot Clinic. This equalled a 
further reduction in pressure of 18.7 ± 12.6% at the second visit (Fig. 6.7). 
One patient (I. T. ) demonstrated a considerable reduction (43.3%) in peak 
pressures at the second visit, after he had worn the bespoke shoes every day. Whereas 
the other 2 patients showed a trend to decreasing the pressures with 3.0% and 9.3%, 
which were within the limits of the coefficient of variation. 
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6.5 Discussion 
This study has suggested that made-to-measure prescription shoes fitted with 
EVA inserts, although expensive, are the most efficient in reducing high plantar 
pressures developed in the neuropathic foot with a history of ulceration. EVA inserts in 
bespoke shoes proved to be better than leather sole High Street shoes and also better 
than trainers. 
Although trainers were found to induce a smaller reduction in pressure than 
bespoke shoes with EVA inserts, trainers can provide a useful alternative to leather sole 
High Street shoes. Furthermore trainers proved to have a comparable effect, if not an 
benefit over prescription shoes fitted with Poron inserts. Trainers also have the 
advantage of being less expensive than the prescription shoes and therefore more 
affordable. They are also easily accessible and often more cosmetically acceptable. 
In the present study, the reduction in pressure found with both trainers and fitted 
shoes was higher than the previously reported variability (10-15%) of the F-Scan insole, 
leading to the conclusion that the effect introduced by the footwear on the foot pressures 
was real. 
Similar results were found in a study using also the F-Scan to assess the effect of 
foot orthoses in healthy subjects. The authors found that all Plastazote, cork, and plastic 
orthoses had the potential benefit of relieving pressure at the forefoot, heel and second 
to fifth metatarsal regions, but with a potential pressure increase in the midfoot area 
(Brown, 1996). 
The prescription shoes newly fitted with EVA inserts significantly reduced by 
26.5±4.9% the peak plantar pressures found in High Street shoes, which had 
predominantly leather soles. The leather sole High Street shoe group included a rubber 
sole shoe, knowing that there is no difference in plantar pressure between leather or 
rubber sole shoes as shown by Nyska et al. (1995), who found that the recordings for 
both leather and rubber sole shoes were almost identical in a study of shear and vertical 
forces. Furthermore when they tested a rocker bottom shoe, they found an important 
decrease (31-71%) in the longitudinal shear, whereas the vertical force was reduced by 
26% but only under the second and third metatarsal heads, in those asymptomatic 
1subjects. These results might be explained by findings of Sarnow et al. (1994) showing 
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that the shoes of the control group provided a lower pressure reduction than did those of 
diabetic patients. Furthermore our findings have shown that the greatest percentage fall 
was detected in the patients with the highest plantar pressures, suggesting that they 
would benefit the most from prescription footwear. As high plantar pressures are 
recognised to be an important ethiological factor in foot ulcer formation (Veves et al., 
1992) it may be of benefit to set up a screening programme for high foot pressures in 
the diabetic population. Thus in order to prevent ulceration, prescription footwear 
would be recommended for those diabetic patients detected to have high foot pressures, 
even in the absence of a history of ulceration. 
The reduction in pressure in prescription shoes was in agreement with a study in 
insensitive feet in Hansen's disease. The author (Coleman, 1985) studied 15 subjects in 
six different types of shoes using four discrete pressure transducers. Significant pressure 
relief in the forefoot was found in all the modified shoes when compared to the 
conventional shoes, with no change in pressure at the heel area. Another study using 
four discrete transducers taped to the sole of the foot, also showed a reduction in 
pressures measured under the forefoot when experimental shoes were compared to 
Oxford conventional shoes. The best results were obtained with extra depth shoes: a 
reduction of 31% was reported under the hallux, whereas all the other experimental 
shoes produced a smaller reduction in foot pressures, predominantly under the third 
metatarsal head (Schaff and Cavanagh, 1990). 
In contrast a F-Scan study found the plantar pressures to be raised by 5% in 
extra-depth shoes when compared to patient's own shoes, however the inserts used in 
those extra-depth shoes were standard manufactured and not moulded (Albert and 
Christiansen, 1994) These findings stress the fact that although extra-depth shoes 
provide accommodation of deformity, they need to be fitted with a moulded insert to 
reduce the foot pressures per se. In a further study Corbett et al. (1993) highlighted the 
importance of a custom-made orthotic device in decreasing the plantar pressures under 
the first metatarsophalangeal joint by 31%, which was comparable to the reduction 
introduced by a fibreglass short leg walking cast, frequently used in the " treatment of 
active ulcers for its qualities in pressure relief. 
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Also in a similar study using the F-Scan to assess the plantar pressures in the 
pronated diabetic foot, a reduction of 30-40% in pressure was found in extra-depth 
shoes fitted with custom-made orthotic inserts. A concomitant increase (5-10%) in total 
contact area between the foot and shoe during gait (Albert and Rinoie, 1994) was also 
described suggesting that the custom-made orthotics can reduce the risk of ulceration by 
redistributing the pressures on the plantar surface. 
When patients were tested in prescription shoes and compared to their own 
trainers, very little difference was detected and the small improvement (10.2 ± 18.5%) 
was not significant. This might be due to the fact that although EVA inserts reduced 
pressures in 3 patients, the Poron inserts worn by another two patients in their 
prescription stock shoes actually increased the pressures. These observations may 
highlight the benefit of moulded inserts, such as those found in good quality trainers, 
over flat inserts, such as those found in stock prescription shoes with Poron insert. 
However further controlled studies with a larger number of patients are required to 
solve this question. 
In a similar study, Schaff and Cavanagh (1990) examined the effect on plantar 
pressures of a conventional extra-depth shoe versus an extra-depth shoe modified into a 
"rocker bottom " configuration with a 24° rocker. They found that the peak pressures in 
the rocker shoe were reduced with approximately 30% in the forefoot (medial and 
central) with an increase in pressure in the heel, midfoot and lateral sides of the 
forefoot. These findings emphasis the influence of a correctly designed shoe on its 
ability to reduce pressure in the areas at risk diffusing it towards other areas of lower 
pressure. 
However it is important that this shift does not increase the pressures over the 
threshold for risk of ulceration in another area. Therefore the moulded inserts as found 
in trainers might be preferable to the flat ones as Poron inserts. Similarly individually 
designed moulded inserts as EVA inserts might be preferable to standard manufactured 
stock moulded inserts as found usually in trainers. In some cases of severely deformed 
feet with a history of ulceration the individually designed moulded inserts are a 
necessity, although they are expensive. 
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Although the findings of these previous studies compare well with the degree of 
pressure reduction in prescription shoes found in the present study, surprisingly we also 
found an increase in pressures. Newly fitted prescription shoes with EVA or Poron 
inserts showed higher pressures than used prescription shoes fitted with the same type 
of insert suggesting that the newly fitted inserts for prescription shoes have not yet 
reached their maximum potential in reducing foot pressures. The EVA polymer is a soft 
insert material easily mouldable and hence with good cushioning qualities (McKenzie 
et at., 1985) and there is the possibility that it continues the moulding process during 
wearing. However its disadvantage may arise from the risk of flattening and cessation of 
cushioning effect. 
Nevertheless from these observations, it seems that the EVA inserts are able to 
maintain their ability to reduce pressure for a long time. The cushioning effect obtained 
in EVA inserts by layering materials with decreasing densities seems to be effective and 
preserved in time. Alternatively there is the possibility that the design of the insole by 
orthotists is not ideal and that the imperfections, which unfortunately are not always 
minimal, are corrected through the wearing-in process. 
Likewise the used prescription shoes with Poron insert had lower pressures than 
the new ones. Although there is very little scientific literature, the Orthotic Department 
suggests that a possible moulding process can not be excluded in Poron inserts. The 
other possibility is that a change in the shape of the extra-depth stock prescription shoes 
fitted with Poron inserts, possibly related to wear-in of the shoes, would allow better 
accommodation of the foot deformity. 
Nevertheless the increase in pressure found in our study, when changing from 
both used Poron and EVA to new Poron and EVA inserts leads to a conclusion with 
clinical implications: although patients have been stabilised in EVA or Poron inserts, it 
is important to note that when they change to a similar new insert it would be advisable 
to warn them to `break in' the insert gradually. 
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Furthermore in the present study, an additional reduction (19%) in foot pressures 
was found at follow-up. This is demonstrated in the three patients who came for 
repeated measurements of their plantar pressures in prescription shoes with EVA 
inserts. The pressures had a trend to decrease from the initial visit when the patients 
received their newly fitted prescription shoes to the second visit a few weeks later, 
during which the patients were supposed to wear the shoes every day. 
However the degree of further pressure reduction varied in each individual, 
being probably related to the level of activity and mobility of each patient and also to 
their compliance with the prescription shoes. Future longitudinal studies are needed to 
assess the compliance of our patients to the inserts. Previously it has only been shown in 
a single follow-up study (Chantelau et al., 1990) that therapeutic shoes with cushioned 
inserts for diabetic feet at risk decrease the morbidity by reducing the recurrent foot 
lesions from 87% in those who wore the shoes irregularly, to 42% in those who worn 
the shoes on a regular basis. 
Nevertheless these observations of the present study, support the previous 
hypothesis that there is a continuation of the moulding process inside the shoe during 
wearing-in. EVA polymer being an easily adjustable material allows a better fit to the 
individual characteristics of the foot and continues the moulding process during 
wearing. The bespoke shoes with EVA inserts are an attempt to combine the use of a 
rigid sole with the necessary cushioning, therefore the apposition of layers with 
different densities. The most dense and rigid layer is placed at the base to support the 
insensitive foot with limited joint mobility, while layers of decreasing density were 
placed on top to insure the cushioning effect. Therefore the upper layers seem to 
continue the moulding process during wearing. Thus, in clinical practice, patients are 
usually advised to wear the newly fitted shoes for longer time intervals each day for 
this purpose. 
Further longitudinal studies assessing the life-time of the EVA and Poron inserts 
are also needed in order to characterise the degradation rate of the material with use and 
its effect on in-shoe plantar pressures. A previous study assessing not the plantar 
pressures, but the shock absorption ability during one year of general use in Poron and 
Viscolas insoles has shown a deterioration in their performance after 6-9 months of use, 
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whereas Plastazote and Gait Aid insoles performed even more poorly (Pratt, 1990). In 
another study which tested different inserts, it was demonstrated that a Plastazote insert 
which was worn for 72 hours produced the worst results in pressure relief (Pratt et al., 
1986), but it seems that there are no similar long term data for the effect of EVA inserts 
on plantar pressures. 
The effect of trainers on plantar pressures varied accordingly to the type of shoes 
the patient was already wearing. When compared to leather sole High Street shoes the 
standard trainers were a clear advantage, reducing the plantar pressures by 19%, 
probably because trainers can provide more cushioning and more support on the 
midfoot area due to their soft moulded insert with a midsole arch. This is in agreement 
with a study by Perry et al., which measured plantar pressures in trainers compared to 
leather-soled Oxford-style shoes and to barefoot conditions. Their findings showed that 
inexpensive running shoes relieved the total load through pressure redistribution to the 
forefoot but also to the heel, although it is known that the neuropathic ulcers which 
occur under the heel are rarely due to gait. The greatest relief was obtained in the feet 
which had the highest pressures when they were unshod. The study concluded that 
patients with neuropathy should be discouraged from wearing leather-soled Oxford- 
style shoes because of the risk of ulceration due to increased foot pressures (Perry et 
al., 1995). 
However in our study there was no statistical difference in the plantar pressures 
measured in standard trainers versus patients' own trainers. Similar results were found 
in another study which ranked for comfort 4 different types of inserts in Adidas trainers 
and measured the in-shoe plantar pressures using an EMED system. It found that any 
type of insert which was perceived by subjects as being comfortable, had in fact 'a 
similar effect on peak plantar pressures: all the `comfortable' inserts redistributed the 
pressures evenly on the plantar surface and lowered the pressures at the forefoot (Chen 
et al., 1994). 
In contrast, a trend to increased pressures in standard trainers was found when 
compared to used prescription shoes. As discussed previously, it seems that used 
prescription shoes tend to have lower pressures than the new ones because of a possible 
continuation of the moulding process. Therefore it is not surprising that the new 
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standard trainers which had not been worn extensively previously were less efficacious 
in reducing pressure than used prescription shoes which had been worn every day. 
Nevertheless these findings support Cavanagh's guidelines for prescription footwear 
(Cavanagh, 1995), in which trainers are considered to be an acceptable choice only for 
those individuals who are free from deformity, but an advantageous alternative to 
leather sole High street shoes. 
When compared to standard trainers the effect of prescription shoes varied 
accordingly to the type of inserts the shoes were fitted with. The prescription shoes 
newly fitted with EVA inserts significantly reduced by 32% the peak plantar pressures 
found in standard trainers. This may be explained by the fact that standard trainers 
containing a standard moulded insert made from a semi-rigid material had less 
cushioning effect than the soft moulded EVA insert of a prescription shoe which was 
made to fit the characteristics of an individual foot including its deformity. These 
findings are in agreement with another study of foot pressures measured in running 
shoes (trainers). Although the trainers decreased the pressures by about 30%, they 
showed higher pressure values than the normal street shoe when fitted with a soft insole 
(Schaff et al., 1988). 
In Schaff's study comparisons between different types of insoles were also 
made; the same shoe was fitted with a soft and a hard insole and then compared to 
barefoot conditions. A reduction of 25% was obtained with the soft insole in the 
diabetic group, whereas only a 17% reduction was obtained in the control group 
(Schaff et al., 1988). They concluded that the forefoot pressures are influenced by the 
geometry of the sole and the type of insert material used. All these findings point to the 
fact that the insert effect on plantar pressures is highly dependent on the design and the 
type of material used in its manufacturing, which influences the redistribution of 
pressure and the cushioning effect. 
As a reiteration of the previous statement a trend, although small (10.5% ) and 
not statistically significant, to increase pressure was found in new prescription shoes 
fitted with Poron inserts when compared to standard trainers. The `New Style' 
orthopaedic shoes with Poron inserts are conveniently prescribed because of their 
immediate availability to the patient, but our figures show that the new Poron insert is 
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often associated with an increase in pressures when substituted for patient's used Poron 
insert or even for good quality trainers with extra-cushioning such as standard trainers. 
The cushioned insert with a midsole arch found in our standard trainers was obviously 
more advantageous than the flat insert of the stock shoes with a Poron insert. This 
might be due to the fact that the Poron insert contains a very resilient material, which 
does not deform with time and has good shock absorption properties. However it is flat, 
not moulded, and because of its resilience, the moulding process and the cushioning 
effect are not significant. Furthermore the midsole in trainers is usually considered to 
have as a primary function, the reduction of in-shoe reaction forces or the redistribution 
of pressure over a larger area. These findings are in agreement with those of Lord and 
Hosein showing that the pressure was significantly reduced in moulded inserts when 
compared to flat inserts fitted into the same shoes (Lord and Hosein, 1994). 
Unfortunately the number of patients with Poron inserts who were taken into the 
study was too small to achieve statistical significance, but clinically the standard 
trainers seemed to be more efficient in relieving pressures than the stock prescription 
shoes fitted with a standard, not individually designed Poron insole, which might be 
more expensive than trainers. 
This highlights the potential role which trainers may have in prevention of 
ulceration in the early stages of the foot at risk, when is not deformed and has good 
proprioceptive sensation. Trainers also provide an option which is more socially and 
cosmetically accepted by patients. At this stage the protection can be achieved without 
the expenses implied by individually designed inserts and bespoke shoes such as our 
prescription shoes with EVA inserts. They are nevertheless vital for patients with 
recurrent ulceration and feet at risk, who need an individualised choice of cushioning 
materials and insert design. 
This study discusses both the principles and practice of prescribing therapeutic 
insoles and indicates that much greater attention should be paid to in-shoe dynamic 
pressure measurement. It would be advisable that shoes should be prescribed and fitted 
in centres which use this equipment to achieve the optimal outcome. 
This study also indicates that in certain circumstances there is an increase in foot 
pressures in patients going from their own shoes to the trainers supplied or - Poron 
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insoles. Therefore there is a need for immediate 'on the spot' pressure assessment of the 
effect of recommended footwear, particularly of stock orthopaedic shoes with Poron 
insoles in comparison with their own footwear. This stresses the importance of a Shoe 
Clinic within the Diabetic Foot Centre. 
There have been no previous studies examining the value of certain High-Street 
shoes and this study has proven that sometimes trainers could be more efficient than 
certain types of supplied footwear. Therefore there is a need for systematic assessment 
of High Street shoes and their inserts. There is an array of shoes and inserts available to 
our patients and we know very little of their properties and their ability to redistribute 
pressure in diabetic patients. The methods described above allow investigations of the 
prescription footwear and High-Street shoes. This will help to improve the advice given 
to patients about shoes and footwear, which at present is by necessity lacking detail of 
information. 
Despite the apparent success of the fitted shoes in relieving pressures, most of 
the studies were of a cross-over design. The necessity arises now for follow-up studies 
regarding the time-dependent characteristics of different types of footwear and their 
effect in time on the plantar pressures. 
Conclusions and rationale for future studies 
This study has shown that made-to-measure prescription shoes fitted with EVA 
inserts, although expensive, are the most efficient in reducing high plantar pressures 
developed in the neuropathic foot with a history of ulceration. EVA inserts in bespoke 
shoes proved to be better than leather sole High Street shoes and also better than 
trainers. 
However when new and worn-in prescription shoes fitted with EVA inserts 
were compared, the latter showed even lower pressures than the new ones suggestive of 
a continuation of the moulding process with wearing. 
Furthermore when new and used prescription shoes fitted were compared, the 
latter also showed lower pressures leading to the clinical recommendation that new 
prescription shoes should undergo a gradual `break in' process. 
200 
The greatest percentage fall in prescription shoes was found in the patients with 
the highest plantar pressures, suggesting that they benefit the most from prescription 
footwear. As high plantar pressures are recognised to be an important aetiological factor 
in foot ulcer formation (Veves et al., 1992) it may be of benefit to set up a screening 
programme for high foot pressures in the diabetic population. Then in order to prevent 
ulceration, prescription footwear would be recommended for those diabetic patients 
detected to have high foot pressures, even in the absence of a history of ulceration. 
Although trainers were found to induce a smaller reduction in pressure than 
bespoke shoes with EVA inserts, trainers can provide a useful alternative to leather sole 
High Street shoes. 
Furthermore trainers proved to have a comparable effect, if not an benefit over 
prescription shoes fitted with Poron inserts. Trainers also have the advantage of being 
less expensive than the prescription shoes and therefore more affordable. They are also 
easily accessible and often more cosmetically acceptable 
Finally, this study confirms the feasibility of quantitative assessment of foot 
pressure changes with different types of footwear on a cross-sectional basis. It also 
highlights the need for longitudinal studies to assess the characteristics and the life-time 
of the insoles and to correlate these with recurrence of ulceration. 
The life-time of an insole is not known and longitudinal studies to define 
physical and clinical end-points are needed. They could be carried out with the F-Scan 
technology. The definition of the end-points has to be based on quantitative assessment 
of the ability of the insole to maintain the redistribution of pressure as well as its 
usefulness in preventing the recurrence of foot ulcer. 
It is not known for how long an insole should be used. Whether replacement 
should depend on simple assessment of its physical characteristics or be related to more 
scientific pressure measurements to assess its capability to reduce peak pressures and 
maintain them at a safe level to prevent recurrence of ulceration remains to be studied. 
These findings stress the usefulness of modem techniques, such as F-Scan, as a 
visual and quantitative aide in shoe design, as it was used in a similar study using an 
interactive computer graphics system for the design of moulded and orthopaedic shoe 
lasts (Lord and Foulston, 1991; McAllister et al., 1991). These techniques should 
now be used to address the problems of design and manufacture of inserts and 
prescription shoes for the diabetic foot. 
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Chapter 7. MICROCIRCULATORY FACTORS 
AND THEIR ROLE IN THE PATHOGENESIS OF THE DIABETIC FOOT 
The importance of the microvascular defects in the aetiology of foot ulceration 
among many other risk factors has not yet been fully investigated. Healthy tissues with a 
normal structure and function rely on intact microcirculation and on its roles of 
transportation and interchange of hormones and nutrients plus maintenance of tissue 
fluid homeostasis, clearance of waste products of metabolism and not least, tissue 
defence and repair (Tooke et al., 1996) are important in maintaining the viability of 
various tissues. 
This last role of microcirculation can lead to a possibly simplistic, but 
fundamental concept which takes in consideration the role of the skin necrosis (which 
implies microvascular impairment) and the ' potential additional role for intrinsic 
microangiopathy of the foot tissues in the pathogenesis of the foot ulceration. 
7.1 Pathophysiology of cutaneous diabetic microangiopathy 
New techniques for the assessment of the microcirculation have been developed 
in recent years: plethysmography, capillaroscopy, laser Doppler flowmetry and 
iontophoresis (Tooke, 1993) facilitated the deduction of the `haemodynamic 
hypothesis' of diabetic microangiopathy. 
Clinical observation and estimates of blood flow formed the basis for this 
hypothesis suggesting that increased microvascular pressure and flow characterise early 
stages of diabetes. The microvascular endothelium responds to increased capillary 
pressure as an injury, with excessive production of extravascular matrix proteins 
resulting in microvascular sclerosis. In the arterioles, the sclerotic process is expressed 
as hyalinosis and in the capillaries, as basement membrane thickening, which is the 
ultrastructural hallmark of diabetic microangiopathy. This sclerosis continues in time 
and in long-term diabetes, a reduction in vasodilatation occurs with decreased maximal 
hyperaemia plus loss of autoregulation (Tooke, 1986). 
Although this hypothesis takes into account the effect of diabetes per se on the 
microcirculation, IDDM and NIDDM may behave differently. 
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The effect of IDDM on microcirculation seems to be in accord with the 
characteristic stages of the "haemodynamic" theory: capillary pressure increased early in 
the course of IDDM, even in children who also demonstrated autoregulatory 
abnormalities (reduced posturally induced vasoconstriction) (Rayman et al., 1986, 
Shore et al., 1994), whereas long duration IDDM per se introduces a limitation of the 
maximum hyperaemia independent of recent blood glucose control (Walmsley et al., 
1990). However the effect of NIDDM on microcirculation seems to be different from 
IDDM. Early on the course of the disease normal capillary pressure, but abnormal 
maximum hyperaemia were found. This may be related to long periods of 
hyperinsulinemia in response to increased insulin resistance (Jaap et al., 1994) 
characteristic for NIDDM pathogenesis. 
In conclusion, diabetes whether IDDM or NIDDM, has a definite effect on the 
microvascular function inducing a microangiopathy which may play a role in the 
aetiology of the foot ulceration. 
7.2 The role of microvascular function abnormalities in the 
pathogenesis of foot ulceration 
Microangiopathy studies showed an early reduction in maximum hyperaemia in 
NIDDM which might provide an explanation for their increased risk of foot ulceration, 
present frequently at diagnosis of diabetes. The microcirculatory defects interact with 
neuropathy and macrovascular disease, as major risk factors involved in the foot 
ulceration. 
Table 7.2.1 The microvascular haemodynamics in the diabetic foot 
Physiological abnormality 
High resting flow particularly 
on dependency with loss 
of pressure autoregulation 
Impaired peak hyperaemia 





Increased diffusion distances 
Extrinsic pressure 
from footwear 
Impaired healing and inability 
to counteract infection 
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Abnormal pressures were found in the toes of diabetic neuropathic patients with 
a history of ulceration when compared to non-ulcerated neuropathic patients 
highlighting the contribution of distal ischaemia of digital arteries in the pathogenesis of 
foot ulceration (Stevens et al., 1993). 
An impaired blood flow autoregulation concomitantly with increased blood flow 
in the foot leads to oedema formation, visible in neuropathic patients without any 
deficiency in their kidney function. Neuropathic oedema is more likely seen in patients 
presenting with foot ulceration probably because it induces a simple mechanical effect 
with increase in the extrinsic pressure from their footwear. Also the oedema may 
increases the intracapillary diffusion distances disturbing the nutritive blood flow. 
Another possibility might be that capillaries are compressed by the high pressure 
of the interstitial fluid, with subsequent functional failure compromising the nutrition of 
the adjacent tissues and increased risk of localised tissue necrosis. This hypothesis seem 
to be supported by recent studies of magnetic resonance imaging in diabetic patients 
with a history of foot ulceration, which found `drop outs' on the image of the foot. 
These are thought to represent accumulation of haemoglobin degradation products. The 
presence of such soft tissue haemorrhages might be a result of increased pressure load 
or shear forces, although the vertical pressures were not different in patients with or 
without these soft tissue haemorrhages (Brash et al., 1995). These findings may be 
related to the presence of membranocystic lesions found similarly in skin biopsies taken 
from the shin and feet of diabetic patients, which showed microangiopathy changes in 
the small vessels of the dermis and subcutaneous tissue (Sueki et al., 1986) Likewise 
they might reflect intrinsic capillary fragility which is associated with risk of 
microangiopathy, highlighting once more the role of microcirculation defects in the 
aetiology of foot ulceration. 
Furthermore the diminished hyperaemic response to noxious stimuli due to a 
reduced axon reflex in neuropathy is likely to delay healing of lesions precipitated by 
minor or major trauma easily unnoticed by an insensitive foot due to neuropathy. 
In conclusion, abnormal arteriolar pressures, impaired blood flow autoregulation 
concomitantly with increased blood flow leading to oedema formation and diminished 
hyperaemic response to noxious stimuli are important in the pathogenesis of foot 
ulceration. 
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7.3 Neuropathy and microvascular function in the diabetic foot 
The diabetic foot ulcer is the extreme manifestation of the failure of the 
microcirculatory function and peripheral nervous system, which are closely related. 
Diabetic peripheral neuropathy affects the small nerve fibres early in its course: 
unmyelinated sensory C fibres, myelinated A delta fibres (transmitting pain and 
temperature sensation) and sympathetic fibres (Said et al., 1983; Guy et al., 1985) 
which control the autoregulation of skin microvasculature are, thus damaged early. 
The skin microcirculation of the foot consists of nutritive capillaries and arterio- 
venous shunts (predominantly on the pulp of the toes) with a role in thermoregulation. 
In patients with peripheral neuropathy an increased blood flow was found in 
measurements of total forefoot blood flow using venous occlusion plethysmography 
similar to the changes seen after sympathectomy (Watkins 1983; Edmonds et al, 1982; 
Boulton, 1982), which results in arterio-venous shunting by-passing the capillary 
nutritive circulation. Studies of Tc02 in the foot, Doppler sonograms, measurements of 
foot venous pressure and microsphere partioning studies have shown evidence of 
arterio-venous shunting (Tooke and Brash, 1996): however the `steal ` effect from the 
capillary circulation by arterio-venous shunts has not been demonstrated in neuropathy: 
nailfold capillary flow velocity was found to be also increased, although that might be a 
consequence of higher skin temperature due to the increase in the arterio-venous shunt 
flow (Flynn et al., 1988). It remains to be determined whether the increased capillary 
flow has the ability to respond to raised tissue demands secondary to the increase in the 
skin temperature and whether the capacity to vasodilate is preserved. 
The effects of diabetic neuropathy on the microcirculation were assessed by 
measuring the posturally induced vasoconstriction which depends on an intact 
peripheral nervous system. In non-diabetic controls when the foot is lowered below 
heart level, both capillary and arteriovenous shunt flow are reduced (Hassan et al., 
1988) to avoid an increase in the hydrostatic pressure on dependency in the 
microcirculation and oedema formation (Flynn et al., 1989). The postural 
vasoconstriction has been found to be reduced in patients with neuropathy (Rayman et 
al., 1986). The capillary blood flow in the dependent foot rises progressively with time 
(Belcaro et al., 1992) leading to an increase in the transmural pressure. In the long term 
this will induce a structural lesion such as thickening of capillary basement membrane. 
In the short term it will lead to oedema formation associated with neuropathy. Also 
206 
dysfunction has been noted in a study assessing the amplitude of flow motion (cyclical 
variation in blood flow owing to the rhythmical opening and closing of arterioles) which 
was reduced in diabetic neuropathic patients (Benbow et al., 1995). The sympathetic 
control of the microvasculature examined by spectral analysis of skin laser Doppler 
fluctuations has shown a loss of rhythmicity of the low-frequency oscillations, mostly 
under sympathetic control, which might be associated to autonomic defects introduced 
by neuropathy (Rossi et al., 1990). 
Diabetic neuropathy has also been associated with paradoxical reductions in 
blood flow, namely failure of vasodilatation of the skin of the foot in response to body 
warming (Martin, 1953) or paradoxical blood flow responses to local heating (Stevens 
et al., 1992) The mechanisms of these findings are not known. A hypothesis might link 
increased sympathetic activity in the early stages of neuropathy manifested for 
example, in increased sudomotor function (gustatory sweating), or to hypersensitivity of 
peripheral vessels to local cold or circulating cathecolamines (Flynn and Tooke, 1995). 
However it is known that denervated peripheral vessels still show an autonomous tone 
suggestive of one or more intrinsic vascular factors which might be implicated in 
maintaining the vascular tone at the smooth muscle level as it has been proven for NO 
(Valiance and Moncada, 1994). In diabetes, when the Lewis' triple response to 
noxious stimuli was assessed, it was found that the neurogenic flare response was 
diminished in diabetic neuropathy (Parkhouse and LeQuesne, 1988). This might 
reflect a decreased vascular reactivity to the local release of neuropeptides from the 
peripheral nerve fibres (Boolell and Tooke, 1990). 
In conclusion, the known effects of neuropathy on peripheral microvasculature 
can be summarised as in 
Table 7.3.1 Effect of neuropathy on foot microcirculation 
Increased Decreased 
arterio-venous shunt flow amplitude of flow motion 
basal capillary blood flow ( although 
not known whether appropriately 
raised for higher skin temperature) leading in: 
short term to neuropathic oedema 
long term to thickening of capillary 
basement membrane 
postural vasoconstriction 
pressure regulation on 
dependency 
axon flare response 
vasodilatatory responses to 
heating and body warming 
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The neurovascular responses have been studied as above, but the function of the other 
two components involved in neurally-stimulated vasodilatation: the endothelium and 
the smooth muscle, are not fully understood in diabetic neuropathy. Further studies to 
assess the interactions between microvascular and nervous system at endothelium and 
smooth muscle level are required in the understanding of the pathogenesis of the 
diabetic foot. 
7.4. Neurovascular responses. Endothelium-dependent and 
endothelium-independent vasodilatation 
The hyperaemic response is part of Lewis' inflammatory response to tissue 
injury, hence its importance in foot ulcer formation which often involves an initial 
injury. When a noxious stimulus is applied to the skin, the nociceptive receptors are 
stimulated and they send pro-dromically the nervous impulse through the C-nociceptor 
primary afferent fibres, responsible for transmitting the pain sensation, to the pre- 
ganglionic neuron and onwards to the central nervous system. 
There is also an antidromic transmission through the small fibres of nerva 
vasorum, which will release vasoactive neuropeptides such as: substance P, CGRP 
along with acetylcholine, prostacyclin and bradykinin. 
In endothelium-dependent vasodilatation, acetylcholine acts on the muscarinic 
receptors of endothelium which synthesises and releases among other vasoactive 
substances, an endothelium-derived relaxing factor (EDRF) = nitric oxide (NO); this 
then induces vascular smooth muscle dilatation. 
In endothelium-independent responses, smooth muscle vasodilatation is 
stimulated by direct donors of NO such as sodium nitroprusside (SNP). Another source 
of NO which is endothelium-independent is the neurone; nitric oxide synthase (NOS) 
has been identified in the cytosol of peripheral as well as central neurones (Bredt et al., 
1991; Valiance and Moncada, 1994; Rand and Li, 1995). 
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7.4.1 The role of nitric oxide (NO) in endothelium-dependent and 
endothelium-independent vasodilatatory responses 
While the sympathetic nervous system serves the organism as a whole, the 
endothelium appears to act as a local regulator adapting blood flow to local metabolic 
needs. A variety of factors derived from endothelium have relaxing actions: 
endothelium-derived relaxing factor (EDRF) = NO, endothelium-derived 
hyperpolarizing factor (EDPF), prostacyclin (PGI2)) or contracting effects: 
prostaglandin H2 (PGH2), thromboxane A2 (TXA2), endothelin 1 (ET1) (Rongen et 
al., 1994) and they play a role in the endothelium-dependent control of the vascular 
tone. 
NO (*N=O) is now known to be the smallest biological product of mammalian 
cells. Its actions are as diverse as the tissues which produce it. NO is the product of the 
five-electron oxidation of one of L-arginine by the enzyme NOS. Three distinct 
isoforms of this enzyme with different functions representing three distinct gene 
products, have been isolated and purified (Nussler et al., 1995; Martinez. Cuesta et al., 
1995). Table 7.4.1 
Table 7.4.1 Human NOS isoforms: function, chromosomal and tissue localisation 
Human NOS isoform Chromosome 
Neuronal cNOS 12 
Endothelial cNOS 7 
Inducible NOS 17 
Localisation Function 
central and neurotransmitter 
peripheral neurones 
endothelium EDRF 
multiple cell types inflammation 
sepsis, shock 
From the endothelial cell the NO diffuses into the smooth muscle cell (which 
has no receptors for NO) and activates the guanylate cyclase leading to production of 
cyclic guanosine monophosphate, which induces vasodilatation by reducing available 
intracellular cytosolic calcium. 
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Figure 7.4.1 NO synthesis in the endothelium and actions on the smooth muscle 
Endothelial cell 




Smooth muscle cell: 
guanylate-cyclase 
cGMP (cyclic guanosine-monophosphate) 
HP 
cAMP hyperpolarisation 
relaxation (mostly due to NO) 
NO + PGI2 act synergistic: inhibition of mithogenesis 
inhibit adhesion and 
The basal formation of NO maintains moderate but significant vasodilatation in 
the systemic resistance vessels. When blood flow in conduit arteries is increased there is 
an augmented endothelial formation of NO, eliciting flow dependent vasodilatation 
(Wennmalm, 1994). Beside this, several vasodilators (acetylcholine, bradykinin, 
histamine, substance P) stimulate endothelial formation of NO. 
However the NO is not the only vasodilator released from the endothelial cell to 
act on the smooth muscle: PgI2 acting via cAMP and EDHF inducing membrane 
hyperpolarisation, have synergistic effects in regards to vasodilatation and inhibition of 
smooth muscle proliferation which is associated with atheromatous plaque formation. 
A defect at any of these steps can induce a deficit in vasorelaxation, such as the 
impaired endothelium-dependent relaxation to acetylcholine in diabetes, which might 
arise from a defect in utilisation of L-arginine by NOS for production of NO (Pieper et 
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at., 1995). However it seems that endothelium-derived hyperpolarizing factor does not 
contribute to the decrease in endothelium-dependent relaxation in the aorta of 
streptozotocin-induced diabetic rats (Endo et al., 1995). 
In contrast, acting on the same system there are also vasoconstricting factors 
such as endothelin-1, thromboxan A2, prostaglandin H2, angiotensin and oxygen- 
derived free radicals. Likewise they are growth promoters. 
Conclusion 
NO is part of a complex system of relaxing and contracting factors acting on the 
vascular smooth muscle. However NO of endothelium-dependent or -independent 
origin (exogenous or neuronal) share the same common pathway to vasodilatation. 
7.4.2 NO role in the interactions between the perivascular nerves and vascular wall 
The perivascular nerves consist of sympathetic nerves (containing neuropeptide 
Y, adenosine triphosphate, noradrenaline), parasympathetic nerves (containing 
acetylcholine), nitrergic nerves (containing NO), sensorimotor nerves (containing 
vasoactive neuropeptides: substance P, CGRP=calcitonine-gene-related-peptide). These 
all will take part in the microvascular autoregulation controlling the release of 
vasorelaxing and vasoconstricting factors. If the sympathetic nerve is removed the 
production of endothelin-1 is increased. Therefore in a disease such as diabetic 
neuropathy known to affect peripheral nerve fibres, defects of neurovascular reactivity 
might occur. 
Moreover when the levels of plasma endothelin-1 were found to be raised in 
diabetic rats, the endothelial-dependent relaxation was also found to be significantly 
attenuated (Tada et al., 1994). 
Furthermore the same vasoactive substances released from the perivascular 
nerve can have a dual action, vasodilatation or vasoconstriction, according to the type of 
receptor to which they bind (Fig. 7.4.2). 
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Fig. 7.4.2 Vasoactive effects of neurotransmitters 
SYMPATHETIC NERVE 
ATP neuropeptide Y 
noradrenaline (NA) 
alpha 1 receptor alpha 2 receptor 
relaxation contraction 
receptor P2y receptor Y1 receptor 
itraction relaxation increases sensitivity of 
alpha 1 and 2 receptor to N 
Smooth muscle 
In conclusion, in the neurovascular responses most of vasoactive compounds from the 
perivascular nerve act ultimately via the endothelium on the vascular smooth muscle in 
a very complex manner. A fine balance between vasoactive substances from the 
endothelium and from the perivascular nerves has to be achieved for maintaining the 
basal vascular tone and a normal microvascular function in healthy subjects. If any of 
these factors is in excess or in deficit, abnormalities of the vascular function will occur. 
7.4.3 Increased oxidative stress in diabetes 
and its effect on NO and endothelial function 
In diabetes endothelial cell impairment and increased vasoconstriction might 
involve a mechanism which activates the PGH2/TXA2 receptors (Tesfamariam et al., 
1995). This impairment has been shown to be restored by blockade of PGH2/TXA2 
receptor or superoxide dismutase suggesting that PGH2, TXA2 and/or superoxide anion 
contributes to this abnormality (Dai et al., 1993). 
The effects of elevated glucose are exacerbated by increased aldose-reductase 
activity leading to depletion of NADPH and generation of reactive oxidants 
(Tesfamariam, 1994). Because NADPH is required for generation of NO from L- 
arginine , the depletion of NADPH may lead to reduced nitric oxide formation. 
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It has also been hypothesised in diabetes that oxygen-derived free radicals generated 
during both glucose autooxidation and formation of advanced glycosilation end 
products may interfere with NO action and attenuate its vasodilatatory activity. The 
oxidative injury may also be increased in diabetes because of weakened defence due to 
reduced endogenous antioxidants (vitamin E, reduced gluthathione) (Giuliano et al., 
1995). Findings to support this hypothesis show that intracellular hydroxyl radicals 
mediate injury to endothelium-dependent relaxation in diabetic rat. (Pieper et al., 1993) 
and that advanced glycosylation products quench nitric oxide and mediate defective 
endothelium-dependent vasodilatation in experimental diabetes (Bucala et al., 1991). 
In conclusion, in diabetes an increased oxidative stress occurs resulting in 
endothelial cell dysfunction. Hyperglycemia leads to NADPH depletion with a 
subsequent decrease in NO production. Furthermore advanced glycosylation end 
products quench nitric oxide inducing abnormalities of vasodilatation. 
7.4.4. The effect of diabetes on endothelium-dependent 
and endothelium-independent responses 
In diabetes cumulative effects of oxidative stress on endothelial cell together 
with complex interrelationship of cyclooxygenase catalysis, increased protein kinase C 
activity and increased flux through the polyol pathway (Cameron et al., 1993) would 
have an effect on the endothelium-dependent relaxation and/or smooth muscle 
contraction . 
In animal studies, a selective impairment of receptor-mediated endothelium- 
dependent relaxation to acetylcholine has been reported in isolated resistance arteries of 
the streptozotocin-induced diabetic rat. These results suggest that the ability of 
endothelium to relax arteries via nitric oxide may involve a defect of a specific signal 
transduction pathway leading to reduced production of nitric oxide (Taylor et al., 1995) 
In NIDDM, in aortae from non-insulin-dependent diabetic rats impaired endothelium- 
dependent vasodilatatory responses resulted in increased noradrenaline-induced 
contractions (Karasu et al., 1994). Moreover in vitro studies using human arteries 
obtained from patients undergoing coronary artery by-pass surgery showed that whereas 
endothelium-independent responses to SNP were not influenced by NIDDM, this 
produced a deficit in the vasorelaxant activity of endothelium (Karasu et al., 1995). 
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However in patients with NIDDM but also with some diabetic complications, impaired 
endothelium-dependent and independent vasodilatation was reported (McVeigh et al., 
1992; Morris et al., 1995). When the vascular reactivity was compared in a IDDM 
versus a NIDDM rat model, a depression of endothelium-dependent responses was 
found in both of them, the IDDM model had also increased beta-adrenergic reactivity, 
whereas the NIDDM model had increase responses to serotonine (Feletou et al., 1994). 
In IDDM, in vitro studies using isolated resistance vessels from patients with 
insulin-dependent diabetes mellitus found also an impaired contraction and 
endothelium-dependent relaxation suggestive of a defect in the endothelial cell 
acetylcholine receptor excitation-coupling (McNally et al., 1994). In IDDM patients 
conflicting reports were published showing: impaired (Johnstone et al., 1993) or 
preserved (Smits et al., 1993) endothelium-dependent vasodilatation in uncomplicated 
patients with insulin-dependent diabetes mellitus. Others have shown an inhibition of 
nitric oxide synthesis with blunted vasoconstriction only in forearm vasculature of 
complicated insulin-dependent diabetic patients: with microalbuminuria (Elliott et al., 
1993). 
In complicated diabetic patients, such as diabetic men with impotence a 
significantly reduced response to endothelium-dependent vasodilators was reported in 
isolated cavernosal smooth muscle, but not to endothelium-independent vasodilators 
suggesting that the endothelial dysfunction seems to play an important role in 
diabetogenic impotence (Kim et al., 1995). 
Conclusion 
Most of these studies showed abnormal endothelial function with preserved 
smooth muscle function in diabetes. There are only a very few studies reporting 
endothelial dysfunction and also an alteration in the responsiveness of smooth muscle in 
mongrel dogs with long-duration diabetes and probably complications such as 
neuropathy (Sarioglu et al., 1993) and in patients with hereditary sensory radicular 
neuropathy in the areas of defective neurogenic inflammation (Westerman et al., 
1992). ""'` 
From recent research it has become apparent (Harrison et al., 1995) that 
abnormal endothelium-dependent vasodilatation leading to altered regulation of the 
vasomotion precedes atherosclerosis in large vessels; whereas in microcirculation, in 
which atherosclerosis does not develop, it is related with the development of other 
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microangiopathic complications in diabetes. Therefore, taking into account the close 
inter-relation between the perivascular nerves and the endothelial and smooth muscle 
function, the necessity raises for further studies to be undertaken in order to assess the 
endothelium-dependent vasodilatation (as a test of endothelial function) and 
endothelium-independent vasodilatation (as a test of smooth muscle function) in the 
presence of diabetic neuropathy. This evaluation of two major risk factors for the 
diabetic foot, such as neuropathy and microangiopathy, should bring further 
understanding in the foot ulceration pathogenesis. 
7.5 Neurovascular responses assessment by a non-invasive method: iontophoresis 
As outlined in the preceding section, the mechanism responsible for 
neurovascular responses in the skin, as by example in nocifensor responses, involves the 
three elements: 
1) polymodal nociceptors, primary afferent fibres and NANC (non-adrenergic-non- 
cholinergic) nerves. 
2) microvascular endothelium 
3) microvascular smooth muscle. 
. Testing the neurovascular function therefore ought to assess: 
1) the nerve function using standard tests of nerve fibre: vibration perception threshold, 
thermal perception threshold etc. or noxious transcutaneous electrical stimulation 
(TENS) evoking the axon reflex dilatation of skin microcirculation which examines 
indiscriminately the three components of the nocifensor response. 
2) the endothelium function using methods of endothelium-dependent vasodilatation, 
such as acetylcholine (ACh) iontophoresis. 
3) the smooth muscle function using methods of endothelium-independent 
vasodilatation to direct donors of NO, such as iontophoresed sodium nitroprusside 
(SNP) (Furchgott, 1984). 
Iontophoresis for delivery of vasoactive substances plus laser Doppler flowmetry 
for subsequent vasoreactivity measurements form together a battery of tests 
recommended for the non-invasive assessment of neurovascular responses. Basic 
principles will be discussed together with a summary of recent observations using these 
techniques to investigate the skin microvasculature. 
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7.5.1 Iontophoresis principle and limitations 
Iontophoresis ( or ion transfer) is a non-invasive technique of drug delivery 
which allows the local transfer of charged substances (ions) across the skin using a 
small electric current. 
It is preferred in studies assessing the vasodilatatory responses of the skin 
superficial microcirculation because no demonstrable spread takes place in 
subcutaneous or deeper structures except in special circumstances such as ischaemia or 
when very strong currents are used, which also would be likely to induce an axon reflex 
(Harris, 1978). 
Having the advantage of a non-invasive and uniform method which is free of 
unwanted side-effects and minimises trauma or risk of infection, iontophoresis is an 
important alternative to needle. Furthermore when testing solely the endothelium- 
dependent and smooth muscle vasodilatation is even important to avoid triggering an 
axon reflex which will involve also the neurogenic flare. 
This is the reason why iontophoresis of small currents (<=100 microAmpers) is 
preferred to intradermal injection which is an invasive technique inducing a skin injury 
and delivering the active substance at variable depths in or under the skin. 
The iontophoresis term comes from the Greek derivative and indicates the 
transfer of ions into the body, in our case into the skin. In studies using potentiometry 
and X-Ray fluorescence it has been shown that iontophoresis does not result in 
superficial migration of the applied ions on the skin from one pole to another but leads 
to penetration into the skin (Puttemans et al., 1982). 
The substances used for vasodilatation are in a stable form; in order to became 
active ions they need to be dissolved in a vehicle, usually in distilled, deionised water 
which does not conduct electric current in its pure state (Westerman et al., 1988). 
However recently a vasodilatatory effect has been reported to be introduced by the 
vehicle alone: more for SNP (which used water as a vehicle) than for ACh (which used 
mannitol as a vehicle) (Morris et al., 1995) underlying the importance of choosing an 
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appropriately inert vehicle for iontophoretic studies of neurovascular function or 
deducting the vehicle response from the total vasodilatation. Electric potential by itself 
does not change the skin permeability (Schaefer et al., 1982). 
When salts, acids or bases are dissolved in water, the resulting aqueous solution 
becomes a conducting liquid called electrolyte containing positive and negative-charged 
ions of the initial substance. The direct current passes through the electrolytic solution 
by migration of ions: the positive ions travel towards the negative pole (anode) and the 
negative ones towards the positive pole (cathode). 
The polarity of the active electrode is determined by the ion to be introduced 
into the skin: e. g. for acetylcholine chloride, anodal currents are used to transfer the 
cathion (Ach+) or for sodium nitroprusside cathodal currents are used to deliver the 
anion nitroprusside (NP-). The substances are usually placed under a chamber fixed at 
the surface of the skin with double-adhesive tape, which is connected to an 
iontophoresis device. This is a constant current generator, for which the chamber 
represents the active electrode. 
The range of response to iontophoresis does not depend on the concentration of the 
electrolyte solution but on the total charge applied accordingly to Faraday's law (the 
amount of substance deposited at each electrode is proportional with the amount of 
electricity passing through the system). 
Therefore, the iontophoresis is a local and non-invasive method for drug 
delivery. It consists in the transfer of active substances ions into the body proportional 
with the total charge of electric current applied. 
Sources of variation and dose-response curves 
Due to the complexity of factors involved during the process of iontophoresis 
through living tissues theoretical predictions based on Faraday's law are virtually 
impossible (Tyle, 1986). 
Experimental variables include: 
- pH: changes in pH of the fluid at the driving electrodes produced only minor changes 
on the uptake of the ions by the tissue. 
- ionic strength might influence the uptake although there are not many reports to 
support this supposition. 
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- size and charge of the electrodes: greater amount of drug is introduced by bigger 
electrodes. 
- type of electrode: those which have a good adherence to the skin surface would 
increase the uptake. 
- duration and intensity of current: varying one or another can help maintain/ change the 
amount of ions introduced by iontophoresis. 
- resistance of the skin can vary widely at different sites of the body; using the same 
testing site will reduce variability although individual variations might occur. 
- season: in summer responses tend to be smaller probably due to increased thickness of 
the epiderm. 
Individual variables: 
- sex: female subjects have larger responses probably due to differences in epidermal 
thickness and structure. 
- regional variations: gradient of response in upper and lower limbs. 
Thus in clinical studies of neurovascular function in diabetic patients 
Westerman et al., (1988) have determined dose-response curves to increasing intensity 
of iontophoretic stimulus by varying the intensity of current or the duration of 
iontophoresis application but they maintained the other variables constant: 
q= Ixt 
where q= charge given in millicoulombs (mC) 
I= current intensity given in miliAmpers (mA) 
t= time given in seconds 
In a study assessing the endothelial function (by iontophoresis of acetylcholine) 
and the smooth muscle function (by iontophoresis of sodium nitroprusside) in the 
forearm of NIDDM patients cumulative dose-responses were used (Westerman et al., 
1988). Repeated stimuli of equal intensity and duration plus a last one of double 
intensity and same duration were applied. The vasodilatatory response for acetylcholine 
reached the plateau quicker than for sodium nitroprusside whose response was slower, 
but more persistent (Morris et at., 1995). However one has to be careful in using 
excessive current intensity (> 1 mA) because this can directly injury the skin when 
applied for a longer period of time or induce an axon reflex even when short duration 
stimuli are applied (Magerl et at., 1990). Similar studies have been done in diabetic 
animals and humans for the development of a battery of neurovascular tests 
(Westerman et al., 1987; 1988) 
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7.5.2 Recent studies of iontophoresis use in the study of skin responses 
Interest and research in this technique has increased because of therapeutic uses 
in different areas of medicine e. g. in cystic fibrosis, in dermatology for the diagnosis 
and treatment of various skin disorders (Sloan et al., 1986); being extensively used in 
the assessment of inflammatory, sudomotor and vasomotor cutaneous responses. 
Cutaneous inflammatory responses 
Histamine iontophoresis has been demonstrated to be a reliable model for the 
study of inflammatory skin responses (Mager!, 1990). 
Noradrenaline iontophoresis used in a study which has shown that noradrenaline 
and sympathetic stimulation increase nociceptor discharge in inflamed skin suggesting 
that sympathetic neural activity might increase pain associated with skin damage in 
healthy subjects (Drummond, 1995). 
Cutaneous sudomotor responses 
Also iontophoresis has been used widely for tests of sudomotor function such as 
the classical pilocarpine iontophoresis test used in the diagnosis of cystic fibrosis. 
In diabetes, muscarinic receptors situated on the sweat glands were directly 
stimulated by iontophoresis of acetylcholine and then their response was compared to 
the axon reflex-mediated sudomotor responses via nicotinic receptors. 
Overrepresentation of large sweat droplets was found in patients with mild diabetic 
neuropathy, while patients with severe neuropathy had a markedly reduced density and 
small size droplets (Kihara et al., 1993). 
Also the failure of sudomotor axon reflex preceded the defect in direct response 
suggesting that abnormality of sympathetic nerve component occurs early in diabetic 
neuropathy. Likewise in another study of basal and stimulated sweating by acetylcholine 
iontophoresis, in diabetes showed that both low- and high- amplitude responses are 
seen in diabetic neuropaths, the latter being suggestive of denervation hypersensitivity 
(Levy et al., 1991). 
219 
A reduction in the sudomotor response to acetylcholine iontophoresis has been 
found only in late stage neuropathy, whereas the neurogenic response to histamine 
iontophoresis seems to be decreased in all stages of neuropathy suggesting that is more 
sensitive in detecting impairment of unmyelinated fibres affected early in the course of 
neuropathy (Lang et al., 1995). 
Cutaneous vasomotor responses 
Physiological studies showing the role of baroreflex control on the cutaneous 
active vasodilator system in humans (Kellogg et al., 1990) used the iontophoresis of 
bretyllium, which is a selective blocker of noradrenergic vasoconstrictor nerves in the 
skin (Kellogg et al., 1991). Furthermore fundamental research on adrenoceptors, which 
have demonstrated that postjunctional alpha-adrenoceptors in human finger skin vessels 
are of both alpha-1 and alpa-2 subtypes (Linblad et al., 1986) and that vasoconstriction 
on local cooling in human finger skin is mainly mediated by alpha-2 adrenoceptors 
(Ekenvall et al., 1988), used a iontophoresis of a variety of adrenoceptor agonists: 
(phenilephrine or B-Ht 933: alpa-2 agonist) and alpha-1 (doxazosine ) and alpa-2 
(rauwolscine) antagonists . 
Conclusion. Limitations and advantages of iontophoresis 
The iontophoresis process consists in passing polar drugs across the skin using 
small, direct currents (Trubach et al., 1972). The exact concentration and distribution 
of active ion is not known precisely since a determined charge (product of current and 
time) has to transport the ions through the skin, which has variable mechanical and 
electrical properties (Edelberg, 1970). However if standard stimuli are used in standard 
conditions the effect of this sources of variation can be minimised. Thus iontophoresis 
has been extensively used in the assessment of inflammatory, sudomotor and vasomotor 
cutaneous responses. Specifically in studies of skin vascular reactivity, dynamic changes 
in blood flow following iontophoresis of vasoactive substances, should be determined 
ideally using a non-invasive method of blood flow measurements, such as laser Doppler 
flowmetry (LDF). 
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7.6 Laser Doppler flowmetry: a non-invasive method of 
dynamic blood flow measurements in neurovascular responses 
Most of the techniques for blood flow measurement have the disadvantage of 
being invasive. In contrast Laser Doppler flowmetry (LDF) is a non-invasive test of skin 
blood flow. Furthermore LDF has a special characteristic: is sensitive to dynamic 
changes in the blood flow, therefore being of potential use in studies of vascular 
reactivity. 
The low power laser used by the LDF generates a non-noxious beam of infrared 
light transmitted through an optical fibre to illuminate a small area on the skin. The red 
blood cells moving inside the microvessels of the illuminated skin scatter the photons 
generated by the laser and they will undergo a frequency shift according to the Doppler 
principle. The resulting light is collected and transmitted to a photodetector. The 
photodetector signal is amplified and processed by an analogue processor then the 
signal is sampled and further processed by the digital processor which will perform the 
interface and display functions providing a reading proportional to the local blood flow. 
The resulting measurement is expressed in arbitrary units of blood flux, more 
correctly as blood cell flux - which can be argued that is a more realistic measurement 
since the flow of red blood cells delivers the oxygen to the tissue and not the simple 
plasma (fluid) flow. (Almond, 1994). The measurement is continuous and has spatial 
and temporal resolution so dynamics associated with local skin blood flow regulation 
can be followed concomitantly on the screen. These perfusion data are automatically 
stored by the computer and could be printed out. Recently it has also become possible to 
separately quantitate the two components of blood flow: red blood cell concentration 
and red blood cell speed and to use new Laser Doppler techniques such as dual channel 
systems (Obeid et al., 1966) or laser Doppler imagers (Wardell et al., 1991) allowing a 
better understanding of blood flow changes and the complexities of the 
microcirculation. 
7.6.1 Standardisation of LDF instruments 
LDF by using Doppler shifts in the range of helium-neon laser light wavelength 
632.8nM or infrared 760-800nM would be sensitive to all microscopic movements. 
Those devices with two optic fibres for pick up of the reflected signal and differential 
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recording have been more sensitive and less prone to movement artefacts (Nilsson et 
al., 1987, Johansson et al., 1987). Filtering and improvements in fibre optic cables 
have further reduced this problem (Kilpatrick et al., 1988; Salerud et al., 1987). 
Comparison of LDF with accepted and accurate methods of blood flow 
measurements showed good correlations with microsphere flowmetry (Kiel et al., 1985; 
Kvietys et al., 1985), 133 Xenon clearance (Stern et at., 1977) and electromagnetic 
flowmetry (Shepherd et al., 1982; 1983). When LDF was compared to optical 
plethysmography and heat thermal clearance the results suggested that the different 
methods measured blood flow at different depths in the skin vascular beds (Saumet et 
al., 1986). 
One of the main problems with calibration of LDF is the lack of suitable 
standard against which it may be compared because all the methods used ` for 
comparison have their own variability. The moderate correlation found with these other 
methods of blood flow is not surprising as the measurements are done in different ways 
and sometimes in different vascular beds. 
7.6.2 Limitations of the LDF method 
Different techniques of blood flow measurement have various degrees of 
variability and a reproducible standard of blood flow would be required when 
comparisons among them and LDF are made. Unfortunately this standard has not been 
yet established; therefore the necessity of variability tests in each study using LDF. 
The skin microcirculation has large periodic oscillations (Seifert et al., 1988) 
due to cyclical opening and closing of the arterioles related to the sympathetic tone, 
inducing oscillations in tissue perfusion within tissue regions'of the order of lmm3 
(which is the usual sample size for LDF). The oscillations are thought to be caused by 
vasodynamic activity in the precapillary vascular bed of the skin (Fagrell, 1985). Also 
the microcirculatory architecture of the skin is not homogenous with possible effect on 
LDF variability. 
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When measuring red cell flux, the measurements ought to be averaged over long 
periods of time or from independent sites assessed simultaneously (Borgos, 1994). It is 
recommended to estimate where possible the relative changes in blood flow in response 
to a provocation and not rely entirely on the absolute measurements of basal blood flow. 
Factors which can influence the LDF reproducibility are: 
a) Individual variables of the subjects: 
- sex and age 
- time of testing (sympathetic tone is changing during the day) 
- anxiety (vasoconstrictor tone) 
- current medication and/or ingestion of vasoactive substances: tea, coffee etc. 
- basal blood flow 
- site to site variability. 
b) Biological variables: 
1) skin and adjacent tissues variables: 
- skin thickness, pigmentation, presence of hair and freckles. 
- skin and ambient temperature 
- sweat pore distribution and density 
- volume of tissue in which the microcirculation is assessed because of 
uncertainty about the depth of laser penetration. 
2) microvascular variables: 
- capillary density 
- capillary flow distinguished from arterio-venous flow 
- microvascular bed distribution and density 
- permeability differences 
- presence of non-cellular elements such as lipids droplets in the vessels assessed 
- haematological features such as the haematocrit which might affect the LDF 
measurements in the absence of flow. 
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c) Technical variables: 
1) Equipment: 
- variable sensitivity to any microscopic movements. 
- variable voltage output for standard calibration signal 
- laser gain settings, time constant, filters 
- laser probe at variable distance from the skin 
- analogue chart recorder settings 
- response increase (% rise in laser Doppler flux) depends on the basal blood 
flow level which can be influenced by biological variables. 
2) Operator error: - different operators performing and/or analysing the recordings. 
In clinical use LDF reproducibility can be improved by a careful choice of 
protocol in order to minimise the effect of some of these variables. Matching patients 
and healthy subjects taken into the study for age, sex and when possible for lipids and 
haematological profile helps in reducing the variability. Also testing all the subjects at 
the same time of day in a temperature controlled and quiet room and asking them to 
abstain from previous ingestion of vasoactive substances or medication would 
contribute to a decrease in the coefficient of variation. 
The effect of variable skin thickness can be reduced by choosing the same 
testing area which will be free of hair, freckles, pigmentation in all the subjects of study. 
This achieves some control on the density of sweat glands but also on the density of 
capillaries versus the density of arterio-venous shunts which are known to be more 
frequent in some areas (e. g. the pulp of the toes) plus will provide an assessment of the 
same vascular bed in all subject. 
As regards the technical variables, using only one type of laser Doppler 
flowmeter with a single wavelength would allow a quasi-constant depth of penetration 
and therefore a comparable volume of tissue and its microcirculation will be assessed; 
as well as maintaining constant equipment characteristics and a comparable sensitivity 
to all microscopic movements. If only one operator is involved with the study, the 
variability can be reduced furthermore. 
224 
As the response increase depends on the basal blood flow and measurements of 
absolute levels of basal blood flow might be variable, ratioing the peak blood flow to 
basal blood flow might be recommended. It has been shown that this ratio remains 
constant, despite basal blood flow variations (Gardner-Medwin and MacDonald et 
al., 1995). Furthermore the ratio of peak to basal blood flow would also be independent 
of other variables such as differing skin temperatures which could also affect basal 
blood flow. 
Conclusion 
The most potent use of LDF lies in its sensitivity to quantify relative changes in 
blood flow in response to vascular stimulation. The variability of LDF measurements is 
still a question which requires careful methodological standardisation, in order to 
minimise the effects of technical, individual and biological variables. In such studies the 
final response measured by LDF is microvascular vasodilatation or constriction 
probably involving only epidermal microvessels, particularly precapillary arterioles or 
postcapillary venules (Westerman et al., 1988). Therefore LDF should be particularly 
advantageous in assessing neurovascular reactivity (responsiveness and sensitivity) of 
the cutaneous microcirculation. 
7.6.3 Recent studies of LDF use in testing neurovascular reactivity 
in diabetes 
Reactive hyperaemia 
In diabetes, numerous studies have employed LDF for assessing reactive skin 
hyperaemia in response to a standard ischaemic stimulus and have demonstrated the 
value of LDF in quantitating dynamic vasodilator responses when trying to measure 
subtle functional disturbances of microcirculation resulting from chronic peripheral 
arterial disease (Walberg et al., 1990). 
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In diabetic versus non-diabetic patients with peripheral vascular disease the ratio 
between capillary blood cell velocity measured by videophotometric capillaroscopy and 
LD flux (representing distribution of flow between nutritional and non-nutritional 
blood compartments) was found to be reduced suggesting increased risk of foot 
ulceration (Jorneskog et al., 1995). 
These studies also demonstrate the reasoning for LDF most efficient use: to 
measure changes without attempting to extrapolate absolute flow data. Post-ischaemic 
hyperaemia tests in diabetic patients reveal cutaneous microcirculatory changes which 
are associated with the presence of diabetic microangiopathic complications such as 
retinopathy (Tur et al., 1991). 
However in long-duration IDDM the peak flow (which is a predominant smooth 
muscle response) occurring post- ischaemia was impaired, but this impairment was not 
associated with the presence of microangiopathy or with recent blood glucose control 
suggesting a specific defect introduced by IDDM per se (Walmsley et al., 1990). 
Moreover when diabetic neuropathy is present a shortened time to half peak 
flow, representing a speedy vasodilatation, reflected a reduction in the viscoelasticity of 
the arterial wall. Furthermore when the veno-arteriolar (VAR) response to standing was 
measured by LDF, an impairment of VAR was found in diabetic patients with 
neuropathy suggesting that the postural control of blood flow in the skin of the foot is 
decreased (Belcaro et al., 1991). 
Reactive vasoconstriction 
Studies of reactive vasoconstriction to different stimuli such as inspiratory gasp, 
ice-water immersion, spring-loaded pin-prick or postural change, which depends on an 
intact peripheral nervous system were also selectively using LDF. Inspiratory gasp 
vasoconstrictive responses as assessed by LDF were considered to be sensitive 
techniques for evaluating sympathetic efferent function (Valley et al., 1993) and could 
be used as tests for peripheral sympathetic neuropathy identification (Wilson et al., 
1992). In diabetic neuropathic patients a lack of vasomotor activity was found to 
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correlate with increased blood viscosity but not with the increased aggregation index 
(Zioupos et al., 1993). 
Furthermore impaired posturally induced vasoconstriction was found even in 
postpubertal diabetic children most of them being free of complications (Shore et at., 
1994). Indeed the vasoconstrictor responses to inspiratory gasp and arm cold challenge 
, assessed by LDF, were proven to decline with age even in non-diabetic controls 
suggesting once more the hypothesis that diabetes and moreover diabetic neuropathy, 
act as an accelerated ageing process (Khan et al., 1992) 
Maximum hyperaemic response to heating 
Detection of microvascular impairment by using laser Doppler flowmetry in 
type 1 diabetes, before complications became apparent, was demonstrated in a study 
measuring the hyperaemic response to local heating (44°C) (Wilson et at., 1992). Also 
it has been shown that an impaired maximum hyperaemic response to heating occurs 
even in prepubertal diabetic children in the absence of clinically detectable 
microangiopathy (Shore et al., 1991). 
Autonomic dysfunction as investigated by LDF measurements in response to 
hyperthermal stimulus has been shown to occur early in the course of NIDDM 
(Koltringer et al., 1992). Diabetic neuropathy was shown in another LDF study to 
introduce a paradoxical decrease to local heating to 44 C in arteriovenous flow 
(Stevens et al., 1991). 
Neurogenic responses 
Neurogenic inflammation, mediated by nociceptor C fibres, is part of the acute 
neurovascular response to injury producing the axon reflex flare. In a study by 
Walmsley and Wiles (Walmsley et al., 1991) Laser Doppler flowmetry was used to 
measure the flare response induced by the electrophoresis of a ring of acetylcholine 
solution into dorsal foot skin and found it greatly reduced especially in patients with a 
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history of foot ulceration. Furthermore impairment of this nociceptor C fibre response 
can develop before clinical large-fibre neuropathy and could itself predispose to foot 
complications. 
In another study of LDF in the foot, acetylcholine mediated endothelial response 
to noxious stimuli (induced by mechanical stroking of the skin) was decreased, but 
smooth muscle reactivity was not tested (Parkhouse and LeQuesne, 1988). 
Another interesting study (Lang et al., 1995) compared the sensitivity of 
histamine induced neurogenic vasodilatation (measured by LDF) to acetylcholine 
induced sudomotor axon reflex (measured by hygrometry) in diabetic neuropathic 
patients. The histamine induced vasodilatation was significantly impaired in early stages 
of neuropathy. This can be used as an acceptable test of small nerve fibre impairment, 
which occurs early in progression of neuropathy (Said et al., 1983) 
Furthermore in order to gain insight into the mechanisms of reduced skin 
hyperaemia to local injury, another group has injected intradermally capsaicin and 
substance P, known as a potent vasodilator involved in the axon reflex flare response, 
and evaluated the response by LDF. In diabetes impaired hyperaemia to substance P but 
not to exogenous capsaicin, was demonstrated. This might reflect a decreased vascular 
reactivity to the local release of neuropeptides from the peripheral nerve fibres (Boolell 
and Tooke, 1990). 
Conclusion 
Laser Doppler flowmetry (LDF) has proved to be a useful non-invasive test of 
blood flow in skin microvessels, allowing a constant monitoring of the blood flow. 
Moreover LDF is able to assess relative changes in the blood flow under dynamic 
circumstances, therefore being particularly beneficial in studies of neurovascular 
reactivity such as: reactive hyperaemia and vasoconstriction, maximum hyperaemic 
response to heating and neurogenic vasodilatation, all of which were extensively 
investigated in diabetes. 
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7.7 Rationale for studying neurovascular reactivity in diabetes 
Therefore the combination of drug iontophoresis with LDF utilises their 
strongest features namely that iontophoresis is not invasive and is confined to the 
epidermis, and LDF is also non-invasive and is very sensitive in detecting dynamic 
changes in the blood flow (Westerman et al., 1988; Lindblad et al., 1986). 
These tests together are recommended for the assessment of vascular reactivity 
in the skin providing a convenient way to evaluate the effects of transdermally applied 
vasoactive substances without risking the central effects of the substance to influence 
the registered blood flow. 
The neurogenic component of the neurovascular response has been thoroughly 
researched and indicates that diabetic neuropathy plays an important role in reducing 
the ability of foot to defend itself against noxious stimuli because of a reduced axon 
reflex. 
Further studies to examine the effects of neuropathy on the vascular: 
endothelium-dependent and endothelium-independent components of the neurovascular 
response are needed and this chapter will describe two studies of neurovascular 
responses in patients with neuropathy, with or without diabetes. 
The role of microcirculation vascular reactivity as a factor involved in the 
mechanism of foot ulceration, needs to be evaluated in an attempt to go a step further in 
the understanding of foot ulceration aetiology. 
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7.8 Endothelium-dependent and endothelium-Independent responses 
in diabetic patients with peripheral neuropathy 
7.8.1 Introduction 
Neuropathy leads to considerable pathology in the diabetic foot, in which the 
blood flow and neurovascular responses are abnormal. Abnormalities introduced by 
neuropathy in the diabetic foot can lead ultimately to foot ulcer formation and 
furthermore can have a negative impact on the tissue repair and wound healing 
potential. 
The neural component of the neuro-vascular responses has been studied in 
neuropathy, but their vascular component: the endothelial and smooth muscle, function 
in neuropathy is less well known. Although endothelium-dependent and endothelium- 
independent vascular responses have been extensively studied in diabetes, they have 
been not fully investigated in diabetic patients with neuropathy. 
Recently there has been increasing interest in the regulation of the vascular tone 
by perivascular nerves and endothelial cells (Burnstock and Ralevic, 1994). In 
endothelium-dependent vasodilatation, acetylcholine acts on the muscarinic receptors of 
endothelium which releases nitric oxide (NO); this then induces vascular smooth muscle 
dilatation. In endothelium-independent responses, smooth muscle vasodilatation is 
stimulated by direct donors of NO such as sodium nitroprusside (SNP). Another source 
of NO which is endothelium-independent, is the neurone (Bredt et al., 1991; Valiance 
and Moncada, 1994; Rand and Li, 1995). In patients with diabetic neuropathy and 
possibly with subsequent neural depletion of NO, abnormal responses might occur. 
Aim of the study 
The aim of this study was to investigate vascular responses to acetylcholine and 




Three groups of subjects were studied: 10 patients with diabetic neuropathy, 10 
diabetic patients without neuropathy and 10 non-diabetic control subjects. 
They were matched for age, sex and type of diabetes. The HbAlc was similar in 
the three groups of diabetic patients. Foot pulses were present in all subjects. 
Neuropathy was defined by the absence of ankle reflexes accompanied by 
abnormal vibration perception threshold (VPT> 25 Volts) measured with a 
Biothesiometer (Vickers, Ohio, USA). 
Six out of ten patients with neuropathy had a history of foot ulceration although 
none of the neuropathic patients had active ulcers at the time of the study. None of the 
subjects had peripheral oedema. 
Seven patients with neuropathy had also diabetic retinopathy and five 
neuropathic patients had proteinuria. In the diabetic control group a similar number of 
patients with retinopathy and proteinuria was selected. 
As there may be important differences in the microvascular responses between 
IDDM and NIDDM patients, it was decided, for analysis purposes, to assess the trends 
present in the NIDDM patients, as a separate group. 
Eight NIDDM patients with peripheral neuropathy and 7 NIDDM patients 
without neuropathy were studied versus 10 non-diabetic control subjects. Six out of 
eight patients with neuropathy had a history of foot ulceration although none of the 
neuropathic patients had active ulcers at the time of the study. 
None of the subjects had peripheral oedema. 
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Number 10 10 10 
Sex (F/M) 4F/6M 5F/5M 4F / 6M 
Age (years) 48.2±11.5 56.8±14.7 51.7±15.2 
IDDM/NIDDM - 3/7 2/8 
Diabetes duration (years) - 9.1±7.7 12.5±6.5 
Plasma glucose 
(mmol/l) 
- 9.6±4.5 10.2±5.1 

















Meant SD VPT = vibration perception threshold 
Six patients with neuropathy had also diabetic retinopathy and five neuropathic patients 
had proteinuria. 
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In the diabetic control group a similar proportion of patients with retinopathy 
and proteinuria was selected. 
Table 7.8.2 Clinical details of the NIDDM patients in which neuro-vascular 
responses were measured 
Controls Diabetic Neuropaths 
(C) Controls (DbC) (Np) 
with NIDDM with NIDDM 
Number 10 7 8 
Sex (F/M) 4F/6M 3F/4M 3F/5M 
Age (years) 48.2±11.5 58.1±13.1 52.3±13.7 
Diabetes duration - 8.9±1.2 13.7±5.0 
(years) 




4.4±0.8 9.1±1.9 9.9±1.0 
VPT (volts) 6.4±1.3 9.7±2.5 43.1±8.4 
Proteinuria - 4 5 
History of foot ulceration - - 6 
Mean ± SD VPT vibration perception 
threshold 
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There were no statistically significant differences between the NIDDM 
subgroups and the all diabetic groups. 
All patients had their usual dose of insulin or tablets in the morning of the 
experiment and they abstained from caffeine, alcohol and tobacco overnight. 
Informed consent was obtained from all the subjects and the project had been 
approved by the King's Healthcare Ethical Committee. 
7.8.3 Methods 
The changes in skin blood flow were assessed with a Moor Laser Doppler (Moor 
Instruments Ltd., Axminster, UK). The probe of the Laser Doppler was attached to a 
plastic chamber placed on the dorsum of the foot. The patients were lying down on a 
couch at lm above the ground, in a room with an ambient temperature of 22-23°C. The 
left foot was tested in all patients in order to standardise the method for statistical 
reasons and knowing that all the neuropathic patients had symmetrical peripheral 
neuropathy. 
The iontophoresis technique was used in this study because this is the only 
technique which allows the drug application solely to the superficial vessels of the skin. 
Intradermal injection techniques deliver drugs at unknown depths and being invasive 
themselves induce a flare response. 
The dorsum of the foot was chosen as the testing site because diabetic 
neuropathy affects first the longest nerve fibres which innervate the feet and also 
because it has been shown that the skin thickness on the dorsum of the foot in 
neuropathic patients is not increased (Forst et al., 1994). None of the subjects had 
peripheral oedema. The skin of the dorsum of the foot was prepared for iontophoresis 
and cleaned with an alcohol swab (Morris et al., 1995). 
The round iontophoresis chamber was then fixed to the skin by a double-sided 
adhesive disc. The chamber was designed with a space in the middle to accommodate 
the Laser Doppler probe and with a ring-channel situated at 5 mm from the margin of 
the chamber. The substances to be iontophoresed were placed with a fine pipette under 
the probe on the surface of the skin. 
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The chamber was considered to be the active electrode and was connected with a 
battery-operated iontophoresis device. The indifferent electrode was a wet band applied 
to the ankle. A small constant current (100µA) transported the ions of substance from 
the active electrode to the indifferent electrode through the superficial layers of the skin. 
The iontophoresis device would deliver a constant intensity of electric current adjusting 
for each individual skin resistance. 
To transfer the drugs into the skin the polarity of the active electrode had to be 
the same charge as the drug. Therefore, for acetylcholine chloride (Iolab, a Johnson & 
Johnson Co., Bracknell, Berkshire, UK) anodal currents were used to transport the 
cation acetylcholine+; for SNP (Roche Products Ltd., Welwyn Garden City, UK) 
cathodal currents were employed to transfer the anion NP-. 
As the solutions are unstable with time, the drugs were dissolved on the day of 
the test in sterile deionised water for SNP and in mannitol (inert vehicle) for 
acetylcholine to produce a I% solution. Doses of acetylcholine and SNP were calculated 
from the dose-responses curves published by Westerman et al. (1988) with the aim to 
evaluate the maximum vasodilatatory response without inducing an axon reflex. 
Therefore considering that the vasodilatatory response is dependent on the 
intensity of the electric current (100µA) and the time of exposure (2 minutes) to this 
current, a total charge of 12 mC was applied. At this low intensity, the current was either 
imperceptible or a very faint sensation of tingling was reported by the patients. If higher 
currents are employed, local electrically induced axon reflex vasodilatation could be 
induced. 
The application of each drug was given at a different site on the dorsum of the 
foot to avoid interference with any previous vasodilatation. 
The Laser Doppler blood flow measurements were done using a linear scale 
(Nitzan et al., 1988; Ahn et al., 1987) and the Moor LD flowmeter settings comprised 
of a recording bandwidth of 14.9Hz and a time constant of 0.5 seconds. 
At the beginning of the test, basal blood flow was measured for 30 seconds; then 
iontophoresis was performed for 2 minutes and then the vasodilatatory responses were 














































Reproducibility of the laser Doppler measurement 
Laser Doppler measurements had a coefficient of variation of 45±21.2% 
(Mean±SD) in the non-diabetic control group and of 38±6.6% in the diabetic control 
group while in the neuropathic group, this was 1110.2%. 
Analysis of recordings 
In order to analyse the recordings, the blood flow was measured in arbitrary 
Laser Doppler Flow units (LDFu) and then the ratio of peak blood flow to basal blood 
flow was calculated. Laser Doppler measurements of absolute levels of basal blood flow 
might be variable, but the ratio of peak blood flow to basal blood flow remains constant, 
despite basal blood flow variations (Gardner-Medwin and MacDonald, 1995). 
Furthermore the ratio of peak to basal blood flow would also be independent of other 
variables such as differing skin temperatures which could affect basal blood flow. 
Statistical Analysis 
The data from were first tested for significant deviation from normality of 
distribution: neither the measures in the acetyl-acetylcholine test (c2=2.45, df=3, 
p<0.48) nor the measures in the sodium nitroprusside test ( c2 =4.2, df=3, p<0.24) 
differed significantly from a normal distribution. 
Then the data from all diabetic groups (IDDM and NIDDM) were analysed using 
a standard one-way analysis of variance model implemented on the Statgraphics 
package to show the statistical significance of the overall effect. 
Post-hoc comparisons using multiple range analysis for measure by group were 
done in order to show the significance between groups. 
The data from the NIDDM groups were also analysed and described as 
geometric mean±anti-logged SD using a Minitab package. 
The figures used a logarithmic y axis in order to present the data on a 
multiplicative scale. The ratios were compared between groups using the log- 




The basal blood flow values, before iontophoresis was performed, were not 
found to be statistically significantly different in the three groups in the study, whether 
they included all diabetic (IDDM and NIDDM) patients or only the NIDDM patients 
versus the control subjects. 
Table 7.8.3 Basal blood flow and vasodilatatory responses to acetylcholine 
and SNP iontophoresis in NIDDM patients with and without neuropathy compared to 
non-diabetic controls and expressed as geometric mean±anti-logged SD. 







Controls 14.01±1.71 9.81±1.65 7.02±2.05 
(n=10) 
Diabetic controls 12.55±1.69 3.49±1.67 6.42±1.56 
(n=7) (p=0.67, NS) (p<0.005) (p=0.75, NS) 
Neuropathic patients 10.91±1.59 3.50±2.03 2.10±2.0 
(n=8) (p=0.30, NS) (p<0.005) (p<0.005) 
Geometric mean±anti-logged SD 
The values of the difference between basal blood flow and peak blood flow after 
iontophoresis of acetylcholine were also expressed as mean±SEM as seen in Table 7.8.4 
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Table 7.8.4 Vasodilatatory responses to acetylcholine and sodium nitroprusside 
iontophoresis in all neuropathic and non-neuropathic diabetic patients compared to 
controls and expressed as Mean±SEM. 
Acetylcholine Sodium nitroprusside 
LDFu Ratio LDFu Ratio 
Controls (n=10) 109.7±18.9 10.9±1.8 68.1±8.7 8.5±1.6 
Diabetic controls (n=10) 67.0±9.4 5.8±1.1 70.8±16.4 9.2±2.4 
(p<0.05) (p<0.05) (NS) (NS) 
Neuropathic patients (n=10) 29.6±9.8 4.1±0.7 15.5±6.8 2.8±0.7 
(p<0.01) (p<0.01) (p<0.01) (p<0.01) 
Mean±SEM LDFu = Laser Doppler 
Flow units 
Vasodilatatory responses to acetylcholine iontophoresis 
Compared to non-diabetic control subjects, who showed a considerable increase 
in their blood flow (109.7±18.9 LDFu), all the diabetic groups showed a significantly 
reduced vasodilatatory response: diabetic controls (67.0±9.4 LDFu, p<0.05) and 
neuropathic patients (29.6±9.8 LDFu, p<0.01). 
Although some of the neuropathic patients had no response at all to 
acetylcholine iontophoresis (Figure 7.8.2), there was no significant difference between 
the neuropathic group and the diabetic control group (p=0.9). 
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The ratio of blood flow increase versus the basal blood flow (Table 7.8.4) also 
showed that both the IDDM and NIDDM controls (ratio=5.8±1.1, p<0.05) and the 
diabetic (IDDM and NIDDM) neuropathic patients (ratio=4.1±0.7, p<0.01) had a 
significant decrease in their endothelial vasodilatatory response to acetylcholine versus 
non-diabetic subjects (ratio= 10.9±1.8). 
When the geometric mean of the ratio was calculated in the NIDDM patients, 
similar results became apparent (Table 7.8.3). All the NIDDM groups showed a 
significantly reduced (Fig. 7.8.3) vasodilatatory response: diabetic controls (ratio= 
3.49±1.67, p<0.005) and neuropathic patients (ratio=3.50±2.03, p<0.005) when 
compared to non-diabetic control subjects (ratio=9.81±1.65). 
Vasodilatatory responses to sodium nitroprusside iontophoresis 
The blood flow increase in response to the iontophoresis of SNP was assessed in 
the three groups (Fig. 7.8.4): the neuropathic patients, the diabetic control patients 
without neuropathy and the non-diabetic control subjects. 
Compared to non-diabetic control subjects who showed a good vasodilatatory 
response (68.1±8.7 LDFu), the neuropathic group including IDDM and NIDDM patients 
was the only group which had a reduction in their vasodilatation (15.5±6.9 LDFu, p< 
0.01). The diabetic (IDDM and NIDDM) control group showed a similar vasodilatation 
(70.8±16.4 LDFu) when compared to non-diabetic controls (68.1±8.7 LDFu). 
There was also a significant reduction in vasodilatation in the diabetic (IDDM 
and NIDDM) neuropathic patients (15.5±6.9 LDFu) when compared to the diabetic 
(IDDM and NIDDM) controls (68.1±8.7 LDFu, p<0.01). 
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When the ratio between the peak blood flow after iontophoresis and the basal 
blood flow before iontophoresis was calculated as Mean±SEM (Table 7.8.4), again the 
only group which had a significant reduction in their ability to vasodilate to SNP was 
the diabetic (IDDM and NIDDM) neuropathic group. 
Similarly when the geometric mean and the anti-logged SD (Table 7.8.3) were 
calculated in the NIDDM only groups, the neuropathic NIDDM patients showed a 
significant decrease (Fig. 7.8.5) in the smooth muscle ability to produce vasodilatation 
in response to SNP (ratio=2.10±2.0, p<0.005) when compared to both non-diabetic 
control subjects (ratio=7.02±2.05) and the NIDDM diabetic control group 
(ratio=6.42±1.56, p=0.75). 
Comparison of the vasodilatatory responses to acetylcholine and to SNP 
iontophoresis in the neuropathic group 
When the responses to the two agents were compared in the neuropathic patients 
(Figure 7.8.6), the response to SNP in the same individual was always smaller than the 
response to acetylcholine. 
The results found in the NIDDM subgroups were not statistically different from 
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This study shows that acetylcholine induced endothelium dependent 
vasodilatation in the foot was impaired in all the diabetic patients whereas the smooth 
muscle response to sodium nitroprusside was severely blunted only in diabetic patients 
with peripheral sensory neuropathy. This was true for both the difference between peak 
and basal blood flow and for the ratio of peak to basal blood flow in both IDDM and 
NIDDM patients as well as in those with non-insulin dependent diabetes mellitus only. 
Endothelial-mediated dysfunction in diabetes has been well demonstrated in 
animal studies (Oyama, 1986; Meraji, 1987). In human studies, abnormal circulating 
levels of von Willebrandt factor (Porta et al., 1990) and a reduction in the maximum 
dilatatory capacity (Tooke, 1986) have been reported. Others have also demonstrated 
endothelial dysfunction in corpora cavernosa responses of impotent diabetic patients 
(De Tejada et al., 1989), in patients with microalbuminuria (Elliot et al., 1993) and in a 
group of uncomplicated NIDDM patients (McVeigh et al., 1992). In contrast, 
acetylcholine endothelial responses of forearm blood flow in a group of IDDM patients 
did not show any abnormality (Calver et al., 1992). However the differences between 
studies could be related to differences in the type of vascular bed (Kiff et al., 1991), the 
size of the arteries (Mayhan, 1989) or the thickness of basement membrane of the skin 
vessels (Vracko, 1970) at the site tested. In our study the endothelial mediated reactivity 
on the dorsum of the foot was found to be reduced in diabetic patients of medium to 
long duration of diabetes with or without neuropathy. However endothelial dysfunction 
probably occurs early in the course of diabetes and may even occur in those with IGT 
(Jaap et al., 1994). 
Although it is widely recognised that the acetylcholine vasodilatatory response is 
endothelium-dependent and involves NO (Pieper, 1995) the protocol used in the 
present study does not directly prove that; ideally a NO-synthase inhibitor, such as L- 
NMMA (NG-monomethyl-L-arginine), should have been used, but unfortunately this is 
not iontophoresable. 
Endothelial responses may be affected by blood glucose levels as shown in 
animal studies (Tesfamariam et al., 1991). It is possible that NO produced by the 
endothelium may be quenched by glycation end products deposited in the subendothelial 
space (Bucala et al., 1991). However in animals this only occurs during very high blood 
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glucose levels constantly maintained over a week (Lash, 1991), which would be 
unusual in diabetic patients. Furthermore in humans, sustained moderate 
hyperglycaemia (blood glucose 10-15 mmol) does not affect these responses (Houben 
et al., 1994) and levels of HbAlc do not correlate with vascular reactivity (McVeigh, 
1992). Nevertheless, both basal plasma glucose and HbAlc levels were comparable in 
all groups of diabetic patients and it is therefore unlikely that the differences in vascular 
responses in our study were influenced by diabetic control. 
A diminished response to SNP was found only in the neuropathic group 
indicating that reduced endothelium-independent vasodilatation (vascular smooth 
muscle sensitivity to NO) is associated with neuropathy. However this association 
might also reflect either a more advanced state of the disease or less well controlled 
diabetes, with subsequent accumulation of advanced glycation end-products which leads 
to NO quench (Bucala et al., 1991). In uncomplicated IDDM, vasodilatation in 
response to SNP was found to be normal or minimally impaired in (Smits et al., 1993). 
In NIDDM there have been two recent studies: the first, in a group of NIDDM patients 
(although not totally free of diabetic complications) showed a blunted response to 
glyceryl trinitrate, which shares a common pathway with NO (McVeigh, 1992). 
However in another study (Morris et al., 1995) a reduction in both the vasodilatatory 
responses to acetylcholine and SNP were found in a group of NIDDM patients, but the 
majority of patients in that group had one or more diabetic complications such as 
retinopathy, nephropathy and neuropathy. Therefore the association of NIDDM with a 
defect of the SNP vasodilatation might be related to the presence of these diabetic 
complications. In this study, our diabetic patients both with and without neuropathy 
were matched for other complications namely retinopathy and nephropathy. This makes 
our findings in the neuropathic group even more interesting suggesting that the 
dysfunction at the smooth muscle level might be associated specifically with 
neuropathy. 
Previously there have been only few studies on diabetic patients with well 
documented neuropathy. In the foot, acetylcholine mediated endothelial response to 
noxious stimuli (induced by mechanical stroking of the skin) was decreased, but SNP 
reactivity was not tested (Parkhouse and LeQuesne, 1988) and in a further study a 
reduction in the neurogenic response to acetylcholine was also demonstrated in patients 
with a history of foot ulceration (Walmsley et al., 1991). In vitro studies of isolated 
corpora cavernosa, taken from impotent diabetic patients ( but with no indication of 
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their peripheral neuropathy status) confirmed impairment of the acetylcholine responses, 
although SNP reactivity was normal (De Tejada et al., 1989). However in experimental 
neuropathy a reduced vasoreactivity to nitric oxide has been described, with impairment 
of NOS activity and less NO production, together with an increased endothelin-1 effect 
(Kihara et al., 1995). 
The localisation of NO-synthase in the autonomic and peripheral nerves (Bredt, 
1990) suggests furthermore that synthesis of NO occurs directly in neurone. Evidence 
for neuronal production of NO has been also demonstrated in neuroblastoma cells 
(Gorsky et al., 1990) and in cerebellar cells (Garthwaite et al., 1988). Thus the 
neurogenic origin (as opposed to the endothelial origin) of NO is relevant to our 
findings: the reduction in SNP response may be related to depletion of NO as 
neurotransmitter in the perivascular nerves as a result of neuropathy. 
In a previous study the neurogenic origin of a diffusible NO-like factor which 
may act as an inhibitory neurotransmitter, was demonstrated in penile corpus 
cavernosum smooth muscle (Kim et al., 1991). A messenger similar to NO was also 
found to mediate the non-adrenergic non-cholinergic relaxation in anococcygeus muscle 
of rat and mouse (Gibson et al., 1990) and an NO-like factor was shown to be released 
by nerves in the canine ileocolonic junction (Bull et al., 1990). 
In the skin the role of NO in maintaining the basal dilator tone is recognised 
(Coffman et al., 1994), but there is also evidence that small afferent nerve fibres in the 
skin depend on NO as an essential intermediate for the amplification of the CGRP- 
mediated vasodilatation (Herbert and Holzer, 1994). 
Although the cause of the reduced response of the smooth muscle to SNP in the 
diabetic neuropathic patients is not known, it may be that neuropathy decreases the 
neurogenic production of NO or increases the production of vasoconstrictor 
neuropeptides or simply the smooth muscle is less responsive. A decreased vascular 
reactivity to the local release of neuropeptides from the peripheral nerve fibres has been 
reported previously (Boolell and Tooke, 1990). 
Reduced exposure of smooth muscle to NO of both endothelial and neurogenic 
origin might initially be expected to lead to smooth muscle up-regulation and increased 
vascular responses, which would contrast with our findings in severe neuropathic 
patients. In the early, mild stages of neuropathy denervation sensitivity and increased 
vascular responses might occur. However, in the late stages of neuropathy, smooth 
muscle dysfunction might progress to an impaired ability to react to NO donors. A 
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similar process has been described in iontophoresis studies of sudomotor responses in 
diabetic patients: in mild neuropathy there was increased sudomotor reactivity after 
iontophoresis in contrast to severe neuropathy, which was characterised by reduced 
responses (Kihara, 1993; Lang, 1995). 
In the present study, the neuropathic patients were selected by measuring the 
vibration perception threshold which assesses only large fibre damage accepted as an 
indicator of late stage neuropathy (Said et al., 1983; Guy et al., 1985). In future studies 
to elucidate the mechanisms which underlay our observations, a more detailed analysis 
of the early stages of nerve damage, characterised by small fibre and autonomic defects, 
will be needed. 
When we compared the responses to both vasodilatatory agents in the 
neuropathic group, the response to SNP was always smaller. The explanation might be 
that the SNP does not penetrate the skin in the same degree as acetylcholine. 
Another possible explanation would be that SNP has a more direct, targeted 
approach to the smooth muscle, whereas acetylcholine triggers a cascade of events 
including prostacyclin, bradykinin and NO pathways. 
The perivascular nerves, the endothelium and the smooth muscle create a 
complex system in which vasodilator agents such as prostacyclin (PG12), endothelium- 
derived hyperpolarizing factor (EDHP) and NO counteract vasoconstrictor factors such 
as endothelin, angiotensin 2, thromboxan 2 and oxygen derived free radicals. 
Furthermore, there are neurotransmitters such as noradrenaline, neuropeptide Y and 
ATP which have a relaxing and/or contracting effect on the vasculature, according to the 
type of receptors to which they bind. 
This highlights the need for further studies which ought to explore these 
different pathways using other vasodilator or vasoconstrictor neurotransmitters, in order 
to establish more precisely the site where neuropathy affects this complex system. 
Conclusion 
We have found that vascular endothelial responses are blunted in non-insulin 
dependent diabetes, while neuropathy might affect specifically the NO dependent 
smooth muscle reactivity. Future studies are needed to elucidate the underlying 
mechanisms of these observations. 
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7.9 Endothelium-dependent and endothelium-independent 
responses in non-diabetic patients with peripheral unilateral neuropathy 
7.9.1 Introduction 
The diabetic neuropathic foot suffers frequent ulceration, which is slow to heal, 
and is typically associated with abundant callus formation (Edmonds et al., 1986). 
Since neuropathic ulceration is often found in the presence of "bounding" pedal pulses, 
it has been suggested that there might be a specific diabetic "microangiopathy" which 
may be an important factor in ulceration by causing skin ischaemia (Ward, 1982). 
Peak skin blood flow in response to thermal stimuli when measured from the 
dorsum of the foot has been shown to be reduced in diabetic patients without evidence 
of neuropathy (Rayman et al., 1986). 
This has been interpreted as evidence of a diabetic microangiopathy, although 
the possibility of some degree of vascular denervation can not be excluded. Blood flow 
and its neurogenic control in the diabetic neuropathic foot is known to be abnormal: 
there is excess arteriovenous shunt flow due to a reduced sympathetic tone (Watkins 
1983; Edmonds et al, 1982; Boulton, 1982), and this flow is also controlled by local 
reflexes, whose function may be altered in diabetic neuropathy (Rayman, 1986). Indeed 
it has been suggested that Charcot arthropathy may result primarily from loss of 
vascular control which may result in exaggerated inflammatory vascular responses to 
trauma. This may result in bony reabsorption and precipitate fractures. 
Also in the previous subchapter we have demonstrated that in the presence of 
neuropathy specifically, neurovascular reactivity is decreased in response to 
iontophoresis of SNP. Thus local neurogenic control may be of primary importance in 
the development of complications of the neuropathic limb, rather than a specific 
diabetic microangiopathy. 
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7.9.2 Aim of study 
To assess the effect of nerve damage per se on vascular reactivity in non-diabetic 
patients and to ascertain whether neuropathy in the absence of diabetes, which might 
introduce a specific microangiopathy, could reproduce the skin blood flow 
abnormalities which we had previously demonstrated in the diabetic neuropathic foot. 
The microvascular reactivity to SNP and acetylcholine iontophoresis in non-diabetic 
subjects with a predominantly unilateral neuropathy and foot ulceration was assessed. 
The contralateral limb served as the control in these patients. 
7.9.3 Methods 
Neuropathy assessment 
The presence of nerve damage was assessed in both lower limbs by clinical 
examination of the ankle reflexes and foot pulses, together with recording the vibration 
sensory threshold (VPT). Thermal sensory thresholds (TPT) were also recorded with a 
Thermal tester (Somedic, Stockholm, Sweden) from the dorsum of the foot and the 
response to five warm and five cold stimuli delivered at random time intervals was 
recorded (normal range 1-5°C). 
The temperature of the skin was also measured on the dorsum of the both feet 
using the thermocouple attached to the Laser Doppler probe. 
lontophoresis and Laser Doppler flowmetry 
Iontophoresis of acetylcholine and SNP and skin blood flow measurements were 
done using a Moor Laser Doppler flowmeter and iontophoresis device (Moor 
Instruments Ltd., Axminster, UK), which were described in the previous subchapter. 
The protocol for skin blood f low measurement 
As before, the changes in skin blood flow in response to iontophoresis were 
assessed with a Moor Laser Doppler. A probe of the Laser Doppler was attached to a 
plastic chamber placed on the dorsum of the "neuropathic" foot and the other probe was 
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similarly placed on the unaffected foot which acted as a control. The dorsum of the foot 
was also chosen as the testing site in these patients as those described in the previous 
subchapter. The study conditions were similar and the iontophoresis and Laser Doppler 
techniques were used as described in the previous subchapter. 
Vasodilatatory responses were compared between `neuropathic' limbs and 
`control' limbs. One patient had undergone major amputation of the contralateral leg 
and thus it was not possible to carry out control measurements. Finally vasodilatatory 
responses from the `neuropathic' limbs were compared to those obtained from 
neuropathic patients in the previous subchapter, and respectively responses from 
'control' limbs were compared to responses from non-diabetic control subjects in the 
previous subchapter. 
7.9.4 Patients 
There were 5 patients with neuropathy due to tumour or of traumatic origin 
which induced predominantly unilateral nerve damage and foot ulceration. Their 
microvascular reactivity to iontophoresis of acetylcholine and SNP was 
assessed. 
Table 7.9.1 Clinical details of non-diabetic patients with unilateral nerve damage 
Patients Age Sex Aetiology of nerve damage (yrs. ) 
1. T. Q. 21 F tumour at L5 - Si level 
2. D. T. 27 M gun shot wound in the groin in `88 
3. A. M. 63 F hereditary sensory neuropathy 
4. P. P. 42 M gun shot wound in L leg in `75 
5. J. G. 65 M spina bifida 
The patients included in the study were free from major peripheral arterial 
disease: foot pulses were easily palpable and ankle: brachial ratios were > 1. None were 
on vasoactive drugs at the time of their assessment. None of the subjects had peripheral 
oedema. Individual neurophysiological characteristics in control limbs versus 
neuropathic limbs in non-diabetic patients are shown in Table 7.9.2 
263 
U 
c a_. o N N ý - 
00 
1 0 -4 " r i . C 4 `" 
tn z 









bo C) cl r- 00 
U 
0 In N O N Oý OR 
0 
'o $. cn 
O Ö O N 





v) ' O tq in in ýD 
M 
N w z 0 
ö 
c d p p I, - W) N in 1-4 N 




cl: Ö kn ti O - Cl ý=+ 0 
c0 M 
00 N i M M N cl-i 
U 
4Z e-, ° A 3 




1" 1 a' 'o h ý' ö 14 
ýO, 
ý O. V1 ti 
-o 
y v (U 4r -a 
Cd 
o 0 8. 
w cl 2 m 12 4. ) nn 




y .O O Q 
¢ a y x 
' (4 
:Q 







































Patient 1 (TQ) 
This 21 year old woman was diagnosed as having a yolk sac tumour of the 
pelvis at the age of six. This resulted in damage to the sacral plexus and nerve roots L4 
to S I. She developed weakness of dorsiflexion of the right toes and foot and an 
extensive sensory loss under the right foot. C. T. scan confirmed a soft tissue mass 
inferior to the coccyx extending from the sacral coccygeal junction to the ischia. 
Histology revealed an endodermal sinus tumour. Myelogram was normal. 
Chemotherapy was given, with resolution of the tumour mass, but the neurological 
deficit remained predominantly on the right limb. 
Three years subsequently, she developed a paralytic equinovarus of the right foot 
with trophic neuropathic ulceration under the 5th metatarsal head. The ulceration 
healed, but was recurrent, and required regular chiropody to remove callus tissue. Her 
random blood glucose was 5.1 mmol/L. 
Although the VPT was 40 volts in her right "neuropathic" foot, the VPT in the 
left "control" foot was also high (30 volts). However the TPTs for both hot and cold 
temperature were abnormal only in the right "neuropathic" foot. On the dorsum of the 
"neuropathic" foot the skin temperature was 32.5°C versus 33.6°C on the dorsum of the 
"control" foot. 
Patient 2 (DT) 
The neuropathy in this 27 year old man resulted from a deeply penetrating gun 
shot wound in the left groin, which resulted in damage to both the peroneal and tibial 
division of the left sciatic nerve. This resulted in weakness of both dorsiflexion and 
plantar flexion of the left foot an toes and sensory loss over the sole of the foot in the 
L5-S 1 nerve root distribution. 
The left foot became intermittently swollen over the following year, and the 2nd 
and 3rd toes became ulcerated with hyperkeratosis of the skin, and exuberant callus 
formation. The most persistent ulceration occurred however over the plantar phalangeal 
surface of the Ist toe, which has persisted for over 18 months. The random blood 
glucose was 4.9 mmol/L. 
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The VPT was increased (27 volts) only in his left "neuropathic" foot whereas his right 
"control" foot had a normal VPT (5 volts). In the "neuropathic" foot the TPT for both 
hot (15°C) and cold (15°C) temperature were abnormal. However in the "control" foot 
the TPT for hot temperature (6.3°C) and cold temperature (3.6°C) were moderately 
increased. On the dorsum of the "neuropathic" foot the skin temperature was 32.8°C 
and on the dorsum of the "control" foot, 33.7°C. 
Patient 3 (AM) 
This 63 year old lady developed a peripheral neuropathy of unknown aetiology 
30 years previously, which resulted in a distal sensory loss of light touch, temperature 
and pain sensation over the lower legs and feet. 
The plantar surface of the foot was particularly anaesthetic. This resulted 
initially in hyperkeratosis under the 1st metatarsal head of the left foot and subsequent 
ulceration which required a below knee amputation. The right foot also developed 
trophic ulceration under the 2nd to 4th metatarsal heads which necessitated a ray 
amputation of the 2nd toe. This required 6 months to heal and became recurrently 
ulcerated. This patient had a random blood glucose of 5.3 mmol/L. 
The VPT in the remaining "neuropathic" foot was 35 volts. The TPT for hot 
temperature was 15, whereas the TPT for cold temperature was 3.6, nearly normal. 
Patient 4 (PP) 
A penetrating gun shot wound in the left upper thigh in 1975, during the 
Vietnam War, was the origin of a sciatic lesion in this 42 years old Vietnamese man. He 
had also a glancing bullet wound in the right leg. This resulted in weakness of both 
dorsiflexion and plantar flexion of the left foot and toes and sensory loss over the sole 
of the foot in the L5 nerve root distribution. 
At his first appointment at the Diabetic Foot Clinic he presented with an 
ulceration of the heel and a history of foot ulceration. The random blood glucose was 
4.8 mmol/L. 
The VPT was much more raised (50 volts) in his left "neuropathic" foot than in 
his right "control" foot which had a moderately increased VPT (18 volts). Also in the 
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"neuropathic" foot the TPTs for hot(15°C) and cold (15°C) temperature were abnormal 
compared to the "control" foot where the TPT for hot temperature was moderately 
increased (5.5°C), whereas the TPT for cold temperature was normal (1.3°C). The 
"neuropathic" foot had a skin temperature of 26.7°C and the "control" foot had 28.5°C 
skin temperature. 
Patient 5 (JG) 
A lumbar myelomeningocele resulted in damage to the nerve roots L4, L5 and 
S l, innervating the right limb. This resulted in weakness of all movements of the right 
foot and an extensive sensory loss in this 65 year old man. This foot developed a talipes 
equinovarus deformity and subsequently became ulcerated on the prominent plantar 
surface of the mid foot. 
The right foot has been recurrently ulcerated over the past 15 years, and has 
required regular chiropody to remove callus tissue. The random blood glucose was 5.0 
mmol/L. VPT was 50 volts in his right "neuropathic" foot, but it was also slightly 
raised(25 volts) in his left "control" foot. However the TPTs for both hot and cold 
temperature were similar in both feet. Skin temperature on the dorsum of the 
"neuropathic" foot was 31.8°C versus 32°C on the dorsum of the "control" foot. 
All patients gave their informed consent and the protocol was approved by the 
hospital ethical committee. 
7.9.5 Results 
In this study the foot with evidence of unilateral nerve damage was considered 
the neuropathic foot, as defined by significantly higher thresholds for vibration and 
thermal sensation, whereas the other foot was considered the control foot. The skin 
temperature was not significantly different between the neuropathic and the control 
limbs (Table 7.9.3). 
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Table 7.9.3 Neuropathy details of the `control' limb versus the `neuropathic' 
limb in non-diabetic patients with unilateral nerve damage 
Control Neuropathic 
TEST foot foot 
VPT (V) 19.5 ± 5.4 40.4 ± 4.4 p<0.05 
TPT+ (°C) 4.5 ± 0.5 13.2 ± 1.7 p<0.01 
TPT- (°C) 2.8 ± 0.6 12.4 ± 2.5 p<0.005 
Skin 31.9 ± 1.2 30.9 ± 1.4 p=NS 
temperature (°C) 
Ankle Present Absent - 
reflexes 
VPT= vibration perception threshold 
TPT+ = thermal perception threshold for hot 
TPT- = thermal perception threshold for cold 
Vasodilatatory responses to acetylcholine iontophoresis 
The values of the difference between basal blood flow and peak blood flow after 
iontophoresis of acetylcholine were expressed as mean±SEM. 
Compared to the control feet, which showed an increase in the blood flow 
(21.1±6.5 LDFu), all the neuropathic feet showed a significantly reduced vasodilatatory 
response (4.0±2.9 LDFu, p<0.05) (Table 7.9.4), some of them had no response at all to 
acetylcholine iontophoresis (Figure 7.9.1). 
When the ratio of peak blood flow to basal blood flow was calculated, again the 
neuropathic feet showed a significantly reduced vasodilatation to acetylcholine (2.2±1.1 
versus 4.0±2.9, p<0.05 in controls). 
270 
Fig. 7.9.1 Vasodilatatory responses to 
ACh iontophoresis 
ö 100 in non-diabetic patients 
g with unilateral nerve damage 
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Table 7.9.4 Vasodilatatory responses to iontophoresis of acetylcholine and 
SNP in `control' limbs versus `neuropathic' limbs in non-diabetic patients 
Acetylcholine Sodium nitroprusside 
LDFu Ratio LDFu Ratio 
Control limbs 21.1±6.5 3.7±1.5 51.0±21.1 7.4±5.6 
Neuropathic limbs 4.0±2.9 2.2±1.1 32.6±21.0 5.0±2.1 
(p<0.05) (p<0.01) (p=NS) (p=NS) 
Mean±SEM LDFu = Laser Doppler Flow units 
Vasodilatatory responses to SNP iontophoresis 
The blood flow increase in response to the iontophoresis of SNP was calculated 
in the two groups (Table 7.9.4). Compared to control feet which showed a good 
vasodilatatory response (51.0±21.1 LDFu), in the neuropathic feet a reduction in 
vasodilatation was noted (32.6±21.0 LDFu). However one patient (PL) exhibited a 
massive response to SNP (124.2 LDFu) in the neuropathic foot, even higher than the 
range (7-100 LDFu) of the control foot responses (Figure 7.9.2) 
When the ratio between the peak blood flow after iontophoresis and the basal 
blood flow before iontophoresis was calculated in the 5 patients, a reduced 
vasodilatation was found in 4 out of 5 patients in the neuropathic foot . However the 
difference between the control (7.4±5.6) and the neuropathic (5.0±2.1) groups did not 
reach statistical significance (Table 7.9.4) because of the excessive vasodilatation 
(ratio=30) demonstrated by one patient (PL) in the neuropathic foot. 
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Fig. 7.9.2 Vasodilatatory responses to : iontophoresis 
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7.9.6 Comparisons with results from previous subchapter 
Comparison of vasodilatatory responses to acetylcholine iontophoresis 
"Control" limbs versus non-diabetic controls 
When comparing the vasodilator response to acetylcholine iontophoresis, the 
"control" limbs (21.1±6.5 LDFu; ratio=3.7±1.5) had a smaller response (Table 7.9.5) 
than the non-diabetic controls (109.7±18.9 LDFu; ratio=10.9±1.8) from the previous 
subchapter. 
"Neuropathic" limbs versus diabetic patients with neuropathy 
The response of the "neuropathic" limbs (4.0±2.9LDFu; ratio=2.2±1.1) to acetylcholine 
iontophoresis was even more decreased (Table 7.9.5) than the vasodilatatory response 
of the diabetic patients with neuropathy (29.6±9.8LDFu; ratio=4.1±0.7). 
Comparison of vasodilatatory responses to SNP iontophoresis 
"Control" limbs versus non-diabetic controls 
The vasodilator reactivity to SNP was slightly reduced in the "control" limbs 
(51.0±21.1 LDFu; ratio=7.4±5.6) versus the non-diabetic controls (68.1±8.7 LDFu; 
ratio=8.5±1.6) from the previous subchapter. (Table 7.9.5). 
"Neuropathic" limbs versus diabetic patients with neuropathy 
However because of one patient `s (PL) massive vasodilatation to SNP, the 
"neuropathic" limbs response (32.6±21. OLDFu; ratio= 5.0±2.1) was actually higher (Tb 
7.9.5) than the reactivity of diabetic patients with neuropathy (15.5±6.8LDFu; 
ratio=2.8±0.7) from the previous subchapter. 
277 
Table 7.9.5 Comparisons of vasodilatatory responses to acetylcholine and sodium 
nitroprusside iontophoresis in neuropathic diabetic patients versus `neuropathic' limbs 
in non-diabetic patients with peripheral unilateral neuropathy and 
control subjects versus `control' limbs in non-diabetic patients with peripheral unilateral 
neuropathy 
Acetylcholine Sodium nitroprusside 
LDFu Ratio LDFu Ratio 
Control subjects 109.7±18.9 10.9±1.8 68.1±8.7 8.5±1.6 
Control limbs 21.1±6.5 3.7±1.5 51.0±21.1 7.4±5.6 
Neuropathic patients (n=10) 29.6±9.8 4.1±0.7 15.5±6.8 2.8±0.7 
(p<0.01) (p<0.01) (p<0.01) (p<0.01) 
Neuropathic limbs 4.0±2.9 2.2±1.1 32.6±21.0 5.0±2.1 





In the previous chapter it has been reported that diabetic patients with 
neuropathy have a reduction in their vasodilatation to acetylcholine and specifically to 
SNP. This decrease in response was also found in 4 out of 5 patients with unilateral 
neuropathy we studied. However one patient developed a massive response to SNP 
iontophoresis in the predominantly neuropathic foot. It is difficult to explain it although 
it may be related to denervation hypersensitivity. 
Since perivascular nerves are separated from endothelial cells by vascular 
smooth muscle, it is possible that there are functional and trophic interactions between 
the perivascular nerves, smooth muscle and endothelial cells. Close apposition of 
perivascular nerves varicosities to the endothelium has been demonstrated. Furthermore 
it has been strongly suggested that neuropeptides play a role in neurochemical control of 
vascular reactivity and in cell differentiation, proliferation, hypertrophy and 
regeneration (Burnstock, 1993). 
Studies regarding the neurotransmitters involved in the dynamics of the 
vasculature have clearly proven the role of NO released from the vasodilator nerves in 
producing arterial smooth muscle vasodilatation (Toda et al., 1993). Furthermore an 
ultrastructural study has demonstrated the presence of NOS in both the axons and the 
endothelial cells throughout the cell cytoplasm and in association with membranes of 
mitochondria, endoplasmic reticulum and cytoplasmic/synaptic vesicles suggesting that 
both perivascular nerves and endothelial cells may be involved in vasomotor control of 
microcirculation (Loesch et al., 1994). 
Reduced exposure of smooth muscle to NO of both endothelial and neurogenic 
origin might initially be expected to lead to smooth muscle up-regulation and increased 
vascular responses, which would contrast with our findings in severe neuropathic 
patients. Although a study looking at the effect of denervation on bronchial smooth 
muscle has also found that denervation reduced smooth muscle ability to contract 
(McLarty et al., 1993). However in the early, mild stages of neuropathy denervation 
sensitivity and increased vascular responses might occur. In contrast, in the late stages 
of neuropathy, smooth muscle dysfunction might progress to an impaired ability to react 
to NO donors. A similar process has been described in iontophoresis studies of 
sudomotor responses in diabetic patients: in mild neuropathy there was increased 
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sudomotor reactivity after iontophoresis in contrast to severe neuropathy, which was 
characterised by reduced responses (Kihara et a1., 1993). Furthermore another study 
which induced autonomic neuropathy in the rat perivascular nerves, found a graded 
destruction of nerve types: CGRP-immunoreactive nerves greater than 
NA(noradrenaline)-immunoreactive nerves greater than substance P-imunoreactive 
nerves suggestive of a differential sensitivity of different nerve types (Ralevic et al., 
1991). 
The importance of the perivascular innervation in lesions of the arterial wall is 
highlighted by an ultrastructural study showing that in regions of the carotid artery 
where intimal thickening occurred there was an associated degeneration of the 
perivascular nerve network (Scott et al., 1992). It is recognised that sympathetic nerves 
can also exert atrophic influence (Bevan et at., 1979) on the structure and function of 
the smooth muscle (Scott et at., 1995). Furthermore the presence of sympathetic nerve 
fibres in association with single isolated smooth muscle cells appears to prevent their 
phenotypic modulation to a synthetic state: this trophic influence was demonstrated to 
be dependent upon a substance present within the nerve. (Chamley et al., 1976). 
However the role of both the sympathetic and peptidergic perivascular nerves networks 
in modulating the function, the structure and the proliferative behaviour of vascular 
smooth muscle cells remains to be clarified. 
In the present study, the non-diabetic patients have also had a reduced vascular 
reactivity to acetylcholine on their "neuropathic" limb, suggestive of a co-existing 
endothelial defect. This was shown in the previous subchapter to be present in all the 
diabetic patients with and without neuropathy. Then it was considered to be associated 
with the metabolic effects and the abnormal oxidative stress induced by diabetes per se, 
demonstrated as well by animal and in vivo studies (Pieper et al., 1993; Bucala et al., 
1991). 
In non-diabetic patients with predominantly unilateral nerve damage, a reduced 
response to acetylcholine may be related to a direct impairment of the endothelial 
function associated with neuropathy or may be secondary to a defect introduced by 
neuropathy at smooth muscle level. 
In an animal study, endothelium-dependent relaxant responses to acetylcholine 
and substance P were found to be attenuated in the central ear artery of the rabbit with 
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acrylamide-induced neuropathy, raising also the possibility of the endothelial cell 
damage as a primary effect or more likely as a secondary consequence of smooth 
muscle defect associated to perivascular nerve damage (Maynard et al., 1991). After 
experimental sympathetic and sensory denervation of the rabbit ear artery, endothelium- 
dependent relaxation responses to methacholine were significantly depressed. However 
the reduction in response was not found to be related to an impairment of smooth 
muscle function (Burnstock, 1993) suggesting that the nerve defect can influence 
directly the function of the endothelium . 
The reduction in the endothelium-dependent vasodilatation to acetylcholine in 
the present study, could be interpreted as secondary to a defective, non-responsive 
smooth muscle (where the abnormality introduced by neuropathy might have a specific 
effect), which does not react adequately to the signals transmitted by the endothelium 
when triggered with acetylcholine. 
To support this hypothesis, there are studies showing that endothelial cells 
themselves are producing vasodilator neuropeptides (SP, ACh, Ag2, histamine and 
ATP) independent of their perivascular innervation (Parnavelas et at., 1985) and 
furthermore denervation of the hindlimb vasculature of SP-containing nerves by 
capsaicin has been shown not to have effect on endothelial release of SP (Burnstock 
and Ralevic, 1994). Consequently it could be argued that the reduction in the 
endothelium-dependent vasodilatation is unlikely to be a direct consequence of 
neuropathy, but it is more likely a defective smooth muscle response to vasodilators of 
both endothelial or exogenous origin. 
Therefore it seems that neuropathy has an effect on the endothelial function; 
whether this effect is primary or secondary to the smooth muscle defect has not yet been 
established and needs further investigation. 
However it is interesting to point out that in the previous subchapter, the 
diabetic neuropathic group had the smallest (some patients had completely flat traces) 
range of response to acetylcholine when compared to all the other diabetic groups. In 
the view of the present study, this may be interpreted as an additive effect introduced by 
neuropathy to the effect introduced by diabetes on the endothelial function. 
In conclusion, the patients with predominantly unilateral nerve damage 
demonstrated a neuropathy which was similar to that seen in diabetic patients, with 
damage to large and small fibre function, which resulted in an insensitive foot. They 
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developed neuropathic ulceration over the sites of high pressure, which proved very 
slow to heal and became recurrent. The ulceration itself exhibited abundant callus 
formation which needed to be regularly removed, a feature common in the diabetic 
neuropathic foot ulcer, and the neuropathic limb was more pigmented than the 
contralateral side. Paradoxically there was a trend to lower skin temperature on the 
dorsum of the foot in the "neuropathic" limb although not statistically significant. This 
raised the question of a decrease in skin blood flow on the dorsum of the foot due to 
blood being diverted through the arteriovenous anastomoses with a consequent "steal" 
effect, although previous studies have not confirmed this hypothesis (Flynn et al., 
1988), or due to the presence of abnormal vascular reactivity as suggested by the present 
study. Although higher than in the "neuropathic" limb, the range of responses to 
acetylcholine and SNP in the "control" limbs of non-diabetic patients with 
predominantly unilateral nerve damage has been found to be smaller than the range of 
vasodilatatory responses in the non-diabetic controls from the previous subchapter. This 
might be related to the fact that the so-called "control" limbs had also a degree of 
neuropathy depending on the level of the nerve damage origin. 
With the limitation that the nerve damage is very seldom purely unilateral, these 
"traumatic" neuropathy patients made an acceptable model for measuring the skin blood 
flow responses in a neuropathic limb (free from a diabetic "microangiopathy") which 
suffered recurrent ulceration, thus allowing a parallel to be made with the ulcerated 
neuropathic foot. 
In the present study the very abnormal vascular responses found in the 
predominantly unilateral neuropathic foot seem to mirror the results of the previous 
subchapter which showed a reduced smooth muscle reactivity to be associated with 
diabetic neuropathy. 
Conclusion 
The abnormal vascular responses seen in the diabetic neuropathic foot, 
specifically the abnormal vasodilatation to SNP and hence a 'defective smooth muscle 
function, may be reproduced by a peripheral neuropathy alone. Furthermore the nerve 
damage is likely to have an additive effect on the endothelial dysfunction induced by 
diabetes. The extent to which vascular denervation may precipitate complications of the 
neuropathic limb, now needs further investigation. 
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Chapter 8. GENERAL DISCUSSIONS 
8.1 Summary of discussions 
The pathogenesis of plantar ulceration is not fully understood in the diabetic foot 
of either neuropathic or neuro-ischaemic origin. A multitude of factors have been 
implicated in the mechanism of ulcer formation, such as peripheral neuropathy leading 
to an insensitive foot prone to trauma, peripheral vascular disease and soft tissue 
abnormalities such as limited joint mobility and increased callus formation, itself 
leading to high foot pressures. The neuropathic foot has been studied extensively with 
regard to these factors, whereas such data is not available for the neuro-ischaemic foot. 
The main purpose of this thesis was to research the fundamental mechanisms of plantar 
ulcer formation by comparing the foot pressures measured in neuropathic patients to 
those in neuro-ischaemic patients. 
Neuropathic patients, who ulcerate predominantly on the plantar surface, have 
raised plantar pressures in the presence of callus which is a factor considered to play a 
role in increasing further the pressures. These elevated levels of pressure may lead to 
micro-damage of the foot soft tissues and the process of soft tissue repair requires intact 
neuro-vascular responses of the microcirculation. Although it is accepted that the 
neuropathic foot is characterised by hyperperfusion due to arterio-venous shunts in the 
presence of diabetic peripheral neuropathy, the research presented in the thesis has also 
shown that in the skin of the neuropathic foot the vascular reactivity is impaired due to 
abnormalities of the microcirculation, both at the endothelial and smooth muscle level. 
In comparison to the neuropathic foot, the findings of the thesis have shown that 
the neuro-ischaemic foot, which tends not to ulcerate on the plantar surface, but 
predominantly on the margins of the foot, has plantar pressures similar to, if not higher 
than the neuropathic foot. Furthermore callus has been shown to be a feature of the 
neuropathic foot, but it is known to be uncharacteristic of the neuro-ischaemic foot 
(Foster et al., 1997). 
As the foot ulcers occur at the shoe-foot interface, the research carried out in the 
thesis has developed a methodology of in-shoe pressures measurement for clinical use. 
The establishment of this methodology has also enabled supportive studies to be carried 
out monitoring therapeutic and preventative methods employed to reduce high foot 
pressures, such as callus removal and prescription shoewear. These studies can also 
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provide some information regarding the rate of callus formation. Likewise the 
assessment of prescription shoewear efficacy in pressure reduction has supported the 
need for objective measurement of foot pressures. 
The results of the thesis support the multifactorial theory of pathogenesis of 
neuropathic foot ulceration, showing that high foot pressures, peripheral neuropathy, 
abnormal microvascular reactivity, callus formation and unsuitable footwear are 
important risk factors which need to act concomitantly or in addition to each other in 
order to lead to ulceration. In the neuro-ischaemic foot, the absence of one of these 
factors, such as callus or the presence of another factor, such as poor blood supply 
characteristic for the ischaemic patients, can paradoxically `protect' from ulceration on 
the plantar surface. 
8.1.1 Foot pressure measurement in neuropathic and neuro-ischaemic feet 
Neuropathic ulceration has been studied extensively and plantar pressures have 
been found to play an important role in its multifactorial aetiology. In diabetic neuro- 
ischaemic patients, who also have a high risk of ulceration, firstly, because of their 
peripheral vascular disease and secondly, because most of them have an underlying 
degree of neuropathy, there have been no similar studies assessing the foot pressures. To 
the best of our knowledge, this thesis contains the first study measuring plantar 
pressures in neuro-ischaemic patients. 
In neuropathic patients the majority of foot ulcers develop on the plantar surface 
under areas of high pressure, such as bony deformity or metatarsal heads. 
Neuro-ischaemic patients tend not to develop ulcers on the plantar surface but 
more on the sides of the foot or on the upper margin or in between the toes. In the 
present study, although the neuro-ischaemic patients did not have a history of plantar 
ulceration, their vertical plantar pressures were consistently high, even higher than the 
neuropathic patients who tend to develop ulcers underneath the foot. The neuro- 
ischaemic patients taken into the study had also a similar degree of neuropathy to the 
neuropathic patients; their vibration perception threshold was above 25Volts, which is 
considered to be the threshold of risk for ulceration. However this was not associated 
with plantar ulceration, indicating different mechanisms of ulcer formation between 
ischaemic and neuropathic diabetic patients. 
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The neuro-ischaemic patients had a pattern of pressure loading suggestive of a 
constant, normal gait. This pattern of gait was similar to the diabetic controls and non- 
diabetic controls, but the latter had lower foot pressures. However the neuropathic 
patients, who, had also high pressures, showed a pressure loading pattern suggestive of a 
variable gait. 
It is possible that the same mechanism of ulcer formation does take place in both 
the neuropathic and neuro-ischaemic foot, but ulcers do not occur in the absence of 
certain factors associated with ulceration, such as a variable pressure loading pattern or 
callus, which has been noted to be frequently found in the areas of high pressure of the 
neuropathic foot, but it is less prominent, if not absent in the neuro- ischaemic foot. 
Therefore the absence of these factors in the ischaemic foot may have protective effects. 
The limitations of this study are that these were measurements of vertical forces 
only, but the shear stresses have not been assessed in either neuropathic or neuro- 
ischaemic foot due to the absence of a clinically available shear transducer. Shear forces 
developed at the shoe-foot interface, in the absence of reliable evidence, have been 
implicated in the aetiology of foot ulceration in neuro-ischaemic patients. 
Another essential factor in the pathogenesis of foot ulceration, which may be 
possibly reduced in the neuro-ischaemic foot, is the level of activity. - Neuro-ischaemic 
patients may claudicate and simply walk less in comparison to the neuropathic patients 
with insensitive feet. 
8.1.2 Microcirculation neuro-vascular reactivity in the neuropathic foot 
Plantar pressures act on the underlying soft tissues of the foot interacting with 
their properties in the mechanism of ulcer formation. It is already accepted that soft 
tissue abnormalities, such as limited joint mobility can be related to microcirculatory 
defects. The mechanisms involved in repair of micro-damage of the soft tissue also 
require intact neuro-vascular reflexes. In this thesis it was attempted to elucidate another 
possible factor implicated in the foot ulceration pathogenesis, the neuro-vascular 
reactivity of the skin microcirculation. Microcirculatory abnormalities have been studied 
with particular regard to neuropathy, whether or not diabetic. 
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In this thesis the initial study of skin neuro-vascular reactivity has shown that 
endothelium-dependent vasodilatation induced by acetylcholine in the foot was impaired 
in all the patients with diabetes mellitus, whereas the smooth muscle response to sodium 
nitroprusside was severely blunted only in patients with diabetic neuropathy. This was 
true for both the difference and the ratio of peak to basal blood flow. A second study, 
this time carried out in neuropathic patients with a history of ulceration but without 
diabetes, has shown that the abnormal vascular responses seen in the diabetic 
neuropathic foot, specifically the abnormal vasodilatation to SNP and hence a defective 
smooth muscle function, may be reproduced by a peripheral neuropäthy alone. The 
nerve damage is likely to have an additive effect on the endothelial dysfunction already 
induced by diabetes. Recently Veves et al. (1998) have reported work which suggests 
that further reduced responses are found in neuro-ischaemic patients when compared to 
neuropathic patients. The extent to which vascular denervation may precipitate 
complications of the neuropathic limb however needs further investigation. 
8.1.3 Effect of callus formation and removal on plantar pressures 
In the neuropathic foot, callus has been shown to act as a foreign body and to 
increase further the plantar pressures. The neuropathic feet with a good blood supply 
develop `hot' spots and callus build-up in response to continuous repetitive pressure. The 
neuro-ischaemic feet do not build-up so much callus, possibly because of the poor blood 
supply. Therefore the findings of high pressure in neuro-ischaemic patients seem not to be 
related to the callus formation, but they may be possibly related to an atrophic soft tissue 
with altered cushioning properties. 
In this thesis the effect of callus removal in reducing plantar pressures in the 
neuropathic foot has been assessed and then for the first time, to our best knowledge, 
the rate of callus formation has been followed-up in relation to the increase in plantar 
pressures in a pilot study. 
Callus removal lead to a significant reduction in plantar pressures of 32% in 
patients at their first ever visit to chiropodist, of 30% in-patients requiring regular 
chiropody at 6-8 weeks time interval and of 31 % in those coming more frequently at 3-4 
weeks interval. The results obtained suggest either that the chiropodial technique of 
callus removal has a similar effect on plantar pressures at different time-intervals, being 
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able to reduce the pressures overall with approximately 30%, or that the rate of callus 
formation tends to reach a plateau after an initial period of pressure elevation. 
These findings have shown that the F-Scan methodology can provide the facility 
to follow-up the callus formation until it reaches the upper limits of acceptable pressure 
and requires removal. This might prove of benefit for reducing the costs of foot care by 
reducing the frequency of chiropodial treatment and making it more cost-effective. 
8.1.4 Effect of prescription shoewear on plantar pressures 
Whereas callus removal is a short term measure of foot pressure reduction, a 
method for a long term reduction of foot pressures has been also assessed in this thesis, 
a new type of insert for prescription shoewear, the custom-moulded EVA insert. 
The F-Scan technology has allowed the assessment of custom-moulded EVA 
insert fitted in bespoke shoes. This study has shown that made-to-measure prescription 
shoes fitted with custom-moulded EVA inserts, were found to be the most efficient in 
reducing high plantar pressures developed in the neuropathic foot with a history of 
ulceration. EVA inserts in bespoke shoes proved to be better than High Street shoes and 
also better than trainers. When the plantar pressures were measured initially in newly 
fitted prescription shoes with custom-moulded EVA inserts and then the measurement 
was repeated a few weeks later, the latter showed even lower pressures than the initial 
one suggesting a continuation of the moulding process with wearing. Furthermore when 
new and previously issued prescription shoes, which have been worn for a longer period 
of time, were compared, the latter also showed lower pressures leading to the clinical 
recommendation that our new prescription shoes with custom-moulded EVA inserts 
should be `broken in' gradually. 
The greatest percentage fall in pressure with prescription shoes with custom- 
moulded EVA inserts was found in the patients with the highest plantar pressures, 
suggesting that they benefit the most from this footwear. As high plantar pressures are 
recognised to be an important aetiological factor in foot ulcer formation it may be of 
benefit to set up a screening programme for high foot pressures in the diabetic 
population. Then in order to prevent ulceration, prescription footwear would be 
recommended for those diabetic patients detected to have high foot pressures, even in 
the absence of a history of ulceration, particularly for pure neuropathic patients. 
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Although trainers were found to induce a smaller reduction in pressure than 
bespoke shoes with custom-moulded EVA inserts, trainers can provide a useful and 
educative alternative to High Street shoes. Furthermore trainers proved to have a 
comparable effect, if not a beneficial effect over stock shoes fitted with flat Poron 
inserts. This highlights the potential role which trainers may have in prevention of 
ulceration in the early stages of the foot at risk, when is not deformed and has good 
proprioceptive sensation. Trainers also have the advantage of being generally less 
expensive than the stock prescription shoes. They are also easily accessible and a high 
specification pair of trainers is often more cosmetically acceptable. At this stage the 
protection can be achieved without the expenses implied by individually designed 
inserts and bespoke shoes such as our prescription shoes with custom-moulded inserts. 
They are nevertheless vital for patients with recurrent ulceration and feet at risk, who 
need an individualised choice of cushioning materials and insert design. 
This study has confirmed the feasibility of quantitative assessment of foot 
pressure changes with different types of footwear on a cross-sectional basis. These 
findings stress the usefulness of modem techniques, such as F-Scan, as a visual and 
quantitative aide in footwear assessment, to be used for the design of moulded and 
orthopaedic shoes. These techniques should now be used to address the problems of 
design and manufacture of inserts and prescription shoes for the diabetic foot. 
8.1.5 Development of the F-Scan methodology for dynamic 
foot pressure measurement 
Crucial to this thesis it has been the development of in-shoe dynamic foot 
pressure measurement. A methodology for measuring in-shoe foot pressures, which is 
feasible and adequately reproducible has been developed in this thesis. The two most 
commonly used methods for in-shoe foot pressure measurement, F-Scan and EMED 
have both strengths and weaknesses: F-Scan has a better spatial resolution in 
comparison to EMED, which is more reproducible. With the F-Scan, problems were 
experienced due to changes in sensitivity leading to a great variability of measurement. 
Therefore a study was set-up to test the time-dependent behaviour of the F-Scan sensor 
when a cyclical load was applied with an Instron machine. These trials showed an 
increase in sensitivity of this FSR insole transducer during loading. The rapid element, 
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demanded the insole to be conditioned by at least 60 seconds of loading prior to 
calibration, and that a trial walk be undertaken within a few seconds thereafter. Because 
of a creep-like element of the response, sensitivity continued to change slowly over 
several minutes even after the initial rapid rise is finished. This necessitates calibration 
at frequent intervals. 
In this thesis it was the aim to achieve acceptable reproducibility necessary for 
the study of foot pressures in clinical practice. Therefore a methodology has been 
developed which takes into account the technical features of the F-Scan equipment in 
correlation with the clinical conditions in which the tests are performed and the 
subsequent recommendations for a recording technique have been established: 
Recommended recording technique 
If a new insole is used, the patient (wearing standard shoes and socks) is asked to 
walk normally on a flat, even surface for 2 minutes in order to reach a suitable level of 
"bedding-in"/ sensitivity. If an insole had been used previously, the patient is asked to 
walk only for 1 minute in order to acclimatise the insole to the in-shoe conditions and 
the patient's foot temperature is stabilised to the room temperature. Then the insole is 
calibrated against each individual body weight and then the initial run done 
immediately. Calibration again at the end of the F-Scan test is recommended to check 
for major artefacts in insole sensitivity. 
It is recommended that an F-Scan test consists of 3 runs. The initial run is a 
learning one. The next two runs are recorded, i. e. one and a `back-up'. It is advisable not 
to record consecutively more than 3 runs in a patient. 
However it is not recommended to use an insole for more than 20 runs in total 
and if tracks are missing persistently on the screen. It would be advisable to keep one 
insole per patient especially if longitudinal studies are to be done. 
In the analysis of pressure, the second step of the second run or the mean of all 
the steps in a run is advisable in order to standardise the assessment of peak pressures. 
The coefficients of variation were calculated when using this technique of foot 
pressure measurements in non-diabetic controls (10.3%) and diabetic neuropathic 
patients (18.9%). These agree with other methods of foot pressure measurement 
variability suggesting that the F-SCAN offers an acceptable reproducibility in assessing 
the foot pressures during gait. 
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8.2 Rationale for future studies 
Foot pressure measured by analysis of in-shoe dynamic peak pressure using the 
F-SCAN is now suitable for clinical use and should enable further exploration of the 
causative factors of foot problems, notably those of diabetic ulceration, in realistic shod 
conditions. 
Thus this methodology could now be used in future studies for detection of a in- 
shoe foot pressure threshold for ulceration. As high plantar pressures are recognised to 
be an important aetiological factor in foot ulcer formation it may be of benefit to set up a 
screening programme for high foot pressures in the diabetic population. This could be 
part of a wider screening programme for foot ulcer assessing other risk factors involved 
in the multifactorial aetiology of ulceration: peripheral neuropathy, micro- and macro- 
vascular disease and other factors such as limited joint mobility, foot deformity, level of 
activity and type of footwear. 
The findings of the research presented in this thesis have also shown that 
patients with the highest plantar pressures had the greatest percentage fall in pressure 
when wearing prescription shoes, suggesting that they benefit the most from prescription 
footwear. Then in order to prevent ulceration, prescription footwear with fitted inserts 
would be recommended for those diabetic patients detected at screening to have high 
foot pressures, even in the absence of a history of ulceration. Prescription footwear with 
custom-moulded inserts proves to be the most efficient in reducing plantar pressures, 
but is costly. Therefore new technologies such as CADCAM technique need to be 
developed in order to produce this footwear rapidly, reliably and at a moderate cost. 
The research presented in this thesis also highlights the need for longitudinal 
studies to assess the characteristics of prescription footwear and to correlate these with 
recurrence of ulceration. The life-time of an insert fitted in prescription shoes is not 
known and longitudinal studies to define physical and clinical end-points are needed. 
They could be carried out with the F-Scan technology. The definition of the end-points 
has to be based on quantitative assessment of the ability of the insole to maintain the 
redistribution of pressure as well as its usefulness in preventing the recurrence of foot 
ulcer. It is not known for how long an insole should be used. Whether replacement 
should depend on simple assessment of its physical state or be related to more scientific 
pressure measurements to assess its capability to reduce peak pressures and maintain 
them at a safe level to prevent recurrence of ulceration remains to be studied. 
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The findings of the study presented in Chapter 6 put into question both the 
principles and practice of prescribing therapeutic inserts and indicates that considerable 
value might come from the dynamic measurement of foot pressures inside both 
prescription footwear and High Street shoes. It is advisable that shoes should be 
prescribed and fitted in centres which use this equipment to achieve the optimal 
outcome. This study has also indicated that in certain circumstances there is an increase 
in foot pressures in patients going from their own shoes to trainers or Poron insoles. 
Therefore, there is a need for immediate `on the spot' pressure assessment of the effect 
of recommended footwear, particularly of stock orthopaedic shoes and insoles in 
comparison with their own footwear. This stresses the importance of a Shoe Clinic 
within the Diabetic Foot Centre, which would also be able to develop and produce 
guidelines to be used in other centres not having the use of pressure measurement 
equipment. 
There has been no previous studies examining the value of certain High-Street 
shoes and this study has proven that sometimes trainers could be more efficient than 
certain types of supplied footwear. Therefore there is a need for systematic assessment 
of High Street shoes and their inserts. There is an array of shoes and inserts available to 
patients and very little is known of their properties and their ability to redistribute 
pressure although is has been documented that poor footwear is responsible for foot 
ulceration (Edmonds, 1986). Some of these inserts may be found to be efficient in 
redistributing pressures and this information needs to be confirmed with diabetic 
patients. 
Thus the methods described allow investigations of the prescription footwear 
and High-Street shoes. This will help to improve the advice given to patients about 
shoes and footwear, which at present is lacking detail of information. 
Although the in-shoe measurement of foot pressures needs to be included in a 
screening programme for foot ulceration, other factors involved in its pathogenesis still 
ought to be considered in order to have a predictive and preventative tool. There is a 
need for development of technologies assessing other factors involved in the mechanism 
of ulcer formation, such as shear forces, and for further studies to measure the shear 
forces inside the shoe, with special emphasis in the neuro-ischaemic patients who 
possibly are the most vulnerable to shear stress. 
The pathogenesis of the neuro-ischaemic ulcer has been studied critically in this 
thesis: elevated plantar pressures have been found, but in the absence of callus 
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formation and plantar ulceration, with a trend to ulcer formation on the margins of the 
foot. The whole issue of ulceration in neuro-ischaemic patients raises new question for 
future research as regards the time characterisation of pressures distribution inside the 
shoe, the size and role of shear stresses in foot ulceration, and the role of soft tissue 
characteristics in the aetiology of diabetic foot ulcer. 
A soft tissue abnormality playing a role in ulceration is callus formation 
associated in neuropathic patients with increased plantar pressures. Using the F-Scan 
technology, longitudinal studies of plantar pressure in correlation with chiropodial 
follow-up are needed now in a larger number of patients. The measurement of foot 
pressures before and after chiropody may prove to be a useful `on the spot' assessment 
of the efficacy of the callus removal. Longitudinal studies as demonstrated by diagrams 
drawn for our follow-up case studies (Chapter 5) could be included in the notes of the 
patients coming to the Diabetic Foot Clinic in order to provide the necessary 
documentation regarding the change in plantar pressure before and after chiropody at 
each visit. These observations of plantar pressures are of interest, but further close 
follow-up of a larger number of patients is required. Weekly measurement of plantar 
pressures is needed to assess the rate of callus formation and to define, on a larger 
number of patients, the threshold of pressure for removal of callus and also to evaluate 
alternatives to debridement e. g. use of emollients in order to keep the diabetic foot free 
from ulceration. 
Clinical ulceration and soft tissue necrosis is ultimately due to microcirculatory 
failure in a background of neuropathy together with macrovascular disease in certain 
cases. The perivascular nerves, the endothelium and the smooth muscle create a 
complex system in which neuro-vascular abnormalities can have an effect on the tissue 
repair process. The findings presented in the Chapter 7 indicated that vascular 
endothelial responses are blunted in diabetes, while neuropathy might affect specifically 
the NO dependent smooth muscle reactivity. These results highlight the need for further 
studies to explore these different pathways using other vasodilator or vasoconstrictor 
neurotransmitters, in order to establish more precisely the site where neuropathy affects 
this complex system. Also these future studies are needed to elucidate the underlying 
mechanisms of these observations and their relationship with the susceptibility to foot 
ulceration. 
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8.3 Main conclusions 
This thesis has made novel observations in both the neuropathic and neuro- 
ischaemic foot. 
In conclusion, this thesis has shown for the first time that the neuro-ischaemic 
patients had higher plantar pressures than the neuropathic patients, and also higher than 
diabetic control subjects and non-diabetic control subjects. This is of interest, knowing 
that the neuro-ischaemic foot is not characterised by excessive callus formation or by 
plantar ulceration in contrast to the neuropathic foot. 
However the pattern of pressure loading in neuro-ischaemic patients was similar 
to the pattern of pressure loading of the controls groups, whereas the neuropathic 
patients demonstrated a variable pattern of pressure loading suggestive of a variable 
gait. These comparative observations may have relevance to the mechanism of 
ulceration in the diabetic (neuro-ischaemic and neuropathic) foot. 
These findings support the multifactorial theory of foot ulceration. Furthermore 
this thesis has highlighted two other potential factors, the endothelial and smooth 
muscle of the skin microcirculation, whose function is decreased in patients with 
neuropathy and a history of ulceration. When assessing the neuro-vascular reactivity of 
the skin of the foot, the endothelial and smooth muscle function were found to be both 
reduced in diabetic neuropathic patients, as well as in neuropathic patients without 
diabetes, but also with a history of foot ulceration, suggesting that neuropathy seems to 
be associated to microcirculatory defects, which may decrease the ability of the soft 
tissue of the foot to defend itself against the noxious stimuli, such as trauma or high foot 
pressures. 
The role of increased foot pressures in the aetiology of ulceration has been 
extensively assessed by firstly developing and validating a methodology for 
measurement of in-shoe foot pressures, which achieved acceptable reproducibility. Foot 
pressure measured by analysis of in-shoe dynamic peak pressure using the F-SCAN is 
now feasible and adequately reproducible and should enable further exploration of the 




The established F-Scan method has been used to assess the effect of different 
methods used to reduce the plantar pressures. Callus removal and prescription shoewear, 
two measures used in the Diabetic Foot Clinic for the treatment and prevention of foot 
ulceration, have been evaluated regarding their effect on foot pressures. 
This thesis has shown that chiropody is an essential therapeutic tool, callus 
removal leading to a significant reduction in plantar pressures. However independent of 
the time interval between treatments and the rate of callus formation, the actual 
chiropodial technique of callus removal has an overall decreasing effect on the plantar 
pressures around 30%. The rate of callus formation varies in different individuals 
probably related with their level of activity and mobility. By assessing the effect of 
chiropodial treatment on foot pressures further information was obtained regarding a 
factor involved in the mechanism of ulceration, namely on callus and its rate of 
formation. The research presented in the thesis has demonstrated the measurement of 
plantar pressures to be a functional and objective indicator valuable in the assessment of 
chiropodial treatment. 
This thesis has also assessed measures used in the prevention of foot ulceration, 
such as prescription footwear, by comparing the effect of different types of footwear on 
foot pressures. Made-to-measure prescription shoes fitted with a new type of insert, 
custom-moulded EVA insert, which are usually prescribed to prevent recurrence of foot 
ulceration in both neuropathic and neuro-ischaemic patients, have been the most 
efficient in reducing high plantar pressures. They proved to be better than High Street 
shoes and also better than trainers. However when newly fitted prescription shoes with 
custom-moulded EVA inserts were assessed on follow-up, even lower pressures were 
found than at the baseline, suggesting a continuation of the moulding process with 
wearing. 
Therefore these findings of the thesis suggest that measures employed in the 
prevention of foot ulceration, such as prescription footwear need to be assessed and 
developed by using objective measurements, such as dynamic foot pressure 
measurement inside the shoe. 
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